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Abstract 
 
Clustered regularly interspaced short palindromic repeats (CRISPRs) and associated 
(Cas) proteins form the basis of a prokaryotic adaptive immune system.  Acquired 
sections of viral DNA are stored within the host genome as ‘spacers’ flanked by 
‘repeat’ sequences.  The CRISPR arrays are transcribed and processed to release 
mature CRISPR RNAs (crRNAs) – containing an single, intact spacer sequence – 
that are used by effector complexes to base-pair with matching hostile genetic 
elements and silence future infections.  crRNA-biogenesis is thus an essential step 
within the defence pathway.  Within Type I and III systems, the primary processing of 
the CRISPR transcript at repeat sites is performed almost exclusively by the 
CRISPR-specific riboendonuclease, Cas6. 
 
This thesis seeks to probe the catalytic mechanism of a Cas6 enzyme from the 
crenarchaeon Sulfolobus solfataricus (sso).  Despite analogous generation of crRNA, 
ssoCas6 paralogues differ from previously characterised Cas6 examples in their lack 
of a canonical active site histidine residue.  The work here builds on recent 
crystallographic evidence that the ssoCas6-1 paralogue unexpectedly adopts a 
dimeric conformation (PDB 3ZFV, 4ILR), to show that not only is the ssoCas6-1 
dimer stable in solution but that this atypical arrangement is important to the activity 
of this particular enzyme.  Furthermore, the ssoCas6-1 paralogue is shown to be the 
first in this family of endonucleases to employ multiple-turnover kinetics.  The 
widespread diversity in Cas6 catalytic mechanisms reflects the plastic nature of the 
Cas6 active site and rapid co-evolution with substrate repeat sequences. 
 
The CRISPR/Cas environment within S. solfataricus is highly complex, containing 
three co-existing system types (Type I-A, III-A, III-B), five Cas6 paralogues and two 
families of CRISPR loci (AB and CD) that differ by repeat sequence.  By probing the 
activity of an additional ssoCas6 paralogue (ssoCas6-3), which reveals different 
substrate specificities to those of ssoCas6-1, evidence emerges for functional 
coupling between ssoCas6 paralogues and downstream effector complexes, 
sufficient to regulate crRNA uptake and possibly even complex assembly. 
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Chapter 1: Introduction 
1.1 Introduction 
Prokaryotes have multiple innate immune defences to combat the extensive array of 
bacteriophage and plasmid threats encountered within their environments (Bikard 
and Marraffini, 2011; Prangishvili et al., 2006).  Alongside these non-specific barriers 
there is an adaptive immune system, the CRISPR/cas system, which can store prior 
encounters with exogenous DNA threats within a ‘genetic memory bank’ and 
subsequently draw upon this to recognise and silence any future infections by the 
same invader  (for comprehensive recent reviews of the field see Barrangou and van 
der Oost, 2012; Sorek et al., 2013; Barrangou and Marraffini, 2014). Encoded within 
the host’s own genome, this immunity is maintained during cell division, thus 
providing the same protection to subsequent generations in a Lamarckian-like 
mechanism of evolution. 
1.2 Bacterial Defence Mechanisms 
Prokaryotes have a number of innate immune strategies to resist invasion and 
infection by hostile exogenous DNA (Figure 1.1), though an arms race exists as 
phages/plasmids develop necessary countermeasures. 
 
The primary passive defence mechanism aims to prevent attachment of the invading 
phage to cell surface receptors by both mutating exposed molecules and presenting 
extracellular polymer shields, which phages resist by mutating their own surface 
receptors or by carrying enzymes that degrade the polymers (reviewed in Hyman and 
Abedon, 2010).  Upon cell entry, active mechanisms are present to resist any further 
progression of the infection.  The restriction-modification system, which is present in 
over 90% of sequenced bacterial and archaeal genomes (Roberts et al., 2010), 
blocks incorporation of invader genetic material by recognising and degrading foreign 
DNA with a restriction endonuclease (REase) that targets unmodified (typically 
unmethylated) DNA sequences, whilst a methyltransferase (MTase) protects the host 
genome from such activity with the corresponding modification (i.e. methylation) 
(reviewed in Stern and Sorek, 2010).  However, phages have evolved mechanisms to 
evade RM systems, by, for example, blocking the active site of the REase (phage T7, 
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(Bandyopadhyay et al., 1985)) or altering the REase recognition sites (Rocha et al., 
2001).   
 
 
 
Figure 1.1: Application of defensive strategies over the course of phage replication 
cycles.  The application of innate and adaptive immune responses at each stage of the 
phage replication cycle has implications for both phage and host survival as detailed in the 
schematic.  Adapted from Hymen and Abedon, 2010. 
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An additional form of bacterial defence, abortive infection (Abi), refers collectively to 
mechanisms that disrupt an established and productive phage infection, in some 
cases targeting the cell’s own translation apparatus and in others the phage genes 
involved with replication, but which ultimately leads to ‘suicide’ of the host cell and 
prevents further spread of the infection (Hyman and Abedon, 2010; Stern and Sorek, 
2010). Abi mechanisms can be specific to phage strains, though, and like passive 
defences and RM, phages have evolved resistance mechanisms to escape specific 
Abi processes used by host cells (Hyman and Abedon, 2010). 
1.3 Discovery of CRISPR Arrays 
A distinct class of short sequence repeats (SSRs) was first recognised in E. coli K12 
in 1987 by Ishino et al. (Ishino et al., 1987; Nakata et al., 1989), and shortly 
thereafter identified in a diverse range of bacterial and archaeal species (reviewed in 
Mojica and Garrett, 2012). Upon recognition that this group of interspersed SSRs 
represented a single family exclusive to prokaryotes, it was tentatively labelled ‘Short 
Regularly Spaced Repeats’ (SRSR) (Mojica et al., 2000).  A multitude of different 
acronyms were similarly generated by other independent research groups, and so to 
unify the expanding field and avoid confusion, Jansen et al., in collaboration with 
Mojica et al., developed the name ‘Clustered Regularly Interspaced Short 
Palindromic Repeats’ (CRISPRs) to better reflect the characteristic structure of the 
repeats (Mojica et al., 2000; Jansen et al., 2002). However, it has recently been 
called into question whether ‘Palindromic’ is even a truly defining feature of this group 
(Wang et al., 2011; Kunin et al., 2007; reviewed in Lawrence and White, 2011), 
explored further in Section 1.4.1); though, if needs be, a substitution of ‘Palindromic’ 
to the, if not more, valid ‘Prokaryotic’ would avoid any alteration of a now well-
established and recognisable acronym (Lawrence and White, 2011). 
1.4 CRISPR Array Organisation 
The unique architecture of an active CRISPR locus consists of three key 
components: 1) regular ‘repeats’ interspersed with 2) highly variable ‘spacer’ 
sequences which together form cassettes, at the front of which is a 3) ‘leader 
sequence’ (Figure 1.2). The constituent parts of the CRISPR array are briefly detailed 
below. 
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Figure 1.2: A generalised CRISPR locus with associated Cas gene operon.  The 
CRISPR consists of regular repeat sequences (grey hexagons) interspaced with variable 
spacer sequences (numbered rectangles).  Directly upstream of the CRISPR array is a leader 
sequence (pink arrow) that contains a transcription initiation site (red arrow, indicative of 
transcription direction) from which the entire locus is transcribed as a single strand of non-
messenger RNA.  Associated with CRISPR arrays are operons of CRISPR-associated (Cas) 
genes (blue arrows). 
1.4.1 Repeats 
The CRISPR locus repeats, to which the arrays derive their name, range in size 
between 21 – 47 bp, averaging 32 bp in length (Figure 1.4A) (Godde and Bickerton, 
2006; Grissa et al., 2007).  Within a given CRISPR locus, repeats rarely deviate far, if 
at all, from a uniform length and sequence content, though variation in these 
parameters is possible between arrays/loci if there are multiple present within an 
organism (Mojica et al., 2000; Jansen et al., 2002; Grissa et al., 2007; Horvath et al., 
2008).  Outside of closely related species, repeat sequences display extensive 
diversity across the characterised bacterial and archaeal examples (Godde and 
Bickerton, 2006; Kunin et al., 2007, Kunin et al., 2007) that likely correlates to the   
relative phylogenetic distances involved (Mojica et al., 2000; Jansen et al., 2002).  
Whilst not true palindromes, the majority of repeats exhibit varying degrees of dyad 
symmetry (Jansen et al., 2002; Godde and Bickerton, 2006; Kunin et al., 2007), 
generated by the consensus sequence which begins GTT(G/C) and ends 
GAAA(C/G), with internal mirrored runs of G and C (Jansen et al., 2002; Godde and 
Bickerton, 2006).  Such sequence patterns have implications for the secondary 
structure of repeat RNA transcripts (Jansen et al., 2002; Kunin et al., 2007), 
specifically formation of a stem-loop.  Indeed, by combining sequence similarity with 
predicted secondary structure, repeats can be clustered into 12 main and 21 minor 
groups that range from well-defined and highly stable stem-loops to a total lack of a 
discernable folded state (Figure 1.3) (Kunin et al., 2007). 
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1.4.2 Spacers 
Repeat sequences are separated by similarly sized ‘spacer’ regions consisting of 
highly variable sequences (Jansen et al., 2002).  The length of spacers generally 
remains constant within a locus, ranging range 26-72 bp (Bolotin, 2005; Lillestøl et al., 
2006; Grissa et al., 2007); however there are no repetitions of the sequence such 
that the spacer is unique and present as a single copy within the CRISPR locus it 
belongs to (Mojica et al., 2000; Jansen et al., 2002; Godde and Bickerton, 2006; 
Grissa et al., 2007).  It is these unique sequences that match sections of foreign 
nucleic acid, called protospacers, present within hostile genetic elements, and 
provide the CRISPR systems with its stringent targeting ability.    
 
Generally, different species and even strains will possess highly varied spacer 
collections as each population encounters new threats and subsequently 
incorporates spacers to the leading edge of their respective CRISPR loci.  For 
example, S. solfataricus strains P1 and P2 were sampled approximately one metre 
apart, and yet differ dramatically in the new additions to their multiple active loci 
(Lillestøl et al., 2009).  Therefore, because spacers are unique to the threats that an 
individual strain has encountered, spacer content can act as a chronological record 
of past infections and has application for strain identification (Kamerbeek et al., 1997; 
Pourcel, 2005; Lillestøl et al., 2009). The use of spacers in the latter context has 
been coined spacer-oligotyping or ‘spoligotyping’ (Kamerbeek et al., 1997). 
  
Spacers do not contribute to the secondary structure of transcribed RNA and have 
weaker structures than ‘random’ sequence alone due to a higher AT content (46% 
GC) than the typical bacterial genome (53% GC) (Kunin et al., 2007).  Accordingly, 
as viruses are often 7% lower in GC content than bacteria, such a makeup is 
consistent with spacers deriving from a viral origin (Kunin et al., 2007).  Interestingly, 
it appears that selective pressures may constrain the total length of a spacer-repeat 
unit to between 60 - 75 bp (Figure 1.4B) (Pourcel and Drevet, 2012). 
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Figure 1.3: Variation of repeat sequence secondary structure.  Repeats can be categorised into 12 groups based upon sequence similarity and 
propensity for secondary structure.  Individual repeat sequences (dots) are connected upon Smith-Waterman similarity (green lines) in which distance is 
representative of degree of similarity.  Dots are subsequently grouped according to the Markov cluster algorithm and the results of which indicated by colour 
differences.  The 12 largest and most defined groups are circled with the associated consensus sequence displayed alongside predicted secondary structure 
(if present) and course phylogenetic distribution. Adapted from (Kunin et al., 2007). 
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Figure 1.4: Diversity of CRISPRs in published genomes.  Analysis of CRISPRs identified 
from published genomes by the CRISPR Data Base (CRISPR DB, http://crispr.u-
psud.fr/crispr/, Grissa et al., 2007). (A) Frequency of repeat lengths.  (B) Repeat length as a 
function of average spacer length (base-pairs)  (C) Total number of spacers present within a 
given genome.  Adapted from Barrangou and van der Oost, 2012. 
1.4.3 Leader sequence 
Upstream of the active CRISPR array, is a leader sequence that can be several 
hundred bases in length (Jansen et al., 2002; Lillestøl et al., 2006).  Whilst leader 
sequences are not specific to CRISPR arrays, the first identified in such a context 
was in Methanocaldococcus jannaschii (Bult et al., 1996).  All CRISPR leader 
sequences share a common location and orientation to the associated array, as well 
as homopolynucleotide stretches and AT-rich regions; however, little else is 
conserved between species (Jansen et al., 2002; Lillestøl et al., 2006).  As such, they 
have poorly defined boundaries. 
 
The leader sequence is involved in two critical functions (Mojica and Garrett, 2012).  
First, it harbours the transcriptional promoter for the adjacent CRISPR locus from 
which non-mRNA transcripts of the locus are generated during implementation of the 
CRISPR response (Tang et al., 2002).  Second, the leader sequence appears to 
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contain the necessary information to guide addition of new repeat-spacer units at the 
head of the CRISPR array (Section 1.9.1.2) (Mojica and Garrett, 2012).  
1.5 Genomic Distribution of CRISPR Arrays 
The genomic distribution of CRISPR loci bears no obvious pattern (Mojica et al., 
2000).  CRISPR arrays vary in length, sequence and position within the genome, with 
such attributes often varying even between strains (Mojica et al., 2000; Jansen et al., 
2002; Kunin et al., 2007; Horvath et al., 2008).  
 
Individual CRISPR arrays range in size generally between 2–100 repeats (Godde 
and Bickerton, 2006; Kunin et al., 2007), although Haliangium ochraceum DSM14365 
holds the current record at 588 repeats within a single cassette (Mojica and Garrett, 
2012).  Whilst most systems feature one or two CRISPR loci, others possess 
multiple, such as those belonging to the genera Anabaena (sp.7102), Chloroflexus, 
and Methanocaldococcus, which commonly feature up to 11 (Godde and Bickerton, 
2006; Grissa et al., 2007).  Indeed, one recently categorised Methanocaldoccal 
example, spFS406-22, contains 23 distinct CRISPR loci (Grissa et al., 2007).  
CRISPRs represent a large investment in terms of genomic space (in some cases, 
like the Sulfolobales, over 1% of the genome is dedicated to CRISPR arrays (She et 
al., 2001)) and energy required for their maintenance, which ultimately attests to their 
important role.  The overall prevalence of CRISPR cassettes tends to be higher in 
hyperthermophilic bacteria and archaea, than mesophilic bacteria (Nelson et al., 
1999), with the former tending to possess multiple CRISPR loci (Mojica and Garrett, 
2012). 
 
Whilst the majority of CRISPR arrays are located in the host chromosome, they can 
also be located to plasmids.  In T. thermophilus HB8, two of the 11 CRISPR arrays 
present are located on the chromosome whilst nine reside on the mega plasmid 
pTT27 (Agari et al., 2010; Juranek et al., 2012).  In archaea, CRISPR loci have been 
identified on conjugative plasmids such as pNOB8 and pKEF9 associated with 
Sulfolobus species (She et al., 1998; Greve et al., 2004).  Furthermore, CRISPR 
arrays have even been identified in viral genomes, adding a new level to the 
pathogen-host relationship to turn the defence system full circle (Mojica and Garrett, 
2012). 
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1.6 CRISPR-Associated Genes 
Associated with CRISPR cassettes are a diverse set of CRISPR-associated (Cas) 
genes, the expression of which mediate each stage of the CRISPR immune response 
(Section 1.9 and Figure 1.10).  The three main stages of the CRISPR-based immune 
response can be summarised as follows: 1) the acquisition of new spacer sequences 
from hostile genetic elements (Adaptation, Section 1.9.1), 2) the processing of 
CRISPR transcripts to release individual spacers as CRISPR RNAs (crRNA) (crRNA 
biogenesis, Section 1.9.2) and 3) the use of these crRNAs by effector complexes to 
base-pair with matching sequences upon subsequent infections and neutralise the 
threat (Surveillance and Interference, Section 1.9.3). 
 
Whilst the true function of CRISPRs initially remained enigmatic, bioinformatics 
established a firm link between the arrays and diverse clusters of genes, labelled 
CRISPR-associated genes (cas genes), strictly present only in species possessing 
CRISPRs (Jansen et al., 2002; Bolotin, 2005; Haft et al., 2005; Makarova et al., 
2006). As with CRISPR arrays, homologues of the cas genes are not present in 
eukaryotes (Makarova et al., 2006).   
 
Cas genes that are involved in similar biological processes are often conserved 
evolutionarily as physically-linked units (Karginov and Hannon, 2010).  The cas 
genes within these units tend to share a common orientation but can be located 
either side of the CRISPR loci without preference for the direction of the 
transcriptional reading frame (Jansen et al., 2002).  Additionally, cas gene cassettes 
can be located either a few hundred basepairs from the CRISPR loci or be relatively 
distant (e.g. >9000 bp for Methanothermobacter thermoautotrophicum, (Jansen et al., 
2002)), as is favoured by the ‘CMR’ subgroup of cas genes groups that cluster as the 
CRISPR ‘RAMP’ (repeat-associated mysterious protein) module (Haft et al., 2005). 
Where multiple cas gene operons co-exist, they tend to be located seperately. 
 
Jansen et al. first identified a set of four cas genes, Cas1-4, that share homology 
across different species (Jansen et al., 2002).  It has since been recognised that a 
core set of six cas genes (Cas1-6) are widely distributed amongst cas operons, 
although only Cas1 and 2 are near universal in their presence amongst active 
CRISPR/Cas systems (Haft et al., 2005; Makarova et al., 2006).  Indeed, Cas1 is 
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used as the general marker for a CRISPR system (Haft et al., 2005; Makarova et al., 
2006).  A diverse range of cas genes also exist, some of which are species-specific, 
that can further supplement cassettes to reach sizes up to 20 cas genes in length 
(Haft et al., 2005).  The grouping of cas genes into tight clusters suggests not only a 
level of transcriptional co-ordination, but also their co-interaction when expressed 
(Haft et al., 2005). The variable arrangements of cas genes between units are now 
known to govern different forms of the CRISPR response and constitutes the basis of 
the current CRISPR classification system (Section 1.8). 
 
Taxanomic group 
Genomes 
analysed 
Genomes 
containing 
Cas1 
Proportion of 
cas1-containing 
genomes (%) 
Type I 
system 
Type II 
system 
TypeIII 
system 
Archaea       
Crenarchaeota 17 15 0.88 15 0 16 
Euryarchaeota 47 37 0.79 33 0 23 
total 67 54 0.81 50 0 40 
Bacteria       
Actinobacteria 72 26 0.36 28 15 8 
Aquificae 7 5 0.71 7 1 4 
Bacteroidetes–
Chlorobi group 
32 16 0.50 14 2 6 
Chlamydiae–
Verrucomicrobia 
group 
10 2 0.20 0 1 1 
Chloroflexi 10 9 0.90 9 2 7 
Cyanobacteria 14 7 0.50 7 1 7 
Firmicutes 126 56 0.44 40 17 23 
Proteobacteria 318 107 0.34 117 20 22 
Spirochaetes 13 3 0.23 2 1 0 
Thermotogae 11 10 0.91 10 0 9 
Total 639 256 0.40 245 65 99 
 
Table 1.1: Taxanomic distribution of CRISPR-Cas Types I-III.  The ‘universal’ cas1 gene is 
used as a marker for a CRISPR-Cas system, of which multiple can co-exist within a single 
genome.  Archaeal species as a group lack type II systems. Adapted from Makarova, Haft, et 
al., 2011). 
 
Early work suggested that in genomes containing multiple CRISPR loci with identical 
repeat sequences, only a single set of cas genes adjacent to one of the loci would be 
generally present within the genome.  Accordingly, where repeat sequences differ 
between loci, additional sets of cas genes would be present (Jansen et al., 2002).  
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This indicates that the output of a specific CRISPR loci type is governed by an 
exclusive set of cas proteins and co-evolution between the two is likely.  However, 
this scenario may not be strictly true for all systems where a greater degree of 
flexibility may in fact exist (Zhang et al., 2012; Rouillon et al., 2013; Sokolowski et al., 
2014) and will be explored in more detail in Chapter 4 and 5. 
1.7 Discovery of the CRISPR System Function 
The majority of cas gene activities have been predicted in silico from sequence 
(Jansen et al., 2002; Makarova et al., 2002; Haft et al., 2005; Makarova et al., 2006) 
and/or structural homologies (Ebihara et al., 2006) or indirectly from 
knockouts/inactivation (Barrangou et al., 2007; Brouns et al., 2008).  Cas genes 
share prominent motifs occurring within DNA/RNA metabolic systems, a similarity 
that led to early theories of a novel thermophile-specific DNA repair mechanism 
(Mojica et al., 2000; Jansen et al., 2002; Makarova et al., 2002; Haft et al., 2005).  
For example, Cas4 shares sequence similarities with the RecB family of 
exonucleases and Cas3 possesses seven of the functional domains of superfamily 2 
helicases (Jansen et al., 2002; Makarova et al., 2002).  
 
The nature of the CRISPR arrays themselves also added to the speculation that cas 
genes were implicated in a DNA repair mechanism, as both the size of the repeated 
unit and short palindromic core sequences are characteristic of the motifs used by 
DNA-binding proteins (Mojica et al., 2000).  Additionally, the location of CRISPR loci 
close to or even flanking the chromosomal origin of replication, suggested a possible 
role as an anchor point for cellular structures to facilitate the act of replicon 
partitioning (Mojica et al., 1995; 2000). 
 
The pivotal insight into the system’s true purpose came upon the realisation that 
CRISPR spacer sequences matched both phage and hostile plasmid DNA extra-
chromosomal elements, suggesting that the CRISPR/Cas System represented a 
novel, hitherto unknown, nucleic acid based antiviral system within prokaryotes 
(Bolotin, 2005; Mojica et al., 2005; Pourcel, 2005).  Such assumptions were finally 
confirmed experimentally by Barrangou et al. who illustrated that as Streptococcus 
thermophilus acquired resistance to phage attack, it also acquired novel, 
corresponding spacers (Barrangou et al., 2007).  Furthermore, this antiviral activity 
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was dependent upon active and correctly located cas genes (Barrangou et al., 2007) 
and guided by the processed RNA transcripts of individual spacers (Brouns et al., 
2008).  This activity was also eventually demonstrated in vivo for Archaea, including 
S. solfataricus, by Manica et al. (Manica et al., 2011). 
 
In 2006, Makarova et al. summarised these initial findings into a proposed 
mechanism analogous to the eukaryotic RNAi interference mechanism functioning on 
the anti-sense principle (Figure 1.5) (Makarova et al., 2006):  
 
The CRISPR array is transcribed as a single unit from the leader region.  The large 
non-mRNA transcript (‘pre-psiRNA’, hereafter known as ‘pre-crRNA’) generated is 
subsequently processed to release the spacers sequences as individual ‘psiRNA’s’ 
(now generally referred to as ‘crRNA’) by a prokaryotic analogue of the dicer 
nuclease.  The crRNAs were then hypothesised to bind RAMPs in a size-dependent 
fashion to form an RNP complex.  As the targeting element of the RNP complex, psi-
RNAs would anneal to target mRNA based on the anti-sense principle and initiate the 
recruitment of the prokaryotic analogue of RISC (RNA-induced silencing complex) to 
cleave the targeted RNA (Makarova et al., 2006).  
 
At the time there was still uncertainty about which nucleic acids were targeted by the 
CRISPR system, with logic indicating that it was RNA due to the prevalence of 
characterised post-transcriptional gene silencing mechanisms mediated through 
small RNAs (Makarova et al., 2006).  Subsequent dissection of CRISPR/Cas 
systems has since revealed deep mechanistic, functional and ancestral differences 
with its eukaryotic RNAi counterpart, with which no homology of relevant machineries 
exists.  Surprisingly, it emerged that crRNA is used to target either DNA (Marraffini 
and Sontheimer, 2008; Shah et al., 2009) or RNA (Hale et al., 2009) depending on 
the effector complex employed and will be expanded upon in Section 1.9.3 (III-A, 
Marraffini and Sontheimer, 2008), (I-E, Jore et al., 2011), (I-F, Wiedenheft, van Duijn, 
et al., 2011), (I-A, Lintner, Kerou, et al., 2011), (II, Garneau et al., 2010), (III-B, Hale 
et al., 2009), (III-B, Zhang et al., 2012)). 
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1.8 Classification of CRISPR/Cas Systems 
Early bioinformatics analyses identified 65 distinct sets of orthologous Cas proteins 
comprising 45+ cas gene families (Haft et al., 2005).  As a general trend, cas genes 
undergo rapid evolution which generates massive diversity (Makarova et al., 2006; 
Makarova, Aravind, et al., 2011).  However, with improvements to the sensitivity of 
bioinformatics analyses, phylogenetic relationships between distant cas gene families 
have become increasingly apparent and the number of ‘distinct’ families reduced 
(Makarova, Haft, et al., 2011; Makarova, Aravind, et al., 2011).  Moreover, complex 
evolutionary relationships exist between the CRISPR/Cas systems in diverse bacteria 
and archaea, and their orthologous nature is clear (Makarova, Haft, et al., 2011; 
Makarova, Aravind, et al., 2011) . 
 
Although a core set of cas genes may be conserved, their organisation within 
operons is highly varied (Barrangou and van der Oost, 2012). As a result, it has been 
difficult to develop a unified classification system.  In 2011 Makarova et al. proposed 
a flexible ‘polythetic’ approach to CRISPR/Cas system classification, that combines 
the sequence and structural relationships between cas proteins, sequence and 
organisation of CRISPR repeats (defined by Kunin et al., 2007) and the architecture 
of CRISPR loci (Makarova, Haft, et al., 2011). 
 
Cas genes are allocated between three main CRISPR/Cas system types, with the 
universally conserved Cas1 (the marker for the presence of a CRISPR system) and 
the highly conserved Cas2 genes forming the core of all system types (Makarova, 
Haft, et al., 2011).  These genes have predicted roles in the ‘adaptation’ (spacer 
acquisition) phase common to each of the different system types (explored in detail 
Section 1.9.1).   
 
Whilst Cas1 and Cas2 bridge system types, the composition of cas genes otherwise 
varies dramatically between system types, with each identifiable by a ‘signature’ 
gene: in Type I, Cas3, Type II, Cas9, and Type III, Cas10 (Makarova, Haft, et al., 
2011).  Further sub-typing of systems revolves around the cas gene content of the 
surrounding operon and orthology and phylogeny of the Cas1 gene therein 
(Makarova, Haft, et al., 2011).   
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Figure 1.5: Early model of a CRISPR-based antiviral defence in an analogous fashion 
to the eukaryotic RNAi mechanism, CRISPR transcripts are processed to release individual 
spacer sequences (psiRNA) by a Cas analogue of ‘dicer’ protein (given the identifier here ‘p-‘ 
for ‘prokaryotic’) allowing subsequent uptake by ‘repeat-associated mysterious proteins’ 
(RAMP) proteins and the association of p-‘slicer’ to form the minimal p-‘RISC’ complex.  The 
p-RISC is targets and cleaves hostile mRNA via sequence complementarity to the psiRNA 
molecule, upon which the complex is released to participate in additional target molecules and 
thus silence viral gene expression.  Adapted from Makarova et al., 2006. 
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Figure 1.6 illustrates the three major types and ten subtypes of CRISPR/Cas 
systems, and Figure 1.7 displays a summary of the varied activities of the main 
system types with a brief description of each below (system activities will be 
expanded upon in Section 1.9.3).   
1.8.1 Type I systems 
Type I systems (A-F) are identified by the presence of Cas3 (Makarova, Haft, et al., 
2011), a superfamily 2 helicase with an N-terminal HD-nuclease domain (Haft et al., 
2005; Brouns et al., 2008).  Type I systems utilise a CASCADE (CRISPR-associated 
complex for antiviral defence) complex to target foreign ss/dsDNA elements via the 
incorporated crRNA molecule (Brouns et al., 2008; Lintner, Kerou, et al., 2011; Jore 
et al., 2011; Wiedenheft, van Duijn, et al., 2011).  Upon detection of matching DNA, 
Cas3 is recruited to the complex to mediate cleavage of the target via its HD 
nuclease domains (Brouns et al., 2008; Sinkunas et al., 2011). 
1.8.2 Type II systems 
Exclusive to Type II systems is Cas9 (Makarova, Haft, et al., 2011), a RuvC-like 
protein with HNH nuclease domains (Makarova et al., 2006).  Cas9 is a large protein 
that alone coordinates both the crRNA generation and threat response phases of the 
immune response against DNA threats (Makarova, Haft, et al., 2011). Type II 
systems are currently identified as the preserve of bacteria only (Makarova, Haft, et 
al., 2011). 
1.8.3 Type III systems 
The signature protein of Type III systems is Cas10 (Makarova, Haft, et al., 2011), a 
large protein comprising several features including an HD-nuclease component, Zn-
finger and a domain with homology to the ‘palm’ (RNA-recognition motif, RRM) 
domains of polymerases/nucleotide-cyclases (Makarova et al., 2002; Anantharaman 
et al., 2010).  As such, Cas10 is commonly labelled, and predicted to function as, the 
CRISPR polymerase (Makarova, Aravind, et al., 2011).  The protein forms the large 
subunit of both the DNA and RNA targeting CASCADEs of Type III-A (CSM) and III-B 
(CMR) systems, respectively (Hale et al., 2009; Makarova, Haft, et al., 2011; Zhang 
et al., 2012; Rouillon et al., 2013; Staals et al., 2013). 
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Figure 1.6: Distribution of Cas genes between the three major types and ten subtypes 
of CRISPR/Cas systems.  Displayed are the basic operon architectures for each of the 
CRISPR/Cas system types/subtypes, though variations therein do exist. Orthologous genes 
are uniformly coloured and labelled with family name.  The signature gene for each system 
type (Cas3, Cas9, Cas10) and subtype are additionally highlighted with green and red boxes, 
respectively. Cas genes with function in the CASCADE complex are indicated; Large subunit 
(L), Small subunit (S), RAMP (R). Involved with crRNA biogenesis are RAMP-family members 
with restriction endonuclease (RE) capability.  Cas1 and Cas2 genes associated with type III 
systems (dashed outlines) are not necessarily co-located with the system operon.  Alongside 
the system-subtype labels, previous nomenclatures are included in parentheses.  Adapted 
from Makarova, Haft, et al., 2011.  
 
The ‘informational’ (spacer acquisition) and ‘executive’ (interference) branches of the 
immune response appear somewhat independent.  Type III complex components are 
often not even encoded in proximity to Cas1 and Cas2 genes which otherwise 
generally associate with Type I and II components if present within a genome 
(Makarova, Aravind, et al., 2011). 
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Figure 1.7: CRISPR/Cas system stages of activity.  See text for details. Whilst the use of 
the adaptation machinery (Cas1/Cas2) is universal, each of the system types subsequently 
relies on differing sets of cas genes to mediate alternative crRNA maturation and interference 
events. Adapted from Makarova, Haft, et al., 2011. 
1.8.4 CASCADE Complex Proteins 
Type I and III systems consist of six to ten genes, inclusive of Cas1 and Cas2 
(Makarova2011Nature).  The first CASCADE complex to be isolated was the Type I-
E complex from E. coli (Brouns et al., 2008).  Subsequently, CASCADE complexes 
have been characterised in detail from E. coli (I-E, Jore et al., 2011; Wiedenheft, 
Lander, et al., 2011), Pseudomonas aeruginosa (Type I-F, Wiedenheft, van Duijn, et 
al., 2011)), Pyrococcus furiosus Type (III-B, Hale et al., 2009; Spilman et al., 2013)), 
S. solfataricus (Type I-A, Lintner, Kerou, et al., 2011), Type III-A, Rouillon et al., 
2013), Type III-B, Zhang et al., 2012)), B. halodurans (I-C, Nam, Haitjema, et al., 
2012)), and T. thermophilus (III-B, Staals et al., 2013)). The conserved core subunits 
and structural similarities between the CASCADE complexes suggests a common 
ancestry (Reeks, Naismith, et al., 2013). 
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The basic architecture of Type I and III CASCADE complexes consists of (Makarova, 
Aravind, et al., 2011):  
  
1. Two to three RAMPS of Cas5, Cas6, Cas7 families 
2. Multiple subunits of Cas7 
3. Strong associations between Cas7 and Cas5 
4. Variable inclusion of Cas6, where present, as a subunit 
5. Large subunit of a protein with polymerase-like domain architecture 
6. Small subunit in the form of a distinct protein or a subdomain within the large 
protein with a distinct a-helical arrangement. 
 
Whilst Cas5 and Cas7 orthologues form the stable core of CASCADE complexes 
from distinct system types/subtypes (Figure 1.8), biochemical characterisation of the 
complexes has illustrated widespread mechanistic and functional diversity that 
results from gene diversification and the association of more unique, type and 
subtype-specific components (Jore et al., 2011; Wiedenheft, van Duijn, et al., 2011; 
Lintner, Kerou, et al., 2011; Zhang et al., 2012; Staals et al., 2013; Rouillon et al., 
2013).  The protein composition of CASCADEs and the differences that lead to their 
separation between system types will be briefly detailed below (Makarova and 
Koonin, 2012). 
 
Figure 1.8: CASCADE complex models across system types.  Characterised CASCADE 
complexes associated with the E. coli Type I-E system (eCASCADE, (Jore et al., 2011; 
Wiedenheft, Lander, et al., 2011)), P. aeruginosa Type I-F system (Csy Complex/fCASCADE, 
(Wiedenheft, van Duijn, et al., 2011)), S. solfataricus Type I-A system (aCASCADE, Lintner, 
Kerou, et al., 2011), P. furiosus Type III-B system (Cmr complex, Hale et al., 2009; Spilman et 
al., 2013) and S. solfataricus Type III-A system (Rouillon et al., 2013).  Stably associated 
subunits are represented by a solid outline, whilst components that display weak/no affinity for 
the respective complexes are defined by a dashed outline.  Component are coloured by type; 
Large subunits (pink/purple), Small subunits (yellow), Cas6 RAMP (red), Cas5 RAMP (green).  
Where Cas7 subunits within a complex originate from multiple genes, multiple shades of blue 
are used accordingly.  Components are labelled with protein family name and, where relevant, 
subfamily names in parentheses. Adapted and updated from Makarova and Koonin, 2012. 
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1.8.4.1 Large subunit 
The cas genes that comprise the large subunits of both Type I and III systems 
possess polymerase-like domains (Makarova, Aravind, et al., 2011; reviewed in 
Makarova and Koonin, 2012).  Whilst the large Cas8a/b/c subunits of Types I-A/B/C 
complexes share sequence conservation, those of Type I-E (Cse1) and Type I-F 
(Csy1) display higher levels of divergence from the ‘polymerase’ consensus and 
have little/no sequence identity to one another nor to members of the Cas8 family.  
Moreover, Type I-D systems contain a Cas10 variant as the large subunit similar to 
type III systems. However, all Type I system subtypes are nonetheless related by 
tracing Cas1 phylogenies and operon architectures. 
 
Whilst the large subunit of Type III systems shares homology with Cas8, the system’s 
‘signature’ gene, Cas10, contains an additional HD-nuclease domain and the 
complete set of catalytic residues typical of ‘palm’ polymerases and cyclases 
(Makarova, Aravind, et al., 2011).  The domain organisation between large subunit 
proteins from Type I and III systems, and the homology between Cas8 and Cas10 
genes, suggests that all Type I large subunits may be inactivated derivatives of the 
CRISPR polymerase (Makarova, Aravind, et al., 2011).  Operons with such ‘active’ 
Cas10 genes lack Cas3 homologues, whereas, cas3 is always a feature of operons 
with a Cas8/Cse1/Csy1 or ‘inactive’ Cas10 orthologues.  In such situations, Cas3 
may compensate for the loss of the enzymatic functionality from a true Cas10 and the 
large subunit is reduced to a purely structural role (Makarova, Aravind, et al., 2011). 
1.8.4.2 Small subunit 
The small subunits of CASCADEs I-E, I-A and III-B and III-A (Cse2, Csa5 Cmr5, 
Csm2, respectively), appear structurally related as small arrangements of alpha-
helices (Makarova, Aravind, et al., 2011; Reeks, Graham, et al., 2013; Reeks, 
Naismith, et al., 2013).  In systems that lack small subunit equivalents, the large 
subunits (Cas8a1/b/c, Cmx1, Cas10d) from select Type I-A/B/C/D systems have C-
terminal helical extensions of a similar predicted size that may substitute for the 
role(s) of the missing small subunit (Makarova, Aravind, et al., 2011). 
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1.8.4.3 Cas5/Cas7 (Cas6): RNA-binding backbone 
Cas5, Cas7 and Cas6 belong to the Repeat-Associated Mysterious Protein (RAMP) 
superfamily of cas genes. RAMPs are present in several copies within type I and III 
systems, and form the RNA-binding backbone of the associated effector complexes 
(Makarova, Haft, et al., 2011; Makarova, Aravind, et al., 2011). Despite extensive 
sequence diversity, all RAMPs posses at least one RNA-recognition motif (RRM) that 
generates a ferredoxin-like fold common to RNA-binding proteins (Figure 1.9, 
(Ebihara et al., 2006; Makarova, Aravind, et al., 2011)). RAMPs have been 
subsequently classified into three main families - Cas5, Cas6 and Cas7 - that each 
adopt a distinct variation on the RRM (Makarova, Aravind, et al., 2011) (Figure 1.9). 
Sequence/structural features of the RAMP superfamily will be examined in more 
detail in Chapter 3, Section 3.1.1. 
 
The majority of Type I systems encode a single gene from the Cas5, Cas7 and Cas6 
RAMP families (Makarova, Aravind, et al., 2011).  These genes are generally 
adjacent within the operon (Makarova, Aravind, et al., 2011), and the corresponding 
proteins can associate strongly (Lintner, Kerou, et al., 2011).  However, the Type I 
complex itself generally contains only a single Cas5, despite having multiple copies 
of the Cas7 subunit in its helical core (Lintner, Kerou, et al., 2011; Wiedenheft, 
Lander, et al., 2011; Wiedenheft, van Duijn, et al., 2011; Jore et al., 2011; Nam, 
Haitjema, et al., 2012).  Although similarly organised, Type III systems tend to 
encode multiple Cas7 representatives (Makarova, Aravind, et al., 2011), resulting in a 
heterogenous mix within the complex (Figure 1.8) (Hale et al., 2009; Zhang et al., 
2012; Rouillon et al., 2013; Staals et al., 2013). Models of the CMR and CSM 
complexes generated from EM imaging techniques show the Cas7 homologues 
employed in Type III complexes generate a more compact structure than in Type I 
CASCADEs (Zhang et al., 2012; Rouillon et al., 2013; Spilman et al., 2013) with the 
helical twist absent in the S. solfataricus CMR complex (Zhang et al., 2012).  Cas7 
and Cas5 representatives were initially thought to function in a purely structural 
capacity within CASCADE complexes, to bind the crRNA molecule along their entire 
length, and whilst this appears the case for the majority of Type I systems (Lintner, 
Kerou, et al., 2011; Wiedenheft, Lander, et al., 2011), recent characterisation of type 
I-C and III systems suggest that select Cas5 and Cas7 family members may also 
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have some enzymatic functionality (Nam, Haitjema, et al., 2012; Hatoum-Aslan et al., 
2013). 
 
 
 
Figure 1.9: RAMP family classification.  Phylogenetic tree of RAMP-family members 
generated from sequence and structural similarities and neighbourhood analysis 
(Makarova2011BD).  Inset is a schematic of the RNA-recognition motif (RRM) that constitutes 
a primary structural feature of this group; α-helices (grey), β-strand (light pink), N-terminal 
(blue sphere), C-terminal (red sphere).  Adapted from Makarova, Aravind, et al., 2011. 
 
In contrast, members of the Cas6 group tend to possess ribonuclease activity 
specific for CRISPR repeat transcripts and play an essential role in the crRNA 
generation event (Section 1.9.2). In certain Type I system subtypes, such as those of 
T. thermophilus and P. aeruginosa, Cas6 can also be an important/essential subunit 
of the CASCADE complex (Brouns et al., 2008; Jore et al., 2011; Wiedenheft, van 
Duijn, et al., 2011).  This variable dependency as a subunit has important 
implications for the enzymatic activity of Cas6 and will be explored in Chapter 4. 
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1.8.5 Distribution and evolution of CRISPR/cas systems 
The increasing numbers of sequenced prokaryotic genomes have provided a 
substantial database of CRISPR-containing genomes for study (Grissa et al., 2007; 
Rousseau et al., 2009), and it is now recognised that CRISPRs comprise the largest 
family of prokaryotic repeats (Mojica et al., 2005).  Such systems are highly prevalent 
(Mojica and Garrett, 2012) and are present in over 85% of archaea and ~50% 
bacteria analysed thus far (CRISPRdb, Grissa et al., 2007, and CRISPI, Rousseau et 
al., 2009) (Table 1.2). 
 
 
Genomes 
analysed 
Species 
analysed 
CRISPRs found 
Genomes with 
CRISPR 
Species with 
CRISPR 
Archaea 166 135 513 131 (78.92%) 111 (82.22%) 
Bacteria 2457 1199 2675 1141 (46.44%) 714 (59.55%) 
 
Table 1.2: Summary of CRISPRs identified in catalogued genomes.  Whilst CRISPRs are 
widespread amongst prokaryotes they display a higher prevalence amongst archaeal species.  
Table adapted from the online CRISPR database ‘CRISPI’ (http://crispi.genouest.org, 
Rousseau et al., 2009), Archaea data current as of 2014, Bacteria data current as of 2013. 
 
Horizontal gene transfer (HGT) has made a considerable contribution to the evolution 
of prokaryotic genome evolution (Koonin and Wolf, 2008; 2009), notably in the 
dissemination of prokaryotic defence systems, and has undoubtedly impacted 
CRISPR evolution (Makarova et al., 2002; Haft et al., 2005; Makarova et al., 2006; 
Godde and Bickerton, 2006; Kunin et al., 2007; Makarova, Aravind, et al., 2011).  
Indeed, similar/identical CRISPR repeat sequences can be present in taxonomically 
unrelated species (Jansen et al., 2002; Kunin et al., 2007), and that the phylogenetic 
relationships between cas genes do not correlate well with phylogenetic relationships 
of the harbouring species suggests dissemination via HGT (Jansen et al., 2002; 
Makarova et al., 2002).  Some CRISPR/Cas systems even exist on plasmid vectors 
(She et al., 1998; Greve et al., 2004). The presence of multiple CRISPR/Cas systems 
within a genome may stem from a combination of HGT and gene duplication events 
(Haft et al., 2005).  Additional diversity generated by re-arrangements of local gene 
order is common in prokaryotes and can be extensive (Makarova et al., 2002). 
 
Hypervariability in spacer content is a signature feature of CRISPR loci, in which the 
spacer content of closely related organisms and even strains varies dramatically.  
CRISPR loci are inherently plastic, undergoing active alteration by the adaptation 
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machinery (acquisition and loss mechanisms) in response to environmental 
pressures (Section 1.9.1) (Lillestøl et al., 2009; He and Deem, 2010).   
 
Orthology between Types I and III system components is clear, and Mackarova et al. 
propose that such CRISPR/Cas systems have likely descended from an ancestral 
Type III-A-like system in archaea (Makarova, Aravind, et al., 2011).  The subsequent 
acquisition of additional Cas genes (e.g. helicase/nuclease Cas3/Cas4) and loss of 
existing domains (e.g. nuclease domain of Cas10 to generate Cas8) led to 
diversifications in function/mechanism, although the precise origins and associations 
of each component is somewhat enigmatic (Makarova, Aravind, et al., 2011). 
 
CRISPR/Cas systems revolve around the structural feature of the RRM (Figure 1.9 
inset) (reviewed in Reeks, Naismith, et al., 2013).  The RRM is present across the 
RAMP super-family, in Cas10 and even Cas2 (Makarova, Aravind, et al., 2011; 
Reeks, Naismith, et al., 2013). Extreme diversification brought about by rapid 
evolution has enabled application of the RRM in a range of enzymatically active and 
inactive capacities, even within protein families e.g. Cas5 and Cas7 (Makarova, 
Aravind, et al., 2011).  The RRM is a critical tool employed by the Cas6 
riboendonuclease mechanism and will be detailed in Chapter 4 with the 
characterisation of S. solfataricus Cas6. 
1.9 Mediating the CRISPR Response 
The activities of the CRISPR system can be broadly divided into three phases: 1) 
Adaptation, 2) crRNA biogenesis and 3) Interference (Figure 1.10).  Because this 
thesis primary concerns the setup of the CRISPR/Cas system and the crRNA 
biogenesis stage in S. solfataricus, only Type I and III systems will be discussed in 
detail, with the highly dissimilar Type II interference response only touched on for 
comparison. 
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Figure 1.10: Overview of CRISPR-mediated antiviral response.  The three phases of the 
CRISPR immune response are indicated; 1. Adaptation, 2. crRNA Biogenesis, 3. Interference.  
Spacers under certain systems (type I and II) are selected with deference to a protospacer-
adjacent motif (PAM) sequence, additionally important for the subsequent downstream 
interference activity by the associated effector complex (grey box). Spacers are inserted into 
the CRISPR array by the adaptation machinery in a polarised fashion, downstream of the 
leader sequence.  Transcription of the CRISPR locus (dashed arrow) generates pre-crRNA 
molecules to be processed into individual crRNAs by CRISPR-associated restriction 
endonucleases (red arrows) to be utilised by effector complexes.  Adapted from Sorek et al., 
2013. 
1.9.1 Adaptation: The acquisition of novel spacers and 
maintenance of a spacer set 
Generating resistance directly correlates to the acquisition of novel ‘spacers’, made 
up of short sections of an invader’s genome, which are generally inserted in a 
polarised fashion immediately adjacent to the leader sequence at the 5’ end of the 
CRISPR array (Pourcel, 2005; Lillestøl et al., 2006; Barrangou et al., 2007; Brouns et 
al., 2008; Deveau et al., 2008; Lillestøl et al., 2009; Swarts et al., 2012).  As such, 
CRISPR arrays provide, to some degree, a chronological record of past infections 
(Barrangou et al., 2007; Lillestøl et al., 2009).  Since spacer composition matches the 
unique infection experience within an example organism’s environment, closely 
related organisms that otherwise share near total genome identity can thus differ in 
CRISPR content (Pourcel, 2005; Bolotin, 2005; Lillestøl et al., 2009). 
 
Targeting of both coding and non-coding regions indicates that the spacers are 
derived from invading DNA rather than RNA transcripts (Bolotin, 2005; Shah et al., 
2009).  Moreover, the selection of the spacer sequences does not appear to be a 
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random event but rather occurs from specific sites within the invader genome (Bolotin, 
2005; Deveau et al., 2008; Horvath et al., 2008; Lillestøl et al., 2009; Swarts et al., 
2012). Aligning bacteriophage sequences revealed that the site within invading DNA 
from which a spacer is derived, the ‘protospacer’ (Horvath et al., 2008), is often 
flanked 1-2 nt distant by short conserved motifs, the ‘protospacer adjacent motif’ 
(PAM) (Bolotin, 2005; Horvath et al., 2008; Deveau et al., 2008; Lillestøl et al., 2009; 
Mojica et al., 2009; Gudbergsdottir et al., 2010), which vary between 2-4 nt in size 
and can be positioned on either side of the protospacer dependent on system type 
(reviewed in Sorek et al., 2013).  Such variation can even occur between CRISPR 
loci in a single genome. For example, Streptococcus mutans possesses two CRISPR 
loci which differ both in PAM sequence and location 5’ and 3’ of the protospacer (van 
der Ploeg, 2009).  Although such motifs are potentially a ubiquitous feature of spacer 
selection, the specific PAM preferences of each system type differs (Makarova, Haft, 
et al., 2011; reviewed in Sorek et al., 2013).  This not only has implications for 
evolution of a CRISPR array emanating from the different selection criteria of the 
associated Cas proteins involved (Sorek et al., 2013), but critically also in its 
subsequent application, as will be explored in Chapter 5. 
 
Whilst homologous gene transfer (HGT) can account for shared sets of spacers 
between closely related species, the original acquisition of novel spacers is ultimately 
necessary for an adaptive immune response (Bolotin, 2005; Horvath et al., 2008; 
2009; Lillestøl et al., 2009; Horvath and Barrangou, 2010).  Although the 
mechanisms and machinery driving this process are enigmatic at present, the 
adaptation phase is almost certainly driven by the CRISPR-associated machinery 
(Bolotin, 2005; Barrangou et al., 2007; Lillestøl et al., 2009; Mojica et al., 2009; 
Garneau et al., 2010; Datsenko et al., 2012; Swarts et al., 2012; Yosef et al., 2012; M. 
Li et al., 2014; Nuñez et al., 2014). 
1.9.1.1 Cas Genes in Spacer Acquisition 
Several cas gene candidates have been associated with space acquisition, although 
direct evidence concerning a mechanism remains elusive (reviewed in Sorek et al., 
2013).  Cas1 and Cas2 have been long been implicated circumstantially due to their 
universal distribution and lack of involvement in the crRNA biogenesis or 
interference/executive stages of the immune response (Barrangou et al., 2007; 
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Brouns et al., 2008).  Indeed, their deletion from a cas operon does not impact the 
interference phases of the immune response utilising existing spacers present 
(Brouns et al., 2008). More recently, experimental evidence for their involvement has 
emerged from work on the Type I-E system in E. coli and I-B system in Haloarcula 
hispanica (Yosef et al., 2012; Swarts et al., 2012; Datsenko et al., 2012; M. Li et al., 
2014; Nuñez et al., 2014). 
 
Cas1 (Figure 1.11A) possesses conserved nuclease domains coupled with a high pI 
value characteristic of DNA-binding proteins (Jansen et al., 2002), and as such has 
long been identified in silico as a potential integrase and the prime candidate for 
spacer excision/insertion (Jansen et al., 2002; Bolotin, 2005; Haft et al., 2005; 
Makarova et al., 2006).  Experimental characterisation of Cas1 has shown it to be a 
metal-dependent DNase, capable of cleaving single- or double-stranded DNA, 
including branched DNA such as Holliday junctions and replication forks, without 
specificity (Wiedenheft et al., 2009; Babu et al., 2010; Kim et al., 2013).  In isolation, 
the S. solfataricus P2 Cas1 [sso1450] binds both single- and double-stranded DNA 
and RNA, with a lack of sequence specificity, and appears to promote the annealing 
of complementary DNA strands (Han et al., 2009), potentially acting to link excised 
proto-spacers to a new repeat (Bolotin, 2005).  Whilst no nuclease activity was 
detected in S. solfataricus Cas1, the P. aeruginosa homologue was shown to be a 
metal-dependent endo-DNase generating ~80 nt fragments from single- or double-
stranded DNA (Wiedenheft et al., 2009).  
 
Cas2 is consistently found downstream of Cas1 (Haft et al., 2005), and is also 
predicted to play a role in spacer acquisition (Brouns et al., 2008).  Cas2 consists of 
an RRM domain (Figure 1.11B) and has been reported to be a metal-dependent 
endoribonuclease with a preference for U-rich sequences (Beloglazova et al., 2008). 
The presence of cas1 and cas2 genes appears to have no effect on the phage 
resistance profiles mediated by a CRISPR/cas systems already possessing the 
relevant matching spacers (Brouns et al., 2008), and neither show activity/machinery 
components within the context of crRNA processing (Brouns et al., 2008; Carte et al., 
2008) nor interference (Barrangou et al., 2007; Brouns et al., 2008; Lintner, Kerou, et 
al., 2011; Zhang et al., 2012).  To justify their conservation, these cas genes must 
logically participate in the only remaining key stage - adaptation.  Indeed, more 
recently it has been demonstrated that in the E. coli BL21 (DE3) chromosome, 
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overexpression of Cas1 and Cas2 led to new spacer-repeat units added to an 
endogenous CRISPR locus (Yosef et al., 2012). 
 
 
Figure 1.11: Novel fold of the Cas1 family. The novel fold of the Cas1 family is illustrated 
by the P. aeruginosa example (A), which adopts a stable homodimeric conformation (PDB: 
3GOD, Wiedenheft et al., 2009). (B) The active S. solfataricus Cas2 homodimer. Each Cas2 
monomer comprises a single RRM fold, N- and C-terminals have been labelled for clarity 
(PDB: 2I8E, Beloglazova et al., 2008).  (C) The adaptation machinery forms a complex 
comprising two Cas1 dimers and a single Cas2 dimer, as illustrated by the Cas1-Cas2 
complex from E. coli (PDB: 4P6I, Nuñez et al., 2014).  Colour scheme of Cas1 dimers (cyan-
blue) and Cas2 dimers (yellow-orange) has been used in each diagram for continuity, though 
labelled where necessary for additional clarity. 
 
Recently, Cas1 and Cas2 from E. coli have been shown to associate into a stable 
heteromeric complex (Figure 1.11C) that is an essential for CRISPR DNA recognition 
and spacer acquisition activities in this system (Nuñez et al., 2014).  However, the 
authors note that the specific residues/features that contribute to complex formation 
in this case are not well conserved, which may indicate that alternative interactions 
exist for Cas1-Cas2 assembly in a permanent or transient manner.  Curiously, whilst 
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both proteins display nuclease activity in vitro, only active site mutants of Cas1 
inhibited the spacer acquisition process in vivo, indicating a non-enzymatic role for 
the Cas2 subunit during the adaptation mechanism (Nuñez et al., 2014). 
 
From work conducted in S. thermophilus strains possessing CRISPR/Cas systems of 
types I-E, II-A and III-A, de novo spacer acquisition from a novel threat (‘naïve’ 
adaptation) was not predicted to occur with high efficiency as displayed in the low 
rates of resistance generation (Barrangou et al., 2007; Deveau et al., 2008; Horvath 
et al., 2008; Garneau et al., 2010).  Indeed, even when Cas1/Cas2 were over-
expressed in E. coli, spacer acquisition events were only detected in <1% of the total 
cell population (Yosef et al., 2012).  Furthermore, whilst PAMs delineate 
protospacers, Cas1/Cas2-mediated acquisition shows no preference for the DNA 
strand on which they are located (Barrangou et al., 2007; Yosef et al., 2012). 
 
However, whilst Cas1/Cas2 may comprise the minimal machinery for spacer 
acquisition (Yosef et al., 2012), the pattern of spacer acquisition can be modified in 
the presence of other system components (Datsenko et al., 2012; Swarts et al., 
2012; M. Li et al., 2014).  Within the Type I-E system of E. coli K12, after ‘naïve’ 
adaptation occurs, the presence of CASCADE and Cas3 leads to multiple additional 
acquisitions from the same DNA target with a distinct strand-bias established by the 
first spacer acquired (Datsenko et al., 2012; Swarts et al., 2012; M. Li et al., 2014).  
This has been similarly demonstrated for the archaeon H. hispanica Type I-B system, 
where in addition to Cas3 and CASCADE components, the widely conserved Cas4 (a 
RecB nuclease often fused to Cas1 in other systems (Makarova, Aravind, et al., 
2011)) was seen to contribute to this effect (M. Li et al., 2014). This effect is also up-
regulated when a partial match between spacer and protospacer exists (Datsenko et 
al., 2012; Swarts et al., 2012; M. Li et al., 2014; Fineran et al., 2014). 
 
For CASCADE-mediated cleavage of DNA, a perfect match between select 
crRNA/proto-spacer regions is required (Section 1.9.3.1).  Cas1/Cas2 alone possibly 
conducts naïve adaptation to novel viruses and orchestrates acquisition of the first 
spacer in an inefficient manner.  This newly acquired spacer, or an old partial-match 
spacer, is modelled to act as a ‘primer’ for further spacer acquisition (‘primed’ 
adaptation) from the same DNA strand (Figure 1.12) (Datsenko et al., 2012; Swarts 
et al., 2012; Fineran et al., 2014).  In the case of a partial match, the number, position 
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and type of mutation may also influence a priming event, with mismatches of cytosine 
nucleotides within the crRNA appearing to elicit the greatest priming response 
(Fineran et al., 2014).  Upon assembly on the protospacer, the adaptation machinery 
then appears to move in a 3’ to 5’ direction, scanning beyond the primary site for 
additional PAMs (Datsenko et al., 2012; M. Li et al., 2014).  In this context, 
Cascade/Cas3, having already located to the target, may alternatively signal for 
and/or act as a DNA-binding scaffold for the adaptation components (Datsenko et al., 
2012; Swarts et al., 2012).  This system presumably increases the efficiency with 
which the adaptation components can encounter prospective protospacers 
(Datsenko et al., 2012; Swarts et al., 2012; M. Li et al., 2014) and allows a quick 
response to changing virus populations (Swarts et al., 2012; M. Li et al., 2014).   
 
Recently, the strong association of Cas1 and Cas2 into a complex with Csa1 and 
Cas4 has been observed in Thermoproteus tenax Type I-A system (Plagens et al., 
2012).  The Cas1/Cas2/Csa1/Cas4 operon is separately encoded to the components 
of CASCADE and tentatively labelled CASCIS (‘CRISPR-associated Complex for the 
Integration of Spacers’) (Plagens et al., 2012).  Whilst such a complex is currently 
poorly defined, the observation nonetheless clarifies that components of the 
adaptation machinery are unlikely to function on an individual basis and possibly are 
at their most efficient when coalesced with the complementary functionalities of each 
other and/or CASCADE (Figure 1.12) (Plagens et al., 2012). 
 
 
Figure 1.12: Primed adaptation model.  Previously acquired spacers or even older, partially 
matching spacers allow CASCADE to bind target DNA sequences prompting R-loop formation 
and the recruitment of Cas3 to cleave the non-target strand.  Upon dissociation of CASCADE, 
the spacer acquisition machinery (Cas1/Cas2) may alternatively be recruited to Cas3 to 
facilitate protospacer section.  The 5’!3’ mobility of Cas3 may underpin the pattern reflected 
in spacer acquisition from both target and non-target strands relative to the priming proto-
spacer.  Adapted from (M. Li et al., 2014). 
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1.9.1.2 Non-cas Gene Factors 
Other non-cas gene factors appear to be important for the spacer acquisition 
mechanism, such as the leader sequence and the repeats themselves.  In 
Sulfolobus, the leader sequence, when physically linked to certain cas genes, is 
essential to spacer acquisition (X. Peng et al., 2003; Lillestøl et al., 2009; 
Gudbergsdottir et al., 2010).  Whilst shared sets of spacers exist within S. 
solfataricus strains P1 and P2, divergence within ‘active’ loci is also prevalent 
(Lillestøl et al., 2009).  The clusters labelled E and F are identical in each strain, 
indicating a level of ‘deactivation’ with no new spacers being added or removed 
(Lillestøl et al., 2009).  A degenerate first repeat exists in cluster E whereas Cluster F 
lacks a leader sequence (Lillestøl et al., 2009).   
 
The leader sequence thus may provide a platform to assemble the necessary 
machinery (X. Peng et al., 2003), which in turn may utilise the primary repeat of the 
array to locate the correct insertion point (Lillestøl et al., 2009).  Such a mechanism is 
supported by the work of Yosef et al. who demonstrated that the first 60 nt of the 
leader sequence in E. coli BL21 (DE3) is essential for the integration mechanism and 
is sensitive to mutation (Yosef et al., 2012).  Indeed, the Cas1-Cas2 complex was 
shown to specifically recognise and bind to CRISPR DNA featuring this minimal 
leader sequence (Nuñez et al., 2014).  Furthermore, the presence of at least one 
repeat sequence, which is used as a template and copied, is also essential for 
integration to occur (Pourcel et al., 2005; Barrangou et al., 2007;Yosef et al., 2012).  
Whilst most mutations made in this very first repeat are duplicated in all subsequent 
repeat-spacer unit additions (Yosef et al., 2012), any mutations in the final nucleotide 
of the repeat sequence are not propagated and appear to instead derive from the 
PAM itself (Datsenko et al., 2012; Swarts et al., 2012).  In certain systems, this may 
be a mechanism to ensure correct orientation of the added spacer; however, such a 
mechanism appears to be lacking in other systems, including S. solfataricus 
(reviewed in Staals and Brouns, 2012).  
 
Tightly regulating the spacer-repeat unit size is important to downstream effector 
complex functionality and could be the limiting factor on crRNA/acquired spacer 
length (Lillestøl et al., 2009; Lintner, Kerou, et al., 2011). In S. solfataricus, a protein 
that binds specifically to chromosomal DNA repeat sequences and distorts DNA, 
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Cbp1 [Sss0454] has been identified that may delineate insertion points (X. Peng et 
al., 2003).  However, as a small (17.5 kDa) protein belonging to the ‘helix-turn-helix’ 
superfamily populated by other transcriptional regulators, it is possible that Cbp1 may 
play a role in transcriptional regulation of the CRISPR array (X. Peng et al., 2003).  
The S. solfataricus P1 and P2 repeat cluster F has a 106 bp region comprising two 
irregular repeats lying upstream of a half-spacer, followed by a repeat and no spacer 
(Lillestøl et al., 2009).  This unusual pattern matches the exact length of the normal 
repeat-spacer units within the locus, which suggests a ruler mechanism may control 
insertion of new repeat-spacer units (Lillestøl et al., 2009).  Despite commonalities 
between Cas proteins, the specific mechanism of spacer addition could differ 
between not only archaea and bacteria, but also between members of those groups, 
as seen by the wide range of repeat lengths, spacer sizes, and in spacer/repeat size 
ratios (Grissa et al., 2007). 
 
Up to 1% of total archaeal genome length can be dedicated to CRISPR arrays (She 
et al., 2001), which poses several further questions – for example, once spacers are 
acquired, how are the clusters maintained?  Logically there has to be a finite size, but 
how or what does the housekeeping and record maintenance?   
 
The insertion of a new spacer appears to occur concomitantly with the deletion of 
another more distal representative (Deveau et al., 2008; Horvath et al., 2008) so that 
older spacers are preferentially deleted to make room for newer and more valuable 
spacers to best match the current environment (Horvath et al., 2008).  The 
conservation of each end of CRISPR loci suggests deletions can occur internally, and 
large internal deletions within S. solfataricus CRISPR loci have been noted (Lillestøl 
et al., 2009). Whilst no machineries or detailed mechanisms have been proposed, 
this process could possibly entail homologous recombination between repeats 
(Deveau et al., 2008; Horvath et al., 2008; Lillestøl et al., 2009; Gudbergsdottir et al., 
2010).  
1.9.2 crRNA Biogenesis: Generation of the targeting RNAs 
that guide the CRISPR response 
The CRISPR system has long been hypothesised to function through non-messenger 
RNA intermediates (Tang et al., 2002; 2004; Makarova et al., 2006; Kunin et al., 
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2007), and crRNA has since been proven as the targeting element used in all 
CRISPR/cas systems characterised to date (Brouns et al., 2008; Hale et al., 2008; 
Lintner, Kerou, et al., 2011; Zhang et al., 2012).  crRNA biogenesis is thus an 
essential step within the immune response (Makarova et al., 2006). 
1.9.2.1 Transcription of the CRISPR array 
The CRISPR array is transcribed as a single unit to generate a large non-mRNA 
molecule (pre-crRNA), from which individual spacers (crRNA) are subsequently 
released via endonucleolytic processing (Lillestøl et al., 2009) (Figure 1.13). 
 
Regulatory aspects of the CRISPR system as a whole are largely unknown at 
present (reviewed in Sorek et al., 2013).  crRNA appears to be generated 
constitutively rather than through up-regulation (Tang et al., 2002; 2004; Lillestøl et 
al., 2006; Hale et al., 2008; Zhang et al., 2012).  In archaeal systems, RNA 
polymerase recognises the BRE/TATA promoter (hexameric TATA-like sequences) 
within the leader sequence and subsequently transcribes the CRISPR array as a 
single unit (Lillestøl et al., 2006; 2009; Hale et al., 2012), with spacers nearest the 
leader sequence having the highest levels of transcription (Hale et al., 2008; 2012).  
In organisms possessing lengthy CRISPRs, such a transcriptional gradient would 
ensure the most recently incorporated spacers are highly expressed and can be used 
to neutralise current threats whilst the resources dedicated to monitoring for ancestral 
threats are kept to a minimum (Barrangou et al., 2007; Deveau et al., 2008; Hale et 
al., 2008; 2012). As witnessed by the weak transcription levels of S. solfataricus 
clusters E and F (Gudbergsdottir et al., 2010), the leader sequence and first repeats 
may act as a platform to assemble the necessary transcription machinery (Lillestøl et 
al., 2009; Wurtzel et al., 2010). 
 
Additionally, transcription of the CRISPR array may be further regulated by protein 
factors.  In particular, the protein Cbp1 (Section 1.9.2.1, above) may act to occlude 
the necessary binding sites or provide a physical barrier to transcription (X. Peng et 
al., 2003).  Homologues of Cbp1 have so far been identified in sulfolbales spp. (X. 
Peng et al., 2003; Deng et al., 2012) and desulfurococcales only (Brugger et al., 
2007).  Two novel cas gene families have also been identified in archaea with 
features highly reminiscent of transcriptional regulators, which may also function in 
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the specific regulation of CRISPR/Cas systems; Csx1 (COG1517) and Csa3/CasRa 
(COG0640) (Lintner, Frankel, et al., 2011). 
 
 
 
Figure 1.13:  Overview of crRNA biogenesis across system types. Repeat sequences 
(black), spacer sequences (red/yellow/orange/green), tracrRNA (purple).  crRNA biogenesis is 
mediated by different proteins in Type II and I/III systems (Cas9 and Cas6, respectively).  
Within Type III systems, crRNA may undergo additional maturation steps that involve the 
trimming of 3’ handle sequence. Downstream effector complexes utilise appropriately mature 
crRNA (example red spacer) to identify complimentary protospacer sequences (light red) 
alongside, where applicable, a 3’ or 5’ PAM motif (blue).  Adapted from Reeks, Naismith, et al., 
2013. 
 
 
As an interesting side note, some studies have illustrated the presence of CRISPR 
transcripts derived from the reverse strands of S. acidocaldarius and S. solfataricus 
CRISPR loci (Lillestøl et al., 2006; 2009; Wurtzel et al., 2010; Deng et al., 2012).  
However, they are possibly the result of fortuitous transcription initiation sequences 
or sites randomly acquired with the protospacer (given the protospacers 
corresponding to acidothermophiles are AT-rich in sequence) (Deng et al., 2012). 
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Cbp1 may act to limit unintentional transcription from internal initiation sites within the 
array (Deng et al., 2012). 
1.9.2.2 Pre-crRNA Processing 
Releasing individual spacers from the long CRISPR transcripts is an essential step in 
the CRISPR/cas defensive pathway (Figure 1.13) (Makarova et al., 2006; Brouns et 
al., 2008; Hale et al., 2008; Makarova, Haft, et al., 2011).  In Type I and III systems, 
this activity is generally considered to occur by direct cleavage of the repeat 
sequences by the CRISPR-specific riboendonuclease, Cas6 (Figure 1.13) (Brouns et 
al., 2008; Carte et al., 2008; Jore et al., 2011; Wiedenheft, van Duijn, et al., 2011; 
Hatoum-Aslan et al., 2011; Peng et al., 2013; Brendel et al., 2014; Haurwitz et al., 
2010; Lintner, Kerou, et al., 2011; Deng et al., 2013).  Conversely, Type II systems 
utilise an RNA intermediate to base-pair with the repeat site and recruit RNaseIII to 
cleave the now dsRNA region (Deltcheva et al., 2011, see Charpentier et al., 2012 for 
an extensive review of crRNA biogenesis across system types). 
 
Whilst its role was initially enigmatic, the presence of processed CRISPR-derived 
RNAs was noted relatively early on, though the mechanism for their generation was 
unknown (Mojica and Garrett, 2012).  The characteristic arrangement of mature 
crRNAs, as an intact spacer derived from the processing of a long pre-crRNA 
transcript, was determined by Tang et al. by sequencing a cDNA library of small 
RNAs from A. fuldigus and mapping the necessary cleavage sites to the repeat 
sequences (Tang et al., 2002; Mojica and Garrett, 2012). 
 
Brouns et al. were the first to identify an endoribonuclease, from the Type I-E system 
of E. coli K12, capable of processing transcripts in a CRISPR-specific manner 
(Brouns et al., 2008).  Originally designated CasE (and since re-designated Cas6e), 
the isolated protein could cleave repeat sequences 8 nt from the 3’ end/terminus in a 
metal-independent fashion (Brouns et al., 2008).  Similar endoribonuclease activity 
has since been defined for Cas6 family members associated with Type I and III 
systems from a variety of diverse bacterial and archaeal species, such as P. furiosus 
(Type III-B, (Carte et al., 2008)), T. thermophilus (I-E, Gesner et al., 2011; Sashital et 
al., 2011), P. aeruginosa (I-F, Haurwitz et al., 2010), S. solfataricus (Type I-A, Lintner, 
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Kerou, et al., 2011), C. thermocellum and M. maripalaudis (I-B, Richter et al., 2012; 
2013), S. islandicus (I-A, Peng et al., 2013) and H. volcanii (I-B, Brendel et al., 2014).   
 
Despite very little sequence similarity, Cas6 from P. furiosus (Carte et al., 2008), 
Cas6f from P. aeruginosa (Haurwitz et al., 2010) and Cas6 from T. thermophilus 
(Ebihara et al., 2006) are all structurally related, sharing a ferredoxin-like fold 
produced by the RRM, and are functionally homologous, cleaving repeat sequences 
within the CRISPR transcript in a metal-independent manner (Brouns et al., 2008; 
Carte et al., 2008; Haurwitz et al., 2010). This cleavage event releases individual 
spacers flanked with an 8 nt 5’-tag, a universal feature of crRNAs, and 3’-handle 
derived from cleaved repeat sequence (Lillestøl et al., 2006; Brouns et al., 2008; 
Carte et al., 2008; Hale et al., 2008; Haurwitz et al., 2010; Gesner et al., 2011; 
Hatoum-Aslan et al., 2011; Lintner, Kerou, et al., 2011; Zhang et al., 2012; Rouillon et 
al., 2013).  Such products have 5’ hydroxyl and 3’ 2’,3’-cyclic phosphate termini, 
which suggests the enzyme mechanism employs general acid-base catalysis in 
which the deprotonated 2’ hydroxyl performs a nucleophilic attack on the scissile 
phosphate (reviewed in Reeks, Naismith, et al., 2013).  After cleavage, Cas6 remains 
tightly bound to the upstream product via the 3’-handle (Carte et al., 2008; Haurwitz 
et al., 2010; Sashital et al., 2011; Sternberg et al., 2012; Niewoehner et al., 2014) 
which has implications for subsequent effector complex assembly and crRNA 
handover. 
 
However, as a product of the rapid rate of RAMP evolution (Makarova, Aravind, et al., 
2011) and co-evolution with diverse repeat sequences with varying predispositions 
for secondary structure (Section 1.4.1) (Kunin et al., 2007)), mechanistically, the 
characterised Cas6s display extensive variation.  The variety in mechanisms and 
structures will be discussed in detail as the subject of this thesis, alongside the 
categorisation of a Cas6 example from S. solfataricus. 
 
Whilst the 5’-tag is strictly retained in all crRNA, the 3’-handle can undergo a series 
of additional maturation events, primarily for use in Type III systems (Figure 1.7 & 
1.13) (Makarova, Haft, et al., 2011).  Both Type I and III begin with primary 
processing by the Cas6 endonuclease to generate the intermediate-crRNA.  This 
represents the useable crRNA state within the Type I system, and the guide RNA is 
incorporated as such into the DNA-targeting ‘CASCADE’ effector complex (Section 
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1.8.4, Brouns et al., 2008; Lintner, Kerou, et al., 2011; Makarova, Haft, et al., 2011; 
Peng et al., 2013).  crRNA (often referred to as the ‘1x intermediate’ after the primary 
processing step (Hale et al., 2008)) alternatively destined for Type III systems may 
undergo further processing to trim away the 3’-handle (Hale et al., 2008; Carte et al., 
2008; Hale et al., 2009; Lillestøl et al., 2009; Carte et al., 2010; Hatoum-Aslan et al., 
2011; Makarova, Haft, et al., 2011; Hale et al., 2012; Zhang et al., 2012; Rouillon et 
al., 2013).  For instance, in P. furiosus, the 65 nt primary pre-crRNA product is 
predominantly processed into two ‘mature’ sub-species of 45 nt and an ~39 nt mature 
crRNA of the truncated 3’-handle ((Hale et al., 2008; 2009; 2012).  The 3’-termini of 
crRNA extracted from ttCMR are unphosphorylated (i.e. have a hydroxyl terminal) 
(Staals et al., 2013), indicating Cas6 is not the enzyme responsible. 
 
Though the crRNA maturation event(s) likely employ a host enzyme, its identity is not 
known, nor is it known if Cas6 remains bound to the crRNA intermediate to help 
guide such further processing as the endonuclease is not a subunit of Type III 
complexes (Section 1.9.3.2).  Both Type I and III systems (Figure 1.7) are present in 
S. solfataricus, and alternative maturation events may dictate which downstream 
effector complex the crRNA is destined for.  The involvement of Cas6 beyond the 
primary processing event and possible roles in the regulation of the channelling of 
crRNA to different effector complexes will be examined in chapters 4 and 5. 
 
In Types I and III systems, members of the Cas6 family are considered the primary 
pre-crRNA processing endonuclease (Brouns et al., 2008; Carte et al., 2008; Jore et 
al., 2011; Wiedenheft, van Duijn, et al., 2011; Hatoum-Aslan et al., 2011; Peng et al., 
2013; Brendel et al., 2014; Haurwitz et al., 2010; Lintner, Kerou, et al., 2011; Deng et 
al., 2013).  However, in genomes that lack a Cas6 homologue, other subtype-specific 
cas genes have recently been implicated as substitutes in this vital role, such as 
Cas5c in the Type I-C system of Bacillus haodurans (Nam, Haitjema, et al., 2012), 
and Cmr2 in the Type-III B system of Cyanobacterium synechocystis sp. PCC6803 
(Scholz et al., 2013).  However, across the type I-A, III-B and III-A systems 
possessed by S. solfataricus, Cas6 appears to be the only enzyme currently 
implicated in crRNA biogenesis (Lintner, Kerou, et al., 2011; Peng et al., 2013). 
 
Type II systems employ a fundamentally different approach to crRNA biogenesis 
altogether.  Unlike Type I and III systems, which rely on a CRISPR-specific 
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endonuclease, Type II systems instead employ a general non-Cas host nuclease for 
the primary processing step (Figures 1.7 and 1.13) (Makarova, Haft, et al., 2011). In 
Type II systems 89-171 nt transcripts of ‘tracrRNA’ (‘trans-activating CRISPR RNA’) 
base-pair with pre-crRNA (Deltcheva et al., 2011).  With this binding, the 
housekeeping enzyme RNase-III is then recruited to cleave the now double-stranded 
RNA to leave a 20 nt 5’-tag.  Concomitant expression of Cas9 was also essential to 
this mechanism of crRNA biogenesis and may act as a scaffold to facilitate base-
pairing between tracrRNA and pre-crRNA molecules during primary processing.  
Type II processed crRNA undergoes a further maturation event mid-spacer, in which 
Cas9, a large, multi-domain protein which possesses nuclease-like motifs 
(reminiscent of RuvC-like (RNase H fold) and McrA/HNH nucleases) could mediate 
the subsequent cleavage step.  This activity appears to rely on a ruler-like 
mechanism that allows Cas9 to cleave at a standard position within otherwise highly 
variable, spacer-derived sequences (Deltcheva et al., 2011).  Unlike the multi-protein 
effector complexes utilised by Type I and III systems, during Type II interference 
Cas9 protein alone, with crRNA in situ, subsequently orchestrates the cleavage of 
any detected targets sequences, likely mediated through the HNH subdomain which 
is a common feature of restriction enzymes (Makarova, Haft, et al., 2011).  
Inactivation of Cas9 prevents an interference response by Type II systems 
(Barrangou et al., 2007) in which DNA (phage or plasmid) is cleaved at a specific site 
within the protospacer (Garneau et al., 2010). 
1.9.3 Interference: Silencing the threat 
Effector complexes utilise crRNA to silence threats at both the DNA (Brouns et al., 
2008; Marraffini and Sontheimer, 2008; Shah et al., 2009; Garneau et al., 2010; 
Manica et al., 2011) and at the RNA level (Hale et al., 2009; 2012; Zhange et al., 
2012). 
1.9.3.1 Type I: CASCADE-mediated targeting of DNA 
First isolated in E. coli and denoted CASCADE (CRISPR-associated complex for 
antiviral defence) (Brouns et al., 2008), a 405 kDa complex of five cas proteins 
(CasA-E, Brouns et al. nomenclature) was demonstrated to mediate phage 
resistance by recognising invader DNA (Jore et al., 2011), via sequence 
complementarity to an incorporated crRNA molecule (Brouns et al., 2008; Jore et al., 
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2011).  Whilst EM images illustrated that the complex adopts a ‘seahorse’-like 
silhouette (Figure 1.14A) (Jore et al., 2011), subsequent cryo-EM reconstructions, 
aided by the crystal structures of individual subunits (Agari et al., 2010; Sashital et al., 
2011; 2012), have revealed the architecture of the complex in detail (Figure 1.14C, 
(Wiedenheft, Lander, et al., 2011; Hochstrasser et al., 2014)). The Type I-E 
CASCADE – Cse1:Cse2(2):Cas5:Cas7(6):Cas6e – incorporates Type I processed 
crRNA (a complete spacer unit flanked with an 7-8 nt 5’-tag and 3’-handle derived 
from primary processed repeat sequence) (Brouns et al., 2008; Jore et al., 2011).  
The crRNA molecule is anchored at the 3’ end by Cas6e, from which it extends ~45 
nt along the binding groove of a helical core of multiple Cas7 subunits and terminates 
with a hook-like structure in a pocket formed by the last Cas7 and Cse1 (large sub-
unit, Type I-E specific gene) (Wiedenheft, Lander, et al., 2011).  Cas5 abuts the 
Cse1/Cas7 interface, whilst centrally on the crRNA molecule is a Cse2 dimer, which 
forms a protein bridge between the two ends of the complex (Wiedenheft, Lander, et 
al., 2011).  The presence of each subunit of the Type I-E complex is essential for its 
function, and the loss of any one subunit disrupts phage resistance in vivo (Jore et al., 
2011).  A similar subunit stoichiometry was determined for the Type I-F CASCADE 
from P. aeruginosa, though this example lacks a Cse2 equivalent: 
Csy1:Csy2(Cas5):Csy3(Cas7)(6):Cas6f-crRNA (Figure 1.8) (Wiedenheft, van Duijn, et 
al., 2011). 
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Figure 1.14: E. coli Type I-E CASCADE. (A) Composite EM image of E. coli Type I-E 
CASCADE illustrating the resemblance in shape to a ‘seahorse’ (Adapted from Jore et al., 
2011).  (B) E. coli Type I-E system operon and associated CRISPR.  Upon crRNA generation 
Cas6e (CasE) remains bound to the nascent crRNA molecule mediated through stem-loop 
domain (inset).  (Ci) Subunit organisation of CASCADE.  Six copies (C1-6) of the Cas7 
representative (CasC/Cse4) comprise the crRNA-binding RAMP backbone of the complex. 
(Adapted from Hochstrasser et al., 2014).  (Cii).  3D model of CASCADE generated from 
Cryo-EM imaging techniques. C1-C5 helix (~135˚ pitch) forms a continuous groove on the 
concave face of the CASCADE molecule in which the crRNA molecule is nested.  C6 is 
positioned slightly out of sync (160˚) relative to the remaining Cas7 subunits and interacts 
with the crRNA 5’ tag, which forms a hook-like structure (B and Cii, Adapted from Wiedenheft, 
Lander, et al., 2011). 
 
Orthologues of only Cas6, Cas7 and Cas5 family members are present in the 
CASCADE-like cassettes of the Type I-A CRISPR-systems (Haft et al., 2005; 
Makarova et al., 2006; Lintner, Kerou, et al., 2011; Plagens et al., 2012; 2014).  
Variable subunit compositions between subtypes more than likely indicate 
mechanistic and functional differences.  The archaeal Type I-A CASCADE 
(aCASCADE) system has been partially isolated from S. solfataricus (Lintner, Kerou, 
et al., 2011), and the CRISPR-mediated silencing of invading DNA by this 
crenarchaeon demonstrated in vivo (Manica et al., 2011).  Cas6[1437] alongside 
Csa5[Sso1443] (small subunit) and Cas8a2[sso1401] (Large subunit), both of which 
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have unknown function, co-purify with the Cas7[1442]/Cas5[1441] core of the Type I-
A complex, though the associations appear weak and/or transitory (Lintner, Kerou, et 
al., 2011). These protein associates may bind the terminal ends of the Cas7 
backbone to confer specificity for crRNA and/or control complex formation to 
accommodate crRNAs of varying length (Lintner, Kerou, et al., 2011).  In stark 
contrast to Types I-E, I-F, CASCADEs (Jore et al., 2011; Wiedenheft, van Duijn, et al., 
2011), the functional Type I-A complex appears to lack Cas6 as an integral subunit 
and suggests the endonuclease hands over the crRNA product rather than being 
permanently incorporated in the complex (Lintner, Kerou, et al., 2011; Peng et al., 
2013). 
 
 
Figure 1.15: S. solfataricus Type I-A CASCADE. (A) TEM image of Cas7 (Csa2) helical 
filaments that spontaneously form in the presence of RNA.  (B) Model of assembled Cas7 
subunits (alternating light/dark grey) illustrates a helical quaternary structure comprising 10 
Cas7 subunits per complete turn. (C) & (D) Model of Type I-A core CASCADE complex 
consists of 6-8 Cas7 subunits, restricted from unlimited growth by capping factors; a single 
Cas5 (Cas5a) copy at one end and additional factors at the other.  crRNA is held in an 
extended conformation within the concave face of the RAMP backbone of the complex.  
Adapted from Lintner, Kerou, et al., 2011.  
 
The core of all CASCADEs consists of a Cas7/Cas5 backbone, made up of a short, 
partial-helix arrangement of six to eight Cas7 units, that likely supports the binding of 
a single crRNA through the ferredoxin-like folds generated by the RRM present 
(Figures 1.14, 1.15, 3.2) (Lintner, Kerou, et al., 2011; Wiedenheft, Lander, et al., 
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2011).  Whilst the extended conformation of crRNA suggests that it acts as a scaffold 
for Cas7 assembly and other components (Lintner, Kerou, et al., 2011; Wiedenheft, 
Lander, et al., 2011), the precise mechanism of CASCADE assembly is unclear and 
may differ between subtypes.  Given the potential autonomy of Cas6, which has been 
shown to be capable of processing pre-crRNA in isolation from other CASCADE 
components (Brouns et al., 2008; Carte et al., 2008; Haurwitz et al., 2010; Sashital et 
al., 2011), CASCADE assembly could either occur upon pre-crRNA or crRNA.  Cas6 
likely plays a significant role in the assembly process given a propensity to remain 
bound to the products of pre-crRNA cleavage (Carte et al., 2008; Haurwitz et al., 
2010; Sashital et al., 2011; Sternberg et al., 2012; Niewoehner et al., 2014).  In type 
I-E and I-F systems, the Cas6-crRNA sub-complex appears critical for assembly and 
on-going stability of the associated complexes, and as a result, these endonucleases 
adhere to strict single-turnover kinetics (Jore et al., 2011; Wiedenheft, van Duijn, et 
al., 2011; Sashital et al., 2011; Sternberg et al., 2012).  In Chapters 4 and 5, the 
assembly of CASCADEs associated with both Type I and III systems is discussed 
with respect to variations in Cas6 activity across this endonuclease family, of which 
S. solfataricus Cas6 is shown to be a particularly unorthodox example.   
 
In vitro, a minimal subcomplex of Cas7/Cas5-crRNA of the Type I-A system was 
shown to be sufficient to form a heteroduplex with complementary ssDNA targets 
(Lintner, Kerou, et al., 2011).  By itself, the CASCADE-crRNA RNP complex lacks 
interference capabilities, and as such is often referred to as the ‘surveillance’ 
complex.  Interestingly, it was been shown that assembly of the Type I-E CASCADE 
system requires no energy input, suggesting that the CRISPR/Cas system may be 
able to passively monitor for a wide range of threats (Jore et al., 2011).  
 
When a matching protospacer sequence is detected, conformational changes occur 
in both the CASCADE complex (Wiedenheft, Lander, et al., 2011) and the targeted 
DNA strand (Jore et al., 2011; Westra, Nilges, et al., 2012; Westra, van Erp, et al., 
2012). 
 
Base-pairing between the protospacer sequence and crRNA is initialised through a 
region denoted the ‘seed’ sequence, a 7 nt, non-contiguous sequence located at the 
5’ end of crRNA (Figure 1.16, (Semenova et al., 2011; Wiedenheft, Lander, et al., 
2011).  Nucleotides 1-5 and 7-8 of this sequence induce the formation of an R-loop 
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with matching dsDNA such that the targeted region of the protospacer forms a 
heteroduplex with the relevant crRNA region and the non-target strand is ‘displaced’ 
as ssDNA (Figure 1.16, (Semenova et al., 2011; Wiedenheft, Lander, et al., 2011).  
Whilst some mismatches can be tolerated outside the seed sequence, perfect base-
pairing with the complementary 3’-region within the protospacer is essential for 
CASCADE binding and initialising the interference response (Semenova et al., 2011; 
Manica et al., 2013).  Identification of similarly located seed regions in both bacteria 
(Semenova et al., 2011) and archaea (Manica et al., 2013), may illustrate that the 5’ 
located 8 nt stretch of sequence is a universal feature of CRISPR systems or at the 
least Type I systems. 
 
 
Figure 1.16: Target dsDNA melting and R-loop formation with crRNA is nucleated from 
a seed sequence. (A) Schematic of sequence elements involved in the R-loop formation 
between crRNA and target strand (Adapted from Hochstrasser et al., 2014). (B) CASCADE 
scans for potential target sequences in a non-specific manner mediated through the Cse1 
subunit, which contains an exposed loop (L-1) that interacts with PAM sequences (i.).  
Binding between L-1 and a PAM sequence initiates a probe for target-authenticity in which the 
seed sequence is presented an opportunity to base-pair with the target (ii), If successful (iii.), 
complete binding between crRNA and protospacer is propagated in a 3’!5’ direction along 
the remaining length of the spacer domain leading to R-loop formation (iv.).  Adapted from 
Sashital et al., 2012. 
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It has been demonstrated in S. solfataricus that targets are only cleaved when the 
appropriate PAM is present, with point mutations sufficient to abolish interference 
(Lillestøl et al., 2009; Manica et al., 2011; Gudbergsdottir et al., 2010).  Similar PAM-
dependency was shown for Type I-E systems (Semenova et al., 2011; Sinkunas et 
al., 2013; Westra, van Erp, et al., 2012), specifically where the prerequisite R-loop 
only forms if the correct PAM is present (Sinkunas et al., 2013). 
 
Complete type-I CASCADE complexes have been shown to bind dsDNA at low 
affinity in a non-specific manner that is not reliant on crRNA-protospacer interactions 
(Jore et al., 2011; Sashital et al., 2012; Westra, van Erp, et al., 2012).  Given that a 
crRNA is mismatched outside the spacer region, it would imply it is a CASCADE itself 
that recognises the PAM element through protein-DNA interactions (Marraffini and 
Sontheimer, 2010; Gudbergsdottir et al., 2010; Sashital et al., 2012; Westra, van Erp, 
et al., 2012), potentially via the large subunit, Cse1, which is required for Type I-E 
CASCADE to non-specifically bind DNA (Jore et al., 2011).  Indeed, Cse1 possesses 
a flexible loop (L1), that is located adjacent to the PAM sequence when CASCADE is 
in complex with a target DNA and is sensitive to mutation, suggesting that it mediates 
PAM recognition (Sashital et al., 2012; Hochstrasser et al., 2014).  Since Cse1 is not 
conserved in other Type I systems, e.g. S. solfataricus Type I-A and I-F, it suggests 
that either functional orthologues exist (likely Cas8 and Csy1, respectively) or 
alternative mechanisms are employed.  Alternatively located PAM sequences 
favoured by the different system subtypes are also likely indicative of different 
recognition/interaction mechanisms by the associated CASCADEs. 
 
Although the minimal PAM for the S. thermophilus Type I-E system only consists of a 
single nucleotide of A or T downstream, its presence is essential for both CASCADE 
binding and R-loop formation (Sinkunas et al., 2013).  Consequently, a loosely-
associated CASCADE is modelled to slide along DNA sequences, whereupon 
recognition of the PAM sequence by the CASCADE complex may trigger base-paring 
between the crRNA and protospacer (Figure 1.16) (Sashital et al., 2012; Sinkunas et 
al., 2013)) and make for a more energy-efficient way of scanning for threats.  The 
PAM required for adaptation and interference stages, though co-located, may differ in 
length (Swarts et al., 2012; Sinkunas et al., 2013; Fineran et al., 2014), with short 1-2 
nt sequences sufficient for interference but longer regions required for the stringent 
process of spacer selection (Sinkunas et al., 2013). 
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In the Type I-E complex, target DNA binding induces rearrangements in Cse1, Cas6e 
and Cse2 subunits that expose the full crRNA length to potential contacts 
(Wiedenheft, Lander, et al., 2011; Nam, Huang, et al., 2012; Hochstrasser et al., 
2014) that are not exposed prior to target matching by the seed region and 
subsequent DNA/protein rearrangements (Wiedenheft, Lander, et al., 2011). 
 
 
Figure 1.17: Schematic of target recognition and recruitment of Cas3 by Type I 
CASCADE. (A) CASCADE scans for PAM sequences.  (B) & (C) Non-specific recognition of 
PAM sequence by L-1 loop of Cse1 (Sashital et al., 2012) initiates CASCADE re-
arrangements (Wiedenheft, Lander, et al., 2011; Hochstrasser et al., 2014) that facilitate helix 
destabilisation and R-loop formation propagated from the seed region (Sashital et al., 2012). 
(D) The ‘non-target’ strand (NTS) is displaced to the exterior of the molecule, positioned by 
Cse1 for the recruitment of Cas3 (Hochstrasser et al., 2014).  (E) Upon primary nicking of the 
non-target strand by its nuclease domain, Cas3 loads onto the newly single-stranded DNA 
and mediates translocation/cleavage in a 3’!5’ direction coupled to the metabolism of ATP.  
Additional Cas3 molecule(s) may also bind to the now single-stranded ‘target’ strand and 
mediate its concomitant cleavage resulting in degradation of both strands of the invader DNA 
(Sinkunas et al., 2013).  The CASCADE complex is displaced enabling it to perform additional 
target recognition cycles. Adapted from Hochstrasser et al., 2014. 
 
Upon target identification and R-loop formation, CASCADE recruits the system-
specific and essential Cas3 nuclease/helicase (Figure 1.17, (Brouns et al., 2008; 
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Sinkunas et al., 2011; Westra, van Erp, et al., 2012; Sinkunas et al., 2013), a 
polypeptide comprising C-terminal (DExD/H-box) helicase/ATPase and N-terminal 
HD-type nuclease domains (Haft et al., 2005; Makarova et al., 2006), possibly using 
the displaced ssDNA region as a docking site (Sinkunas et al., 2013).  Recently, 
Type I-E Cas3 has been shown to coalesce with CASCADE at Cse1, specifically on 
the opposite face to that containing the L1-loop (i.e. PAM interaction) and location of 
the crRNA/targetDNA duplex (Hochstrasser et al., 2014).  It is possible that the large 
subunit positions the non-target strand exterior to CASCADE for best access by Cas3 
(Hochstrasser et al., 2014).  This association and/or the association with ssDNA 
appears to trigger ATP metabolism (Sinkunas et al., 2011; 2013; Hochstrasser et al., 
2014).  With ATP, Cas3 translocates in a 3’!5’ direction (with respect to the non-
target strand) to unwind dsDNA or RNA/DNA heteroduplexes with the helicase 
domain to allow endonucleolytic degradation of the ssDNA substrate by the nuclease 
domain (Sinkunas et al., 2011; Beloglazova et al., 2011; Westra, van Erp, et al., 
2012; Sinkunas et al., 2013; Mulepati and Bailey, 2013; Plagens et al., 2014).  The 
now single-stranded target strand is also susceptible to cleavage by the same and/or 
additional Cas3 units (Westra, van Erp, et al., 2012; Sinkunas et al., 2013).  In the 
absence of ATP or the helicase domain, Cas3 can still cleave ssDNA, though such 
cleavage activity is weak and restricted to the non-target strand and only results in a 
nicked DNA plasmid (Sinkunas et al., 2011; Westra, van Erp, et al., 2012).  Whilst the 
target DNA is ultimately destroyed, the crRNA guide remains intact permitting 
additional binding/recognition cycles. 
 
A typical feature of archaeal genomes, the Cas3 gene is often split into its constituent 
nuclease (Cas3”) and helicase (Cas3’) domains, which in M. jannaschii appear to 
work together to cleave ssDNA (Figure 1.18) (Beloglazova et al., 2011).  In contrast, 
dsDNA and dsRNA activity has been confirmed for the isolated HD nuclease subunit 
of S. solfataricus P2 Cas3” [sso2001] with only minimal ssDNA/ssRNA activity 
observed (Han and Krauss, 2009).  Associated helicase activity is unproven for 
[sso2001] and/or may be the preserve of a separate cas gene (e.g. [sso1999]), which 
in turn could modify the nucleic acid targets of this particular type I-A Cas3” 
(Makarova et al., 2002; Han and Krauss, 2009).  In S. islandicus, only Cas6, Cas5 
and Cas7, in conjunction with Cas3’/Cas3”, were required to mediate the interference 
response and the remaining subtype specific genes (e.g. Csa5) proved dispensable 
(Peng et al., 2013). The reconstituted Type I-A CASCADE from T. tenax was capable 
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of dsDNA degradation in a 3’!5’ direction to leave 9 nt fragments in vitro, possibly 
reflecting that the cleavage mechanism of Cas3” and the equivalent domain of Cas3 
in the Type I-E system is conserved (Plagens et al., 2014).  In this particular system, 
Cas3’/Cas3” were also revealed to be permanent subunits of the T. tenax Type I-A 
complex (Plagens et al., 2014), which may be a mechanism to alleviate issues of 
Cas3 coalescing with the target-bound CASCADE at elevated temperatures (Plagens 
et al., 2014).  
 
 
 
Figure 1.18: Cooperation between separate proteins with Cas3-like helicase or 
nuclease domains in the Type I-A interference mechanism of M. jannaschii.  After the 
specific nicking of a ss non-target strand by HD nuclease Cas3’’ (MJO384) as directed by 
aCASCADE (A), the surveillance complex is released to expose the non-duplexed target 
strand for association of additional Cas3’’ molecules (B) whilst helicase Cas3’ (MJO383) is 
recruited to unwind remaining dsDNA sections (C) ultimately leading to complete degradation 
of invader DNA.  Adapted from Beloglazova et al., 2011. 
1.9.3.2 Type III Interference: Targeting of both RNA and DNA 
Type III systems are present in only ~30% of bacteria (Shah and Garrett, 2011), but 
are found in 70% of archaea (Haft et al., 2005; Makarova et al., 2006; Shah and 
Garrett, 2011; Makarova, Haft, et al., 2011).  Unlike the relatively conserved Type I 
systems, Type III systems display a higher degree of structural, functional and 
mechanistic diversity.  Whilst the activities of type I and III modules are undoubtedly 
cooperative in their protection activities, they operate independently of one another 
(Deng et al., 2013). 
 
Type III systems contain the system specific gene, Cas10 (the ‘CRISPR 
polymerase’), and can be divided into two main subtypes: Types III-A and III-B, which 
each additionally contain a set of subtype specific genes (Table 1.3 and Figure 1.6) 
(Garrett, Shah, et al., 2011; Makarova, Haft, et al., 2011). Whilst Cas6 is (generally) 
responsible for the initial pre-crRNA processing within Type III systems (Hale et al., 
2012; Peng et al., 2013), the gene itself is not necessarily part of or located in the 
vicinity of the cmr/csm operon as is the case for S. solfataricus (Figure 1.25) (She et 
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al., 2001) and T. thermophilus (Agari et al., 2010).  Indeed, each system type in S. 
islandicus, one I-A and two III-B, relies on a single Cas6 gene for primary crRNA 
biogenesis (Deng et al., 2013).  The apparent independence of Cas6 from Type III 
systems is explored further in Chapter 5, which reveals that functional couplings 
between CRISPR endonucleases and their Type III client complexes may 
nonetheless exist. 
Subtype Cas5 group Cas7 Group 
Small subunit 
(Cas11**) 
Large subunit 
(Cas10 
Polymerase) 
Misc. 
III-A 
(CSM) Csm4 Csm3 Csm5   
Csm2 
(COG1421) Csx1, Csm1 Csm6 
III-B 
(CMR) Cmr3 Cmr1 Cmr4 Cmr6 Cmr7 * 
Cmr5 
(COG3337) Cmr2  
 
Table 1.3: Type III-A and III-B system components. Type III-A and III-B system 
components (Makarova, Haft, et al., 2011). 
* The CMR complex from P. furiosus contains 5 cmr genes (Hale et al., 2009) whereas the 
CMR complex characterised in S. solfataricus possesses an additional cmr component, cmr7 
(Zhang et al., 2012). 
**In addition to subtype specific members of the Cas5/Cas7/Cas10 families, each subtype 
contains an additional signature gene  (Csm2 and Cmr5, III-A and III-B respectively) that 
belong to the putative Cas11 family of small alphahelical proteins designated as the ‘small-
subunit’ (Makarova, Aravind, et al., 2011).  However, they share little/no sequence similarity 
(Makarova, Aravind, et al., 2011). Whilst Csm6 (COG1517) is regarded as a Type III-A 
component, this regulatory family protein is loosely associated with a number of CRISPR/Cas 
systems and unlikely to be a component of the basic CRISPR/Cas mechanism (Makarova, 
Aravind, et al., 2011). 
 
Early studies identified distinctive Cas operons with a high proportion of RAMP-family 
members that, in contrast to classically labelled CRISPR-associated (Cas) genes are 
often located remotely from the CRISPR arrays (Haft et al., 2005; Makarova et al., 
2006).  These highly linked cas genes were accordingly distinguished, as a group, as 
‘CRISPR-module: RAMP’  (CMR) (Haft et al., 2005).  Components of both Type III-A 
and III-B systems were initially labelled with the CMR format (i.e. cmr1, cmr2, etc.) 
due to clear orthologies, similar operon compositions, architectures and locations 
(Table 1.3).  However, especially with the characterisation of functional differences 
between subtypes, components of the DNA-targeting Type III-A system have largely 
been re-classified with the ‘CSM’ label for clarity, referring to the S. thermophilus 
system in which the response was first characterised (Section 1.9.3.2.1).  The Type 
III-B response is unusual amongst CRISPR/cas interference pathways in that the 
associated CASCADE complex (CMR-complex) utilises crRNA to target 
complimentary RNA sequences, rather than DNA (Hale et al., 2009; Zhang et al., 
2012).  Moreover, large differences exist within structure/mechanisms of Type III-B 
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complexes (Hale et al., 2009; Zhang et al., 2012; Spilman et al., 2013; Staals et al., 
2013).  Recently, evidence has also emerged that the Type III-A CASCADE (CSM-
complex) may even cleave RNA targets in addition to, or instead of DNA (White Lab, 
unpublished).  Type III systems thus exemplify the plasticity possible within 
CRISPR/cas systems, despite the use of a similar backbone composition across the 
CASCADES of each system type/subtype. 
1.9.3.2.1 Type III-A: DNA targeting by the CSM complex 
It was in vivo observations of Type III-A system activity that provided the first 
evidence for DNA-interference mediated by a CRISPR-based system (Marraffini and 
Sontheimer, 2008).  However, little progress has been made in the characterisation 
of this particular system subtype and crRNA-dependent cleavage has yet to be 
directly observed. 
 
In Staphylococcus epidermis, the CSM operon comprises single copies of genes 
csm1-6 (Figure 1.19).  The presence of the system was shown to prevent 
conjugation and plasmid transformation at the DNA level where a matching spacer 
was present in the adjacent CRISPR array (Marraffini and Sontheimer, 2008).  This 
activity was critically dependent on mismatch between the 5’-tag of crRNA and 
corresponding protospacer adjacent sequence (PAS, Section 1.10) (Marraffini and 
Sontheimer, 2010). 
 
The Type III-A system incorporates crRNAs truncated at the 3’-handle, though the 5’-
tag is retained (Hatoum-Aslan et al., 2011).  The maturation mechanism in the S. 
epidermis CSM-complex generates 37 and 43 nt crRNA products, whose lengths 
remain constant irrespective of sequence (outside of the 5’-tag), structure, or length 
of the intermediate, which together indicate a ruler-like mechanism at work anchored 
at the 5’-tag.  Crucially, this process appears independent of Cas6 and is instead 
reliant on other Cas genes, possibly by providing a scaffold for trimming by a host 
nuclease (Hatoum-Aslan et al., 2011).  This maturation event will be discussed 
further in chapters 4 and 5. 
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Figure 1.19: Type III-A CASCADE complex (CSM-Complex) from S. solfataricus. (A) 
S.solfataricus (Sso) CSM operon.  Small subunit, Large subunit and RAMP family genes are 
indicated, with the latter components further differentiated between Cas5 and Cas7 
subfamilies.  The associated Cas6 RAMP family member is not co-located with the CSM 
operon as indicated by the broken line.  (B) Subunit stochiometry of SsoCSM and interaction 
map as determined by a variety of methodologies (see (Rouillon et al., 2013)).  crRNA (Red 
line) is coordinated along its length by select Cas7 subunits.  Note the unequal molar ratios of 
Csm2 and one of the Cas7(Csm3) paralogues ([1424] and [1426], respectively).  (C) “Course-
grain” structural model calculated for ssoCSM fitted to EM map (D), in which coloured spheres 
are proportional in size to known subunit mass.  (D) EM surface map as per (C) and rotated 
90˚.  The same colour scheme is adopted in (A), (B) and (C) to differentiate between subunits 
Adapted from Rouillon et al., 2013. 
 
The structure of the CSM complex from S. solfataricus (ssoCSM) has recently been 
characterised by Rouillion et al. (Rouillon et al., 2013).  Whilst any DNA cleavage 
activity by a CSM complex has yet to be confirmed/directly observed, a role in DNA 
interference is inferred by the co-purification of ssoCSM with dsDNA and a high 
affinity for dsDNA substrates in vitro (100 nM, (Rouillon et al., 2013)).  In contrast to 
the Type III-A crRNA maturation pattern in S. epidermis CSM-complex (Hatoum-
Aslan et al., 2011), when purified SsoCSM was probed for crRNA content, only a 
single discrete band of 50 nt was observed (Rouillon et al., 2013).  Given the 
variability in S. solfataricus spacer sizes (34-48 nt) a ruler-like mechanism is likely 
still employed (Rouillon et al., 2013). 
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The ssoCSM operon is similar to those of other crenarchaea, comprising multiple 
csm3(Cas7) paralogues though lacking a csm5 gene as per S. epidermis (Haft et al., 
2005, Fig 1.19A).  The ~430 kDa (205x125x100 Å) ssoCSM-complex comprises 
each of the available gene products [sso1424 - 1432] (Figure 1.19, (Rouillon et al., 
2013). The complex consists of two, intertwining, helical filaments that are capped at 
one end by the large subunit csm1(Cas10) and at the other by select Csm(Cas7) 
paralogues.  The crRNA is bound along its length by the filament composed of 
entirely of RAMP family members (Rouillon et al., 2013).   
 
The pitch of helical twist, identical to that of Type I-E Cascade (Wiedenheft, Lander, 
et al., 2011; Rouillon et al., 2013), and other general similarities in overall Cascade 
structure suggest that the CSM complex adopts a similar mechanism of R-loop 
formation during interference and, given the dimensions of the subdomains, could 
feasibly accommodate duplex formation with a ~38 nt stretch of target DNA (Rouillon 
et al., 2013).  Recent uncertainty over whether Cas10 harbours the nucleolytic centre 
of Type III complexes has emerged (Section 1.9.3.2.2), which coupled to the lack of 
observed DNA nuclease activity by ssoCSM, may indicate that, as in Type I 
interference, the CSM complex is a ‘surveillance’ complex that recruits an external 
Cas3-like factor (Rouillon et al., 2013).  Type III-A systems may even share Cas3 
with Type I systems in the same manner as Cas6, though Rouillion et al. note that 
Cas3 is not always present in genomes that possess a Type III-A operon (Rouillon et 
al., 2013). 
1.9.3.2.2 Type III-B: RNA-silencing by the CMR complex 
In species possessing cmr genes, RNA-silencing disrupts the viral lifecycle by 
targeting mRNA transcripts (Hale et al., 2009; Zhang et al., 2012; Staals et al., 2013) 
and serves as an additional protective measure to complement the DNA-targeting 
activities of Type I and III-A systems (Brouns et al., 2008; Lintner, Kerou, et al., 2011; 
Sinkunas et al., 2011; Rouillon et al., 2013).  CMR subtypes have been delineated by 
Cas10 sequence (Garrett, Shah, et al., 2011); however, structural and functional 
characterisation of CASCADEs associated with Type III-B systems from P. furiosus 
and S. solfataricus have revealed deep mechanistic and structural differences within 
this subtype (Hale et al., 2009; 2012; Zhang et al., 2012; Staals et al., 2013; Spilman 
et al., 2013).   
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Figure 1.20: P. furiosus Type III-B Cascade complex.  (A) Schematic of the P. furiosus 
Type III-B system operon.  (B) Type III-B crRNA biogenesis from the associated CRISPR 
array leads to the accumulation of two crRNA species of different lengths (45 and 39 nt).  (C) 
Cryo-EM structure of the full Type III-B CASCADE complex (CMR-Complex) and identified 
subunit locations.  (D) Cmr4-Cmr5 alone spontaneously form extended helical filaments and a 
helical reconstruction of the filament is illustrated.  Matching densities in both the CMR-
Complex (C) and the Cmr4-Cmr5 filament (D) are circled (dashed line).  (E) Model in which 
Cmr6 and Cmr2-Cmr3 act as capping factors to restrict growth of the Cmr4-Cmr5 backbone 
helix.  As such, different lengths of crRNA may be accommodated by the complex.  Adapted 
from Spilman et al., 2013. 
 
CMR complexes incorporate mature, 3’-trimmed crRNA as the guide to mediate 
specific RNA silencing (Hale et al., 2009; Zhang et al., 2012; Spilman et al., 2013).  
The conserved 8 nt 5’-tag and complete spacer is present, although little to no 3’-
handle remains, suggesting that further crRNA maturation step(s) occur beyond 
primary processing by Cas6 (Carte et al., 2008; Lintner, Kerou, et al., 2011; Zhang et 
al., 2012). The 5’-tag is highly conserved and essential for activity by CMR, likely a 
result of having a critical role in full complex assembly (Hale et al., 2009; 2012), 
although it may also contribute to activity (Zhang et al., 2012). Across the CMR 
complexes characterised, associated crRNAs appear to exist in two population sizes 
that differ by 6 nt, though inter (and intra) species variation exists (Hale et al., 2009; 
Zhang et al., 2012; Scholz et al., 2013; Staals et al., 2013).  This either indicates a 
stringent selection mechanism by the complex and/or (more likely) a role in the final 
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maturation events (Hale et al., 2012).  The role of Cas6 in CMR and CSM complex 
assembly and subsequent 3’ handle maturation events are explored more fully in 
Chapters 4 and 5.  
 
CMR complexes from P. furiosus (pfCMR, Spilman et al., 2013) and T. thermophilus 
(ttCMR, Staals et al., 2013) have recently been modelled from EM images.  Both of 
these archaeal and bacterial representatives of this CASCADE subtype are similar in 
architecture, which has, somewhat ignominiously, been said to resemble a “sea-
worm” (Figure 1.20) (Staals et al., 2013).  
 
The pfCMR complex comprises six cmr genes (Table 1.3 and Figure 1.20) (Hale et 
al., 2009; Spilman et al., 2013).  The base is formed from Cas10 and Cas5 (cmr3), 
from which the backbone, made up of three copies of Cmr5/Cas7(cmr4), extends 
with a right-handed helical twist to meet Cas7 (cmr6) and finally a cap of Cas7 
(cmr1).  The striking similarity of CMR to the E. coli Type I-E complex is illustrated in 
Figure 1.21, and the authors observe that different stoichiometries of cmr5/Cas7 
(cmr4) dimers may accommodate for alternative lengths of the mature crRNA, which 
is further supported by the 6 nt size difference in the crRNA species that interact with 
the seCSM and pf/ttCMR-alpha complexes which corresponds precisely to the length 
of the RRM domain of one Cas7 (Lintner, Kerou, et al., 2011) or Csm3 subunit 
(Hatoum-Aslan et al., 2013).  The co-location of Cas5 (cmr3) and the crRNA 5’-tag 
may indicate a role for this subunit in crRNA recognition (Spilman et al., 2013), and a 
crystal structure of a crm2-cmr3 heterodimer illustrates a RNA binding cleft formed by 
the RRM on the cmr3 surface that ends with the cyclase domain of Cas10 (Osawa et 
al., 2013; Shao et al., 2013). 
 
In a mechanism reliant on divalent cations, the complex specifically cuts 
complementary target RNA 14 nt from the crRNA 3’-end of the duplexed region, 
irrespective of the size of target strand overhangs (Figure 1.21). Duplex formation 
could not be disrupted, especially within the final 14 nt, without negatively affecting 
cleavage.  This contrasts with the mechanisms of Type-I complexes, which rely on 5’ 
crRNA complementarity and are able to accomodate 3’ mismatches (Sections 1.9.3.1 
and 1.10).  Crucially, in native pfCMR preparations, two product RNAs were 
observed differing by 6 nt; the exact size difference between the two main 
populations of mature crRNA endogenous to P. furiosus (Hale et al., 2008; 2009), 
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indicating a ruler-like mechanism is employed (Hale et al., 2009).  Modelling the 
cleavage point of target RNA locates to a region near the Cas7 (cmr6)/cas7 (cmr1) 
and cmr5/Cas7 (cmr4) interface, with no major structural changes appearing to occur 
upon target binding by the complex (Spilman et al., 2013).  The Cmr1 protein from A. 
fuldigus is homologous to that of the pfCMR representative and has recently shown 
in vitro to be capable of binding and cleaving ssRNA in a metal-dependent fashion 
with no apparent sequence specificity (Sun et al., 2014).  
 
 
Figure 1.21: Conserved CASCADE organisation across system types alternatively 
targeting dsDNA and ssRNA elements elements. (A) Cryo-EM structures of E. coli Type I-
E and P. furiosus Type III-B CASCADEs.  (B) Functional organisation of the respective 
complexes.  Cas6 does not comprise a subunit of the Type III-B complex. Adapted from 
Spilman et al., 2013. 
 
The ~350 kDa ttCMR adopts a similar structure and stoichiometry (Figure 1.21), and 
Cmr1 has been shown to be loosely associated with the complex whilst Cmr2 and 
Cmr3 form stable heterodimers (Staals et al., 2013).  The activity of this CMR 
complex also adopts a ruler-like mechanism (Staals et al., 2013), however there are 
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additional levels of processing to that of the single cut made by pfCMR (Hale et al., 
2009).  Native ttCMR extracted from cell lysate generates five consistent product 
sizes from known target sequences, irrespective of the sequence provided (Staals et 
al., 2013).  Even the reconstituted ttCmr complex where crRNA length is controlled 
still generates three of the product sizes, irrespective of the 40 or 46 nt crRNA used.  
The work illustrates that the tt/pfCMR family employs a 6 nt ruler mechanism 
anchored at the 5’-end of the crRNA molecule, which subsequently progresses in a 
3!5’ direction along the target strand (Figure 1.23) (Staals et al., 2013).   
 
Figure 1.22: Type III-B CASCADE complex (CMR-Complex) from S. solfataricus.  (A) S. 
solfataricus (Sso) CMR operon.  (B) 3D EM visualisation of ssoCMR structures.  A 
subcomplex consisting of Cmr7(6):Cmr2:Cmr3 (blue surface), comprising the ‘crab-claw’ 
element, is superimposed upon the full CMR-complex with bound crRNA (grey mesh).  
Adapted from Zhang et al., 2012. 
 
As the crRNA is likely static within any CASCADE complex (Lintner, Kerou, et al., 
2011), the complex is also fixed in position over the target upon duplex formation 
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(Staals et al., 2013).  Therefore, to generate the multiple product sizes, the complex 
is thus modelled to possess multiple active sites cleaving in 6 nt intervals (Staals et 
al., 2013).  Such sites coincide with the ~25 Å distances between the four Cmr4 
subunits; however, to generate all five products of the native ttCMR requires 
additional endonuclease activity located in the vicinity of Cmr1 or Cmr6 (Staals et al., 
2013), a region similarly identified as nucleolytic site within pfCMR (Spilman et al., 
2013).  Although nuclease activity is well characterised for numerous Cas6 examples 
and even a Cas5 (Nam, Haitjema, et al., 2012), no such ability has yet been 
confirmed directly for any members belonging to the Cas7 family of RAMPs.  
 
The CMR type complex isolated from S. solfataricus P2 consists of seven subunits 
(cmr1,3-7; Cmr7 [sso1986], Cmr4[sso1987], Cmr5[sso1988], Cmr1[sso1989], 
Cmr6[sso1990], Cas10 [sso1991], Cmr3 [sso1992]) (Zhang et al., 2012). The 430 
kDa crRNA-bound complex consists of single copies of Cas10, Cmr1,3-6 and three 
Cmr7 dimers (Zhang et al., 2012) (Figure 1.22).  Contrasting to the ‘seahorse’ shape 
of CASCADE (Jore et al., 2011), but in keeping with an aquatic theme, CMR adopts a 
‘crab-claw’ structure (Figure 1.22 (Zhang et al., 2012)). A reduced CMR structure 
comprising Cas10(cmr2):Cas5(cmr3):Cas7(cmr7) fails to bind RNA, which suggests 
this role is undertaken by the remaining, RAMP-containing, Cas7 members of the 
complex: cmr1, cmr4, cmr6 (Makarova, Aravind, et al., 2011; Zhang et al., 2012).  
Thus, the dsRNA is hypothesised to bind within the cleft formed from the ‘claw’ 
(Figure 1.22) (Zhang et al., 2012). This bears no resemblance to the structures of 
either ttCMR or pfCMR (Staals et al., 2013; Spilman et al., 2013) and lacks the helical 
twist typical of Type I and III cascades (Lintner, Kerou, et al., 2011; Wiedenheft, van 
Duijn, et al., 2011; Wiedenheft, Lander, et al., 2011; Rouillon et al., 2013; Staals et al., 
2013; Spilman et al., 2013) .  Moreover, the underlying mechanism of S. solfataricus 
CMR (ssoCMR) activity differs dramatically.  Instead of a ruler mechanism, 
sequence-specific cleavage of target strands between AU motifs occurs, which are 
highly prevalent within S. solfataricus spacers (Figure 1.23) (Zhang et al., 2012). The 
presence of a 5’-tag, and crucially its mismatch with the corresponding proto-spacer 
flanking region (i.e. unpaired 3’-flap), appeared essential to cleavage (Zhang et al., 
2012).  However, more recently this mismatch has been shown not to be an absolute 
requirement (Zebec et al., 2014).   
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Interestingly, neither the predicted HD nuclease nor adenylyl cyclase-like domains of 
the large subunits (Makarova et al., 2002) were shown to be necessary for the 
otherwise essential role they perform within the CMR complex during crRNA-guided 
RNA cleavage activity (pfCMR) (Cocozaki et al., 2012).  Moreover, the T. 
thermophilus Cas10 lacks the predicted HD nuclease domain (Staals et al., 2013).  
However, an alternative role in regulating CMR complex activity (eg. signalling) has 
been proposed for these domains (Cocozaki et al., 2012), as Cmr2(Cas10) is unlikely 
limited to a purely structural capacity and the possession of a complete set of 
catalytic residues as per palm polymerases and cyclases indicates some form of 
enzymatic activity (Barrangou and van der Oost, 2012).  Whilst not essential, ATP 
presence stimulated ssoCMR activity (Zhang et al., 2012), but such ATP stimulation 
appears to be dependent on 5’-tag mismatch with the target RNA and whatever 
structural effects may ensue (Zebec et al., 2014). 
 
 
Figure 1.23: Functional differences between T. thermophilus and S. solfataricus Type 
III-B effector complexes.  (A) The T. thermophilus CMR-complex (ttCMR) cleaves with a 
ruler mechanism anchored at the 5’ end of the crRNA molecule; a primary cut at 11 nt is 
followed by subsequent cuts spaced at 6 nt intervals (Staals et al., 2013).  (B) In contrast, S. 
solfataricus CMR complex (ssoCMR) cleaves specifically at UA di-nucleotide motifs present 
within the protospacer.  In the example protospacer shown, corresponding to spacer D63, 5 
such cleavage sites are present (Zhang et al., 2012). Adapted from Staals et al., 2013. 
1.10 Preventing Autoimmunity 
The obvious concern with a system that efficiently destroys DNA matching spacer 
sequences is the safety of the host DNA in which CRISPR arrays are located.  
However, CRISPR/Cas systems have in-built safety mechanisms to ensure the 
safeguarding of self-DNA.  The presence of degraded CRISPR systems in some 
organisms may reflect a scenario where these mechanisms have been circumvented 
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and an autoimmune response established, possibly due to accidental incorporation of 
‘self' DNA (Stern et al., 2010). 
 
As seen in Section 1.9.3.1, mismatches between crRNA and the protospacer region 
can still bring about a strong interference response by CRISPR/Cas systems. 
Therefore, having perfectly matching genomic DNA sequences, from which the 
crRNA is derived, becomes a very dangerous proposition.  
 
Types I-E and III-A appear to rely on alternative mechanisms to ensure the safety of 
genomic DNA (Figure 1.24) (Marraffini and Sontheimer, 2010; Westra et al., 2013).  
In the Type III-A system, base-pairing between (PAS) genomic DNA and at least 
three nucleotides within the 5’ region of crRNA will prevent activation of the cleavage 
mechanism, thus recognising ‘self-‘ from ‘non-self’ in a PAM-independent manner 
(Figure 1.24) (Marraffini and Sontheimer, 2010; Manica et al., 2013). Westra et al. 
note that PAMs associated with type III systems have yet to be determined, and as 
such, possibly do not exist (Westra et al., 2013; Hale et al., 2009; Marraffini and 
Sontheimer, 2010).  In contrast, the Type I-E system does not rely on differential 
base-pairing; instead, recognition of a PAM sequence directly by the CASCADE, 
likely mediated by the Cse1 subunit (Sashital et al., 2012), appears to be the critical 
factor to activating subsequent cleavage mechanisms (Westra et al., 2013).  
Similarly, PAM-dependent DNA target cleavage was characterised in the Type I-A 
system of A. fuldigus (Plagens et al., 2014).  Thus, the designation of the Type I-E 
and I-A systems mechanism as ‘target versus non-target’ recognition is potentially 
more accurate (reviewed in Westra et al., 2013). 
 
Whilst either mechanism is sufficient to deter self-targeting (Marraffini and 
Sontheimer, 2010; Westra et al., 2013), it appears that in the Type I-F system they 
are used together, although the parameters of the mechanism have yet to be defined 
(Almendros et al., 2012).  
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Figure 1.24. Alternative target discrimination mechanisms adopted by Type I and III-A 
systems. (A) Type III-A CASCADE (CSM, grey outline) adopts a ‘Self vs Non-self’ 
discrimination mechanism reliant on crRNA 5’ tag identification of the spacer-flanking 
sequence of chromosomal CRISPR DNA.  Complementarity within this region protects the 
DNA whereas a mismatch, recognised by an undetermined Cas subunit, initiates cleavage 
activity.  (B) Type I-E CASCADE (grey outline) alternatively adopts a ‘Target vs Non-target’ 
mechanism, in which the L-1 loop (yellow) of the Cse1 large subunit (purple) specifically 
recognises PAMs present in valid target sequences, subsequently cleaved pending full 
spacer sequence base-pairing.  The absence of PAM (white dashed outline) protects the 
prospective target, irrespective of 5’ / 3’-end mismatches.  Adapted from Westra et al., 2013. 
 
Self-targeting of mRNA by Type III-B likely does not have the same serious 
implications for host survival and likely lacks a preventative mechanism (Sorek et al., 
2013).  Furthermore, most CRISPR arrays are transcribed in a single direction 
(generating the crRNA itself) and so lack a complementary strand in any case.  
Nonetheless, the presence of a mismatch between the 5’-tag and any 3’ target 
sequence was necessary for cleavage by S. solfataricus CMR and suggests that 
discrimination is by structure rather than sequence (Zhang et al., 2012).   
 
Whilst cleavage of endogenous antisense transcripts by P. furiosus CMR has been 
demonstrated, a target recognition role for 5’-tag region of crRNA is unlikely as no 
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change in activity of reconstituted pfCMR was observed at varying degrees of 
complementarity, suggesting that it possibly acts instead only as a scaffold for 
complex assembly/stability (Hale et al., 2012). 
1.11 Virus Escape: The Host-Virus Arms Race 
CRISPR/Cas systems and the selective pressures they apply, from spacer aquisition 
mechanisms which are largely indifferent to the genomic position of protospacers 
(Shah et al., 2009) and the interference mechanism which is not restricted to a 
specific phage feature (e.g. phage surface-exposed receptor), provide an explanation 
for the rapid rate of evolution across the entire phage genome (reviewed in Sorek et 
al., 2013). 
 
Changes within the PAM and/or protospacer regions of are selected for within 
bacteriophage populations (Deveau et al., 2008), where single nucleotide 
polymorphisms can be sufficient to allow escape of resistance (Barrangou et al., 
2007).  No acquisition of new spacers was detected in culture with WT phage at MOI 
of 10-3, a number below which spontaneous mutations are expected, suggesting that 
acquisition of new spacers may be driven by escape mutants (Datsenko et al., 2012).  
In assays conducted with an M13-targeting CRISPR plasmid, the frequency of phage 
escape from the associated Type I-E response was estimated to be no more than 
2x107, which is better than the corresponding values for restriction-modification RM-
based responses and may even be an underestimate of true efficiency (Semenova et 
al., 2011).  Semenova et al. made the observation that CRISPR-based responses are 
likely an ‘all-or-nothing’ protection, circumvented only via point mutations within 
critical (PAM/Seed) crRNA elements (Semenova et al., 2011). 
 
A 100% match within seed sequence is required for interference by the Type I-(E) 
system of E. coli, and five to six mismatches with the remaining sequence can be 
tolerated for an effective immune response against viruses (Semenova et al., 2011; 
Datsenko et al., 2012).  Recently, when challenged by plasmid vectors, even 
mutations in the PAM and seed regions were shown to be tolerated, which may 
indicate a difference in the responses to plasmid or phage threats and/or be a 
product of giving the priming process longer to occur (assay duration 24 vs 48 h, 
(Fineran et al., 2014)).  Flexibility at non-seed region limits the opportunities for 
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escape via point mutations, allowing broad coverage by a single spacer and 
overcoming a key limitation of this ‘all-or-nothing’ response (Semenova et al., 2011). 
 
Protection in archaeal systems appears particularly broad, with a substantially higher 
number of mutations outside of the PAM and seed regions being largely ignored 
(Semenova et al., 2011; Fischer et al., 2012; Manica et al., 2013).  In S. solfataricus, 
mismatches in up to 15 of the base-pairs within the 3’ crRNA region were tolerated 
sufficient to deliver interference with 50% efficiency (Manica et al., 2013).  Up to three 
mutations in the seed region still enabled control of virus populations with 80% 
efficiency.  However, mutations in both seed and 5’ regions appear to have a 
synergistic effect that severely hampers any interference response and boosts the 
overall protection for the virus.  The authors thus attribute an importance to both the 
seed and the seemingly less important 3’ region, thus providing an explanation to the 
strict conservation of spacer sizes throughout CRISPR evolution (Manica et al., 
2013). 
 
It is unknown at present whether an imperfect protospacer match and the ensuing 
reductions in protection efficiency may elicit a latent infection cycle (Manica et al., 
2013).  If the invading genetic element contains advantageous genes that can be 
utilised by the host, there may even be a selective advantage in maintaining a 
‘controlled’ population within the cell (Manica et al., 2013).  Indeed, Gudbergsdottir et 
al. conducted an experiment in which cells carrying a defective growth gene (for 
essential uracil synthesis) are challenged with a virus/plasmid carrying the necessary 
replacement, but which coincidently harbours a protospacer that will initialise the 
endogenous CRISPR/cas response (Gudbergsdottir et al., 2010).  Viable cells 
nonetheless emerged that had spacer deletions or the loss of entire CRISPR/cas 
modules, sufficient to modify/disrupt the interference response and in turn sustain the 
cellular presence of the missing gene (Gudbergsdottir et al., 2010).  The mechanism 
of rapid expansion of the spacer library proposed by Swarts et al. (Section 1.9.1) 
(Swarts et al., 2012), may establish a safety net for such a delicate scenario should 
the virus escape (Manica et al., 2013). 
 
As masters of hijacking host cellular systems, viruses may even apply such logic to 
turn CRISPR/cas interference responses to their own gain.  Prophages (Sebaihia et 
al., 2006) and free viral genomes (Minot et al., 2011; Garcia-Heredia et al., 2012), 
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have been documented with their own CRISPRs, which could allow them to protect 
themselves by ‘guiding’ the host cell’s CRISPR/cas system to block competitor 
phages (Stern and Sorek, 2010; Minot et al., 2011; reviewed in Sorek et al., 2013). 
1.12 General Acid-Base Catalysis 
Enzymes catalyse a wide range of biological reactions using a variety of 
mechanisms (reviewed in Bugg, 2012 and Silverman, 2002).  One prevalent 
strategy is general acid-base catalysis, where the transfer of protons is used to 
lower the free energy needed to adopt the transition state.  General acid-base 
catalysis also activates weak nucleophiles (e.g. O in H2O, or the 2’ hydroxyl 
present on an RNA ribose moeity) and stabilises unfavourable leaving groups 
(Figure 1.25). 
 
The cleavage of nucleic acids is an essential process across all stages of the 
CRISPR/Cas response, including pre-crRNA cleavage by Cas6.  General acid-
base catalysis is a common approach adopted by ribonucleases and even 
ribozymes (Raines, 1998; Calvin and Li, 2008; Lilley et al., 2011; deRose, 2002), 
and, given similarities in the amino acids employed and products generated by 
examples such as RNaseA and splicing endonuclease, parallels have been 
drawn for the potential mechanisms of previously characterised Cas6s (Richter et 
al., 2012; Carte et al., 2010; Sashital et al., 2011; Gesner et al., 2011).  
Accordingly, application of general acid-base catalysis for ssRNA cleavage will be 
briefly examined (reviewed Elliott and Ladomery, 2011). 
1.12.1 pH and pKa 
The pH of a solution measures the concentration of hydrogen ions in a solution 
(Equation 1.1). 
pH = -log10 H+!" #$  
Equation 1.1: pH. H+ is the concentration of hydrogen ions in a solution. 
 
The tendency of an acid to dissociate in solution is represented by the 
dissociation constant, Ka,  (Equation 1.2). 
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Ka =
A−"# $% H+"# $%
HA[ ]
 
Equation 1.2: Ka. [A-] is the concentration of the conjugate base of the acid, [H+] is the 
concentration of hydrogen ions or protons, and [HA] is the general acid. 
 
The Ka can also be expressed as pKa, the inverse log of Ka (Equation 1.3).   
 
pKa = −log10Ka  
Equation 1.3: pKa. Ka is the dissociation constant. 
 
A strong acid will be fully dissociated in water and represented by a low pKa.  
Conversely, as pKa values increase, weak acids will tend to be only partially 
dissociated.   
 
Combining and rearranging Equations 1.1-1.3 generates the Henderson-
Hasselbalch equation (Equation 1.4), which describes the relationship between 
pH and pKa. 
   
pH = pKa + log10
A−"# $%
HA[ ]
&
'
(
(
)
*
+
+  
Equation 1.4: Henderson-Hasselbalch Equation. [A-] is the concentration of the ionic form 
of the acid and [HA] is the concentration of the general acid. 
 
The pKa thus represents the pH above which a given ionisable group will tend to 
exist in a deprotonated state.  Whilst the backbone common to all amino acids 
each contains a Carboxyl (pKa ~2) and an Amino (pKa ~9) group, seven of the 20 
common amino acids also have side-chains which are readily ionisable at 
physiological pH (see Table 1.4). 
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Amino acid 
pKa 1 (COOH, 
carboxyl 
group) 
pKa 2 (NH2, 
amino group) 
pKa 3 
(R-
group) 
Aspartic acid 1.88 9.60 3.65 
Glutamic acid 2.19 9.67 4.25 
Histidine 1.82 9.17 6.00 
Cysteine 1.96 10.28 8.18 
Tyrosine 2.20 9.11 10.07 
Lysine 2.18 8.95 10.53 
Arginine 2.17 9.04 12.48 
 
Table 1.4: Naturally occurring amino acids with readily ionisable sidechains. (adapted 
from Lide, 1991) 
 
1.12.2 Active site residues common to acid-base catalytic 
mechanisms 
As enzyme reactions occur in aqueous solution with a neutral pH of 
approximately 7.0, the most effective weak acids/bases will have a pKa near this 
figure to allow for easy deprotonation/protonation, respectively.  Thus, the amino 
acids listed in Table 1.4 are able to participate as weak acids or bases at 
physiologically relevant pH’s. 
 
Histidine, which has a side-chain pKa of ~6.0, is particularly important in this 
respect. At pH’s above 6.0, the imidazole ring acts as a proton acceptor (i.e. a 
general base catalyst). At pH’s below 6.0, the imidazole ring acts a proton donor 
(i.e. a general acid catalyst). However, the microenvironments (e.g. neighbouring 
amino acids of like charge, solvent exposure, salt-bridge/H-bond formation and 
temperature) of a protein active site can perturb the pKa of a given amino acid 
side-chain, in some cases dramatically (e.g. Tyrosine pKa can be reduced to 6.3 
upon solvent exposure in the active site pocket of Ketosteroid Isomerase, 
Fafarman et al., 2011) that may result in unexpected application as proton 
donors/acceptors (Harris and Turner, 2002; Silverman, 2002).  Since only a 
relatively small shift in pKa is necessary for histidine to fulfil the role of either 
general acid or general base at the physiological pH of 7.0, this amino acid is 
particularly versatile and regularly found in active sites fulfilling either role 
(Raines, 1998; Saida et al., 2003; Nishikawa et al., 1987).  Indeed, the 
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mechanisms of all presently characterised active Cas6s appear to rely on a 
conserved histidine residue (Carte et al., 2008; Gesner et al., 2011; Sashital et al., 
2011; Haurwitz et al., 2012), though its precise contribution as acid or base varies, 
as is detailed further in Chapter 3. 
1.12.3 Application of an acid/base catalytic mechanism 
RNase A is a well-characterised example that uses a general acid-base catalytic 
mechanism, mediated by two histidine residues, to cleave ssRNA (reviewed 
Raines, 1998; Cuchillo et al., 2011; Elliott and Ladomery, 2011).  H12 acts a general 
base to deprotonate the ribose 2’ -hydroxyl group for nucleophilic attack upon the 
adjacent phosphate, whilst H119 acts as general acid to donate a proton to 
stabilise the leaving group oxygen.  The result is a transition state containing a 
pentavalent phosphate intermediate (of trigonal bipyramidal geometry) where the 
atoms involved in bond breaking adopt a highly unstable linear (‘in-line’) 
configuration.  The subsequent transesterification reaction (formation of new 
ester bond with the 2’ oxygen occurring simultaneously with the release of the 
downstream oxygen of the leaving group, i.e. S2N reaction) results in products 
with 3’ 2’,3’-cyclic phosphate and 5’ hydroxyl termini (See Figure 1.25, Elliott and 
Ladomery, 2011). Positively charged, basic side-chains are often arranged within 
the active site pocket (e.g. L41 in RNase A) to orientate the substrate and/or 
stabilise the developing negative charge of this transition state through hydrogen 
bonding events (Raines, 1998; Calvin and Li, 2008). 
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Figure 1.25: Concerted general acid-base mechanism for the cleavage and ligation of 
RNA.  Intramolecular attack by the deprotonated 2’ hydroxyl leads to the adoption of a 
pentavalent phosphate intermediate where an “in-line” geometry exists between the attacking 
oxygen nucleophile, phosphorus atom and the oxygen of the leaving group (joined by dashed 
line).  The resulting transesterification reaction results in cleavage products with 3’ 2’,3’-cyclic 
phosphate and 5’ hydroxyl termini.  The Acid (A) and Base (B) sidechains for the forward 
reaction are contributed by H119 and H12 in RNase A, respectively (Raines, 1998).  Figure 
adapted from Elliott and Lamdomery, 2011. 
1.13 Sulfolobus solfataricus and the CRISPR/Cas 
System 
S. solfataricus is an aerobic crenaracheaon that thrives in acidic (pH 2-3) and high 
temperature (80˚C) environments (Zillig et al., 1980).  Although they are 
extremophiles, Sulfolobus species are found around the world and are relatively 
easily cultivated in the laboratory.  The complete S. solfataricus genome has been 
sequenced (She et al., 2001) and much is understood about its replication, 
transcription, translation and metabolic processes as it has grown to become an 
important model organism. 
 
The two S. solfataricus strains isolated, P1 and P2, are distinct but nonetheless very 
closely related (Zillig et al., 1980).  By examining the CRISPR arrays present in each 
strain, it is possible to map the divergence of the strains from the acquisition of 
different sets of new spacers across each of the active loci present (A-D, (Lillestøl et 
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al., 2009)).  The P1 and P2 strains otherwise share identical E and F loci as well as 
perfectly conserved repeat/spacer sequence stretches in the leader-distal (i.e. older) 
regions of loci A-D (Lillestøl et al., 2009). 
 
S. solfataricus possesses a complex CRISPR/cas environment, in which there are 
three system types (I-A, III-A and III-B), five Cas6 paralogues and six CRISPR loci 
(A-F). This arrangement will be explored further in Chapter 4 and 5.  An overview of 
the Cas gene composition of S. solfataricus P2 is presented below (Figure 1.26) 
alongside a summary of the key details of CRISPR loci A – F (Table 1.4).   
 
 
Figure 1.26: Cas genes present in the S. solfataricus P2 genome. Schematic illustrates 
the operon organisation and distribution of cas genes across the three system types present 
(I-A, III-A, III-B) present in S. solfataricus P2.  The cas genes are named as per the She et al. 
genome sequencing (She et al., 2001), and separated into cas gene families as per Makarova 
et al. (Makarova, Haft, et al., 2011; Makarova, Aravind, et al., 2011).  RAMP genes belonging 
to the Cas5, Cas6 and Cas7 are coloured with the same colour palettes; Cas5 (yellows), 
Cas6 (red), Cas7 (pinks).  Data from She et al., 2001, Lintner, Kerou, et al., 2011; Rouillon et 
al., 2013; Zhang et al., 2012. 
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CRISPR 
Locus 
Family Repeats Genome 
location 
Consensus repeat 
A (3) II (AB) 103 1233466- 
1239959 
GATTAATCCCAAAAGGAATTGAAAG 
B (4) II (AB) 95 1254482- 
1260452 
GATTAATCCCAAAAGGAATTGAAAG 
C (5) I (CD) 32 1297153- 
1299148 
GATAATCTCTTATAGAATTGAAAG 
D (6) I (CD) 96 1305539- 
1311637 
GATAATCTCTTATAGAATTGAAAG 
E (9) I (CD) 8 1744007- 
1744417 
GATAATCTACTATAGAATTGAAAG 
F (10+11) I (CD) 89 1809772- 
1815557 
GCTAATCTACTATAGAATTGAAAG 
 
Table 1.4. CRISPR loci of S. solfataricus P2.  (A) The six S. solfataricus P2 CRISPR loci 
(A-F) are distributed into families I and II based upon repeat consensus sequence as per 
(Lillestøl et al., 2009) (AB and CD as per (Sokolowski et al., 2014), Chapter 5).  Numbers in 
parenthesis reflect CRISPR database loci identifications (Grissa et al., 2007).  Adapted from 
Kerou, 2012.   
1.14 Scope of this Thesis 
This thesis will primarily focus on the characterisation of the active site architecture 
and catalytic profile of the Cas6 homologue, ssoCas6[1437], from S. solfataricus P2 
through a combination of site-directed mutagenesis and enzyme kinetics 
methodologies.   
 
Chapter 2 details the methods used in chapters 3, 4 and 5.   
 
In Chapter 3, the Cas6 homologue, [1437], from S. solfataricus P2 will be 
investigated for Cas6-like activity.  Accordingly, residues involved in the associated 
catalytic mechanism will be probed. This work was performed in close collaboration 
with the Naismith structural biology group (University of St Andrews), specifically Dr 
Judith Reeks whose crystallographic work on ssoCas6[1437] will be also discussed 
in context. 
 
In Chapter 4, the contribution of substrate binding to the ssoCas6[1437] catalytic 
mechanism, which may not be restricted to the single-turnover kinetics expected of 
other characterised members of the Cas6 family, will be investigated.  The behaviour 
of ssoCas6[1437] when confronted with longer pre-crRNA like transcripts, containing 
multiple repeat sites, will also be examined.   
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In Chapter 5, both ssoCas6[1437] and an additional S. solfataricus Cas6 paralogue, 
ssoCas6[1422], will be examined for their substrate preferences towards repeat 
sequences originating from different S. solfataricus CRISPR repeat families (AB and 
CD).  Lastly, the profile of native Cas6 activity present within S. solfataricus P2 lysate 
will be explored.   
 
Finally, Chapter 6 will summarise the conclusions from the presented work and 
examines future directions within related research. 
 
Elements of the work in chapter 3 have been published in: 
Judith Reeks, Richard D. Sokolowski, Shirley Graham, Huanting Liu, James H. 
Naismith, Malcolm F. White. Structure of a dimeric crenarchaeal Cas6 enzyme with 
an atypical active site for CRISPR RNA processing. (2013) Biochem J. vol. 452 (2), 
223-230 
 
Elements of the work in chapters 4 and 5 have been published in: 
Richard D. Sokolowski, Shirley Graham, Malcolm F. White. Cas6 specificity and 
CRISPR RNA loading in a complex CRISPR-Cas system. (2014) Nucleic Acids Res. 
E.pub ahead of print. 
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Chapter 2: Materials and Methods 
2.1 Mutagenesis, Gene Expression and Protein 
Purification 
2.1.1 Vectors and expression systems 
The S. solfataricus Cas6 gene paralogues [sso1437 and 2004] were previously 
amplified from S. solfataricus P2 genomic DNA and cloned into the pET-151/D-topo 
vector (pET-151-1437) by Dr. Huanting Liu and Dr. Melina Kerou.  This vector allows 
IPTG (isopropyl β-D-thiogalactopyranoside) inducible expression of a 6xhistidine 
tagged target protein with intervening TEV cleavage site. 
2.1.1.1 Site-directed PCR mutagenesis 
To probe the ssoCas6[1437] catalytic mechanism, individual residues were mutated 
to alanine to assess their relative contribution to catalysis and/or substrate binding.  
Alanine was selected due to a relatively inert (methyl) functional group and 
small/non-bulky side chain that conserves the secondary and tertiary structure 
preferences of many amino acids.  Appropriate oligonucliotide primers were designed 
in-house and synthesised by Eurofins MGW OPERON 
(http://www.eurofinsdna.com/).  The primers sequences are available on request. 
 
Site-directed mutagenesis was performed using the Fermentas Pfu DNA polymerase 
kit and protocol (Fermentas), in which pET-151-1437 was used as the template.  
Upon completion, mutant plasmids were selected for by digestion of parental (non-
mutated) methylated DNA by DpnI (Thermoscientific, kit and protocol).  Post 
digestion, samples were stored short-term at 4 ˚C or long-term at -20 ˚C. 
2.1.1.2 Transformation 
Two E. coli strains were mainly used during the course of the presented work: C43 
(protein overexpression) and DH5α (plasmid maintenance and growth). 
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2.1.1.2.1 Competent cell preparation 
100 ml autoclaved SOB (Super optimal broth; 2 % (w/v) tryptone, 0.5 % (w/v) yeast 
extract, 10 mM NaCl, 2.5 mM KCL, 20 mM MgSO4) was inoculated with desired E. 
coli strain (C43/DH5α) and incubated at 37 ˚C with shaking at 180 rpm until O.D.600 
(optical density at 600 nm wavelength) of 0.3-0.4 was reached.  Cells were then 
pelleted by centrifugation at 4000x rpm for 15 min at 4 ˚C and the supernatent was 
discarded.  The pellet was gently resuspended within 50 ml of pre-chilled 100 mM 
CaCl2 (autoclaved) and incubated on ice for 30 min.  Cells were harvested by 
centrifugation at 4000x rpm for 15 min at 4 ˚C and supernatent discarded.  The pellet 
was gently resuspended into 5 ml 100 mM CaCl2 and incubated overnight at 4 ˚C.  
The sample was supplemented with glycerol (autoclaved) to 15 % (v/v) and aliquots 
of the competent cells flash-frozen with liquid nitrogen for long-term storage at -80 ˚C. 
2.1.1.2.2 Transformation of competent cells 
The following transformation protocol was adapted from the QuickChangeII 
handbook (Agilent Technologies).  Competent cells (see Section 2.1.1.2.1), thawed 
on ice from -80 ˚C storage, were aliquoted in 50 µl volumes into pre-chilled 
Eppendorf tubes.  5 µl DpnI-digested PCR mutagenesis product was added per 50 µl 
volume of cells, swirled gently with the pipette tip to mix, and incubated for 30 min on 
ice.  Samples were heat shocked at 42 ˚C (30 sec for dH5α cells, 45-60 sec for C43 
cells), and returned to ice for 2 min.  500 µl LB (Lysogeny broth; 10 g.l-1 tryptone, 5 
g.l-1 yeast extract, 10 g.l-1 NaCl) pre-warmed to 37 ˚C was added to each sample, 
and the mixture was incubated at 37 ˚C with 180x rpm shaking for 1 h.  200 µl of 
sample was plated onto Agar plates supplemented with 100 µg.ml-1 ampicillin (AMP) 
and incubated O/N at 37 ˚C to select for successful mutants. 
2.1.1.2 Plasmid sequencing 
To ascertain PCR site-directed mutagenesis success, PCR products were initially 
transformed into DH5α cells.  10 ml volumes of LB+AMP were inoculated with 
colonies successfully appearing upon the selective agar plates, and incubated O/N at 
37 ˚C with 180x rpm shaking.  Cultures were spun down at 4000 rpm at 4 ˚C for 10 
min, and cell pellets collected.  The pellets using the QIAgen DNA Miniprep kit and 
the resulting purified plasmid DNA sequenced by the GATC Biotech sequencing 
service (http://www.gatc-biotech.com).  Upon confirmation of mutagenesis success, 
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the corresponding samples were used to transform C43 competent cells from which 
attempts at protein over-expression and purification were performed. 
2.1.2 Recombinant protein expression and purification 
Over-expression of recombinant ssoCas6 (WT [2004], WT [1437] and [1437] 
variants) was performed using the BL21(DE3) C43 strain containing the pET151-
1437 vector (see Section 2.1.1).  The target protein was subsequently extracted and 
purified to homogeneity through a combined Nickel-affinity and size-exclusion 
chromatography scheme (Figure 3.4A, adapted from Lintner, Kerou, et al., 2011).  
Column-based processing events controlled and monitored by an Åkta 
chromatographic purification system (GEhealthcare) and the associated software (© 
GEhealthcare, UNICORN 5.11 build 407). 
2.1.2.1 Expression of recombinant protein 
Cells were grown in LB medium supplemented with 100 µl.ml-1 AMP at 37˚C.  Upon 
reaching an OD600  of between 0.400-0.600, cultures were induced with 0.4 mM IPTG 
(isopropyl β-D-thiogalactopyranoside) and incubated overnight at 25 ˚C.  Cells 
were harvested by centrifugation at 4000x rpm and the supernatant discarded.  In 
this state, pelleted cells were stored at either -20 ˚C (short-term) or -80 ˚C (long-term) 
until required. 
2.1.2.2 Purification of recombinant protein 
Pelleted cells were resuspended at approximately 1g:5ml in [20 mM Tris-base pH 
7.5, 0.5 M NaCl, 10% glycerol] (GF-Buffer) further supplemented with 10 mM 
imidazole, 1 mg/ml Lysozyme and EDTA-free protease inhibitor tablets (Roche, 
cOmplete) and lysed by sonication (12 µm amplitude for ten two-minute cycles) at 
room-temperature (~22˚C, r/t).  The lysate was subsequently clarified by 
centrifugation at 40 000 rpm at 4˚C for 45 min. 
 
The supernatant was applied to a 5 ml Histrap FF (GEhealthcare) ion exchange 
column and sample washed with 30 mM imidazole supplemented GF-buffer until 
base-line stabilisation.  The target was subsequently eluted by raising imidazole 
concentration over a linear gradient from 30 to 400 mM.  Fractions were assessed for 
purity by SDS-PAGE analysis (Section 2.1.3) and pooled accordingly. Between each 
Chapter 2: Materials and Methods 
 
 72 
use, the Ni-column was stripped and recharged with nickel, protocol as per 
manufacturer’s handbook. 
 
The His6-tag was removed from the target with TEV (tobacco etch virus) protease 
during simultaneous overnight dialysis at r/t into 20 mM Tris-base pH 7.5, 0.5 M 
NaCl, 10% glycerol. Samples encompassing peak fractions were analysed for purity 
by denaturing PAGE analysis, dictating pooling arrangements to maximise target 
protein content but jointly minimise contaminant presence.  Protein content was 
estimated via A280 spectrophotometer readings (accounting for a 1437 specific 
extinction coefficient, 23380 M-1.cm-1, and absorbance 0.1 % (=1 g.l-1) 0.781 values, 
estimated by online bioinformatics tool ProtParam (Gatseiger 2003, 
http://web.expasy.org/protparam) and TEV protease (stocks made in-house) added 
accordingly in a 1:5 TEV (mg) to protein sample (mg) ratio. Imidazole content of 
pooled fractions was simultaneously reduced by overnight dialysis at r/t into 2 l SBuff 
supplemented with 1 mM EDTA and 1 mM DTT using 12-14 kDa MWCO dialysis 
tubing (Medicell International Ltd.). 
 
The sample was re-applied to the Ni-affinity column from which it was eluted with 30 
mM imidazole supplemented GF-Buffer to separate TEV and His6-tag contaminants 
from the cleaved protein. 
 
Final decontamination of the sample by size exclusion chromatography was achieved 
using a Highload™ 26/60 Superdex™ 200 prepgrade (GEhealthcare) gel filtration 
column.  Fractions corresponding to the single UV peak were analysed for 
contaminants via SDS-PAGE and pooled accordingly.  The sample volume was spin-
concentrated (combination, Amicon® Ultra and SartorisStedim Biotech Vivaspin2) to 
required concentration before flash-freezing with liquid nitrogen and storage at -80 
˚C.  Spectrophotometer A280 (absorbance at 280 nm) readings where used to 
estimate concentration using the calculated ssoCas6[1437].  All mutants were 
purified by an identical protocol. 
2.1.3 SDS-PAGE 
15 µl samples were incubated at 90 ˚C with 5 µl 4x disruption buffer (DB, NuPage® 
Invitrogen™, LifeTechnologies).  Samples were loaded onto NuPage® 4-12% Bis-Tris 
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gels (Life Technologies), and run at 200 V for 35 min (volume of sample loaded 
variable depending on gel well number/size) in 1x TBE (TRIS/Borate/EDTA; 45 mM 
TRIS, 45 mM Borate, 1 mM EDTA, pH ~8) running buffer.  A lane was reserved for 4 
µl of ladder (Fermentas PageRuler™ unstained).  Protein bands were visualised by 
incubation of gel at r/t with a coomassie-based stain (Expedeon InstantBlue™), and 
destained by subsequent incubation with H2O. 
2.2 Sequence and Preparation of RNA Substrates  
2.2.1 Isolated repeat sequences 
RNA corresponding to S. solfataricus P2 CRISPR repeat sequences were 
synthesised by Integrated DNA technologies (IDT, http://eu.idtdna.com).  The 
CRISPR repeats of the C and D (CD) and A and B (AB) loci were synthesised in both 
fluorescently-labelled (5’-[FAM]) and unlabelled forms as detailed in Tables 2.1 and 
2.2, respectively;   
Table 2.1: Unlabelled RNA repeat sequences. 
 
 Table 2.2: Fluorescein-labelled RNA repeat sequence derivatives. 
 
A fluorescently labelled F (F) loci repeat sequence and a CD sequence lacking the 
final eight 3’ nucleotides (CDproduct), as well as an unlabelled non-CRISPR derived 
sequence (ncRNA) were also obtained.  Samples were resuspended from lyophilised 
state to ~500 µM with RNA storage buffer (Ambion) and stored at -20 ˚C. Prior to 
Name Sequence Length (nt) Notes 
AB 5’-GAUUAAUCCCAAAAGGAAUUGAAAG 25   
CD 5’-GAUAAUCUCUUAUAGAAUUGAAAG 24  
ncRNA 5’-AAUGUGCCCCAAAAUGAAUUGAUAU 25  
Name Sequence Length (nt) Notes 
AB 5’-[FAM]-
UGAUUAAUCCCAAAAGGAAUUGAAAG 
26   
CD 5’-[FAM]-UGAUAAUCUCUUAUAGAAUUGAAAG 25  
F 5’-[FAM]-UGCUAAUCUACUAUAGAAUUGAAAG 25  
CDprodu
ct 
5’-[FAM]-UGAUAAUCUCUUAUAGA 17 3’ truncation of CD (-8 nt) 
ABrev 5’-[FAM]-
CUUUCAAUUCCUUUUGGGAUUAAUCA 
26 Reverse-compliment of AB 
CDrev 5’-[FAM]-CUUUCAAUUCUAUAAGAGAUUAUCA 25 Reverse compliment of CD 
frev 5’-[FAM]-CUUUCAAUUCUAUAGUAGAUUAGCA 25 Reverse compliment of F 
Chapter 2: Materials and Methods 
 
 74 
their use in assays, RNA stocks were gel purified (see Section 2.2.3) and end-
labelled, where necessary, with [γ-32P]ATP (see Section 2.2.4). 
2.2.2 CRISPR transcripts 
RNA sequences consisting of multiple repeat-spacer (R/S) units were required to 
characterise Cas6 activity in the presence of longer substrate molecules as could be 
expected in vivo.  Thus a construct was prepared in which an artificial CRISPR array 
was positioned downstream of a T7 transcription site to allow generation of a uniform 
(R/S)n RNA substrate by in vitro transcription methods. 
 
 
Figure 2.1: Generation of an artificial CRISPR array – Schematic overview of construct 
generation.  (i) Individual dsDNA oligonucleotides (derived from CRISPR D loci, spacer 63) 
comprising the start (S), middle (M) and end (E) of the synthetic CRISPR unit were incubated 
together at variable ratios in the presence of ligase. (ii) The subsequent insert of n 
repeat/spacer length, flanked by Xho1 and Xba1 restriction sites, was (iii) ligated into the 
pET-28c vector and transfected into E. coli. (iv) The loci were transcribed from the upstream 
T7 promoter to obtain a pre-crRNA analogue (v).  
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2.2.2.1 Construction of an artificial CRISPR array: 
2.2.2.1.1 Insert preparation  
The individual repeat and spacer sequences comprising the array were to be kept 
constant in both length and content. The S. solfataricus P2 spacer sequence 
selected was number 63 from the CRISPR D loci (i.e. D63, (She et al., 2001)) and the 
repeat was that of the CD-type (Sokolowski et al., 2014): 
 
Spacer D63:  TTTCGTATAAGGACCAGAACGGCAATACCCAAACTGT 
CD-type repeat: GATAATCTCTTATAGAATTGAAAG 
 
To enable the construction of a plasmid insert of varying R/S number, three 
oligomers were designed such that they would separately comprise Start (S), End (E) 
and Middle (M) repeat/spacer pairs.  5’ duplex overhangs were incorporated to permit 
Oligo M to ligate to itself and grow to any length, whilst the flanking S or E oligomers 
could only bind to their respective ends of the growing central domain.  In this 
manner, the three oligomers could generate any desired length of repeating 
repeat/spacer units (Figure 2.1 i-iv).  The oligonucleotides were synthesised by IDT 
and the sequences are available upon request.  Upon receipt of the ssDNA oligomers 
and resuspension in TE buffer, complimentary pairs were annealed by mixing at a 
1:1 molar ratio (as calculated from manufacturers documentation) and incubated at 
95 ˚C for 1 min prior to slow overnight cooling to room temperature.  Samples were 
subsequently stored at -20 ˚C. 
 
In an attempt to control the length of the growing spacer/repeat-modules; the relative 
quantities of each construction oligomer were varied.  It was hoped that by altering 
the molar ratio of ‘middle’ oligomer, (relative to ‘start’ and ‘end’ units) would shift the 
tendency for growth towards an R/S-module of the corresponding sum (e.g. Oligos 
S:M:E at 1:3:1 ! (R/S)5 module).  However, only very minor shifts within the end 
populations were ever achieved (data not shown).  As such, rather than individual 
insert construction assays achieving the desired module size, a single scaled up 
assay of 2:10:1 ratio was performed and individual bands within the resulting agarose 
gel, corresponding to expected insert sizes (integer value), were excised and 
processed separately for ligation into the pET28c vector (Figure 2.2A).  DNA was 
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extracted from gel bands/rows using the Wizard® SV gel and PCR-cleanup system 
(Promega) kit and protocol. 
 
 
 
Figure 2.2: Construction of repeat-spacer array insert and successful ligation into 
vector enabled uniform CRISPR RNA transcripts to be obtained. (A) A range of S:M:E 
oligomer ratios were incubated with ligase for 10 min at ~22 ˚C (r/t) in kit buffer and the 
products separated on an agarose gel.  Regulating the growth of the repeat/spacer (R/S) DNA 
insert proved marginal, irrespective of S/M/E ratios selected.  Nonetheless discrete bands of 
the expect unit sizes (n) were identifiable for gel purification and ligation into the pET-28c 
vector.  (B) Successful ligation of inserts into pET28C vector yielded arrays of 2-5 and 11 
repeat-spacer units in length. Illustrated are the products of double digestion (Xba1, Xho1) of 
successfully sequenced plasmid DNA, thus releasing the intact insert, separated on an 
agarose gel (expected insert lengths (bp) indicated). (C) Products of RNA transcription with α-
UTP 32P limiting nucleotide from the (R/S)4 module, separated on a denaturing 
polyacrylamide gel and phosphorimaged.  
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2.2.2.1.2 pET-28c vector purification and linearisation 
Expression from the pET family of plasmids is under the control of a T7-polymerase 
promoter.  pET28c offers a relatively simple platform for straightforward in vitro 
transcription. 
 
100ml LB supplemented with 35 µg.ml-1 kanamycin (+KAN) was inoculated with 
dH5a stock cells containing the pET-28c vector (Novagen) and incubated overnight 
at 37 ˚C with shaking at 180x rpm.  The cultures were spun at 4000 rpm and the 
pellets processed as per the QIAgen DNA Miniprep kit and protocol to extract the 
plasmid DNA present. 
 
The plasmid sample was subjected to a double digest protocol with Xba1 and Xho1 
restriction enzymes (FastDigest, Thermoscientific) as per an adapted kit protocol. 
Double-digestion of the plasmid by two restriction enzymes Xba1 and Xho1, each 
targeting opposite ends of the insert (formed by Oligo S and E, respectively), not only 
minimises any issues concerning insert orientation but crucially allows for later 
digestion by the downstream nuclease (Xho1) to enable plasmid linearization and 
run-off transcription.  Each enzyme (10 U.µl-1) was added in the ratio of 1 µl per 1 ng 
DNA, as estimated from spectrophotometer A260 readings, and incubated in kit 
buffers at 37 ˚C for 3 h.  No STAR activity was discernable over such time frames 
(data not shown).  Enzyme activity was subsequently neutralised by incubation at 
>65 ˚C for 30 min. 
 
To suppress self-ligation and re-circularisation of the  ‘empty’ plasmid, the 5’ 
phosphate termini required by ligase can be removed from the strand of a digested 
vector by Alkaline Phosphatase (Seeburg et al., 1977).  The Xho1/Xba1 digested 
pET-28c sample was subjected to dephosphorylation as per ThermoScientific 
Alkaline Phospatase (FastAP) kit and protocol. 
 
The linearised and dephosphorylated sample was subjected to final cleanup by 
agarose gel (0.75 % Agarose, 1-2 µl Ethidium Bromide per 50 ml) electrophoresis at 
80 V for 90 min in 1x TBE buffer.  Separated from contaminants (protein and DNA 
fragments), the single linearised vector band was excised and gel purified using the 
Wizard® SV gel and PCR-cleanup system (Promega) kit and protocol. 
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2.2.2.1.3 Vector-insert ligation 
Insert sizes of (R/S)3 – 10 were independently ligated into linearised pET28c vector as 
per the Thermoscientific T4 DNA ligase kit and protocol (Thermoscientific).  A 10-fold 
molar excess of insert over vector was employed in each condition (as calculated 
from spectrophotometer A260 readings). 
2.2.2.1.4 Transformations 
Completed ligation reactions were subsequently used in the transformation of 
commercially available DH5α competent cells (MAX efficiency® DH5α™, Life 
Technologies) as per protocol in section 2.1.1.2.2.  Processed samples were 
streaked out on Agar +KAN plates and incubated overnight at 37 ˚C.  Colonies were 
obtained in (R/S)2-4 conditions under this protocol. 
 
Conditions involving R/S sizes in excess of 5 proved resistant to DH5α 
transformation success (Data not shown).  An alternative method was attempted  
(see Section 2.2.2.1.5) which instead utilised competent cells from the E. coli STBL3 
strain (kindly donated by the MacNeill Lab, University of St Andrews); developed with 
compromised house-keeping functionalities to better tolerate the presence of 
plasmids containing unstable inserts (e.g. direct repeats). 
 
Colonies from all successful conditions were used to inoculate 10 ml LB +KAN 
volumes for overnight incubation (<16 h) at 37 ˚C with shaking at 180x rpm.   
Cultures were spun down and plasmid DNA collected via Miniprep as described 
previously.   Samples from each condition were subjected to a double digestion 
protocol with Xba1 and Xho1 to identify the presence of the expected insert size.   If 
successful, the respective plasmid DNA was sent for sequencing by GATC to confirm 
sequence fidelity. 
2.2.2.1.5 Preparation of competent STBL cells and transformation protocol 
20 ml LB was inoculated with STBL glycerol stock and incubated at 37 ˚C with 
shaking at 180 rpm until reaching an OD600 of 0.5.  The culture was spun down at 
3000 rpm for 10 min.  Pellet was resuspended with 1 ml TSP buffer (For 5 ml (0.22 
µm filter sterilised) TSP: 5 ml LB, 250 µl 100 % DMSO, 100 µl Mg Salts, 0.5 g 
Polyethylene glycol) and incubated on ice for 30 min.  Per transformation condition, 
100 µl competent cells were added to 10 µl ligated DNA in chilled 1.5 ml Eppendorf 
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tube and incubated on ice for 30 min.  200 µl TSP was added to the sample and 
incubated at 37 ˚C with shaking at 180x rpm, prior to plating out of entire volume on 
an agar (+KAN) plate.  Plates were incubated overnight at 37 ˚C.  R/S sizes 5 and 11 
were achieved in this manner. 
2.2.2.1.6 In vitro run-off transcription 
The four-unit repeat-spacer - (R/S)4 - module was selected as the model for further 
investigation from which clean substrate CRISPR RNA (4-R/S), internally labelled 
with α-UTP 32P, was produced by run-off transcription (Figure 2.2C). 
 
Stock purified pET28c-(R/S)4 plasmid was linearised by Xho1 digestion as per kit 
protocol.  The 3 h restriction endonuclease digestion was terminated by the addition 
of 1/20th volume 0.5 M EDTA, 1/10th volume 3 M Sodium Acetate and 2 volumes 100 
% Ethanol as recommended by the selected in vitro transcription kit protocol (see 
below).  The solution was spun at 13000x rpm, supernatant removed and 
precipitated DNA pellet resuspended with dH2O to a predicted concentration of ~0.5 
µg.µl-1 (calculated from starting concentration measurements). 
 
RNA was subsequently transcribed from the clean linearised plasmid using the 
Maxiscript® (Life Technologies) in vitro transcription kit and protocol.  UTP was 
selected as the limiting nucleotide due to the higher prevalence of thymine/uracil over 
cytosine within the repeat domain and, crucially, either side of the expected Cas6 
cleavage site.  Certain characteristics of ATP and GTP otherwise make them poor 
choices for such a role, namely due to lower incorporation efficiencies and a 
propensity for increased decomposition during storage, respectively (Melton et al., 
1984).  3.2 µM limiting nucleotide was present within the reaction volume (3 µM 
unlabelled UTP, 0.2 µM [γ32P]-UTP (3000 ci.mol-1, 10 ci.ml-1)).  Transcription 
proceeded as per kit protocol, including optional steps of DNase and EDTA 
treatments.  After completion, the transcript was gel purified on a denaturing 
polyacrylamide (PAA) gel (8 % Acrylamide, 8 M UREA – 3 mm thickness) as per 
Section 2.2.3, with final resuspension of the precipitated sample occurring into 60 µl 
of RNA storage buffer (Ambion). 
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2.2.3 Purification of RNA stocks 
RNA stocks were gel purified to remove breakdown or partial synthesis products.  
RNA volumes were mixed 1:1 with formamide and breakdown products separated on 
a denaturing polyacrylamide gel (12% acrylamide, 8 M Urea – 3 mm thickness) 
running at 80 Watts for ~90 min, temperature-regulated to 45˚C.  Gels were pre-run 
to temperature (45 ˚C) and wells flushed out with running buffer prior to sample 
loading. UV shadowing was used to identify target RNA.  Bands were excised and 
incubated at 4 ˚C with 400 µl RNase-free dH2O on a rocker O/N.  The soluble fraction 
was carefully removed and 1/10th volume 3M sodium and 2x volume 100% ethanol 
added with vortexing to mix.  The mixture was incubated at -80 ˚C for 1-2 h prior to 
centrifugation at 4 ˚C at 13000 rpm for 1 h.  The supernatant was discarded and 800 
µl 70% ethanol added before further centrifugation for 1 h.  The supernatant was 
discarded and any remaining liquid removed by air or vacuum drying, prior to final re-
suspension of sample in 50 µl RNA storage buffer (Ambion).  RNA concentration for 
each sample was estimated via spectrophotometer measurement, accounting for 
sequence specific extinction coefficients as provided by the manufacturer’s 
documentation, prior to storage at -20 ˚C. 
2.2.4 End-labelling RNA with [γ32P] ATP 
Previously purified unlabelled RNA was end-labelled with γ32P ATP (3000 ci.mol-1, 10 
ci.ml-1, MP Biomedicals).  20 µl labelling reactions were constructed, comprising; 1x 
Buffer A (Fermentas cat# EK0032), 0.5 U.µl-1 PNK (Fermentas), 1 µl isotope, 50-100 
µM RNA, RNase-free dH2O to final volume (MELFORD).  The assay was incubated 
at 37 ˚C for 1 h.  Upon completion, volume was diluted 1:1 with formamide and 
incubated at 95 ˚C for 2 minutes prior to separation of products (including free 
isotope) via electrophoresis on a 12% denaturing polyacrylamide gel.  Samples were 
imaged by phosphorimaging, permitting target bands to be selected for excision and 
gel purification (as detailed above). 
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2.2.5 Ladder and marker generation 
2.2.5.1 RNA ladder via alkaline hydrolysis 
Ladders from substrate RNA were created by alkaline hydrolysis (AH) as adapted 
from the LifeTechnologies™ ‘Alkaline hydrolysis’ online protocol: 
http://www.lifetechnologies.com/us/en/home/references/protocols/nucleic-acid-
purification-and-analysis/rna-protocol/rna-structure-function-protocols.html.  0.3-0.5 
nM RNA was incubated at 95˚C for ~15 min in Alkaline Hydrolysis buffer; 50 mM 
Sodium carbonate [NaHCO3/Na2CO3] pH 9.2, 1 mM EDTA.  The reaction stopped 
upon 1:3 dilution with formamide (supplemented with 0.025% Xylene Cyanol, 0.025% 
Bromophenol Blue) to generate a 1x marker solution (3-7 µl loaded alongside 
samples).  Such a ladder provides 1 nt resolution within the length range of an end-
labelled substrate. Incubation time can be adjusted to best accommodate a specific 
RNA fragment range, or multiple time-points can be taken and later re-combined to 
produce a ladder with best signal distribution across the entire substrate length. 
Ladder was stored at -20 ˚C until use. 
2.2.5.2 RNA marker 
Where AH is incompatible (i.e. internally labelled substrates), a commercially 
available marker system (Decade™ marker, Ambion®) was employed to give a 
resolution of 10 nt size intervals.  Marker generated as per kit protocol. 
2.3 Enzyme Kinetics 
2.3.1 Michaelis-Menten model 
The Michaelis-Menten model (Michaelis et al., 1913), alongside the Briggs-
Haldane derivation (Briggs et al., 1925), is an established and simple approach to 
consider non-cooperative enzyme kinetics.  A catalytic cycle involving a single 
enzyme and substrate, as per Cas6 and pre-crRNA, can be displayed as the 
following reaction scheme: 
 
 (Equation 2.1) 
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During a reaction, enzyme and substrate associate reversibly to form an 
intermediate enzyme-substrate complex, with the bimolecular rate constant k1 
describing the forward reaction.  The [ES] enzyme-substrate complex can either 
dissociate back to enzyme and substrate, described by the unimolecular rate 
constant k-1, or it can proceed to an irreversible catalytic step, which results in the 
release of product and free enzyme, described by the unimolecular rate constant 
commonly referred to as kcat.  Accordingly, k1 has units of concentration-1.time-1, 
whereas k-1 and kcat both have units of time-1.  From this simple kinetic model, 
equations can be written to describe the rates of change of each chemical 
species in the closed system illustrated in Figure 2.3. 
 
 
Figure 2.3: Representation of Michaelis-Menten model. The above plot shows a 
representation of the changing concentrations, with respect to time, of chemical species 
involved in a one-enzyme/one-substrate reaction, within a closed system, operating under the 
Michaelis-Menten model. 
 
2.3.1.1 Enzyme substrate affinity 
Assuming the formation of [ES] from [E] and [S] is reversible, the process is 
governed by the rate constants k1 and k-1 for the forward and backward reactions, 
respectively.  At equilibrium, the formation of [ES] is defined as 
C
on
ce
nt
ra
tio
n 
Time 
 
  
 
[P] 
[S] 
[ES] 
[E] 
Δ [ES] 
Δ t = 0
______ 
Chapter 2: Materials and Methods 
 
 83 
 
d ES[ ]
dt = k1 E[ ] S[ ]− k−1 ES[ ] = 0   (Equation 2.4)
 
 
Therefore, equilibrium is achieved when 
 
k1 E[ ] S[ ] = k−1 ES[ ]  (Equation 2.3) 
 
The above equation can be rearranged to illustrate that the ratio of k1 and k-1 is a 
constant that describes binding at equilibrium, e.g. the equilibrium dissociation 
constant, KD: 
 
KD =
k−1
k1
=
ES[ ]
E[ ] S[ ]
 (Equation 2.4) 
 
KD has units of concentration and serves as a useful indication of enzyme-
substrate affinity to indicate the concentration of enzyme at which 50% of the 
substrate population becomes bound (i.e. as a rectangular hyperbole function, 
when [E] = KD, [S] = [ES]).  Such logic is not just restricted to substrate-enzyme 
binding, but can be used to describe any binding event involving two partners, 
e.g. enzyme and product.  The KD can derived experimentally simply by titrating 
one reagent, [R]1, against a low concentration of its binding partner [R]2, where 
[R]2<KD. 
 
2.3.1.2 Reaction velocity and determination of KM and Vmax 
The formation of product, which is also a convenient variable from which to define 
the reaction velocity, adheres to the first order rate equation: 
 
v0 =
d[P]
dt = kcat[ES]  (Equation 2.5) 
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Some assumptions govern this catalytic step, namely that no reverse reaction 
occurs and that the enzyme displays little affinity for product, such that any k-2 
rate is negligible (and therefore not considered).  Accordingly only the initial 
velocity (v0) is considered, as it is assumed that [S]>>[P] at this point in the 
reaction, and thus any influence of [P] is negligible.  To maximize this effect via 
experimental design, a low enzyme concentration is used such that the substrate 
concentration is saturating, i.e. [S]>>[E].  Known as ‘multiple-turnover conditions’, 
the enzyme population is able to engage in multiple rounds of catalysis without any 
significant interference from product concentration. 
 
Within this closed system, the law of mass conservation is in effect.  Therefore, 
the initial concentration of substrate, [S]0, will be a sum of free substrate, [S]F, 
enzyme-bound substrate, and any substrate now converted to product: 
 
[S]0 = [S]F +[ES]+[P]  (which where [S]>>[P] and [S]>>[E]⇒ [S]0 ≈ [S]free)  
(Equation 2.6) 
 
Similarly, the total enzyme, [E]T, concentration is a combination of free enzyme, 
[E], and any enzyme tied up in enzyme-substrate complex: 
 
[E]T = [E]+[ES]  (Equation 2.7) 
 
The rates of formation and breakdown of [ES] can be described as 
[ES]= k1[E][S]  and [ES]= (k−1 + kcat )[ES] , respectively.  
 
Under the steady state approximation (Briggs et al., 1925), the equilibrium 
concentration of ES is reached quickly and does not vary significantly over the course 
of the reaction. In this scenario, the rates of formation and breakdown of [ES] are 
thus equal, i.e.: 
 
k1[E][S]= (kcat + k−1)[ES] . (Equation 2.8) 
 
This can be rearranged to define the Michaelis constant, KM: 
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kcat + k−1
k1
=
[E][S]
[ES]  (Equation 2.9) 
 
By replacing [E] with the rearranged form of the [E]T = [E]+[ES]  equation, KM can 
also be defined as 
 
KM =
([E]T −[ES])[S]
[ES]  (Equation 2.10)
 
 
This equation can then be solved for [ES]: 
 
KM [ES]= [E]T [S]−[ES][S]
KM [ES]+[ES][S]= [E]T [S]
[ES](KM +[S]) = [E]T [S]
[ES]= [E]T [S]KM +[S]  (Equation 2.11) 
 
Substituting the above for [ES] in V0 = kcat[ES]  yields: 
 
v0 = kcat
[E]T [S]
kM +[S]
!
"
#
$
%
&  (Equation 2.12) 
 
An enzyme has a finite number of active sites that can be filled by substrate during a 
reaction. Maximum velocity of the reaction, Vmax, thus occurs when the enzyme is 
fully saturated with substrate, or [ES]= [E]T , and increasing the substrate 
concentration will not increase the rate of the reaction: 
 
Vmax = kcat[E]T   (Equation 2.13) 
 
Substituting the above into the v0 equation for kcat and solving gives the following 
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v0 =Vmax
[S]
[S]+KM
!
"
#
$
%
&=
Vmax ⋅[S]
[S]+KM
 (Equation 2.14) 
 
This is known as the Michaelis-Menten equation.  Two important consequences of 
this derivation present themselves: 
 
First, at high substrate concentrations, v0 no longer depends on [S], and KM becomes 
irrelevant. Therefore: v0 =Vmax . 
 
Second, at low substrate concentrations, v0 depends on KM, [S] and [E]T: 
 
v0 =
Vmax⋅[S]
KM
=
kcat[E]T [S]
KM
 (Equation 2.15) 
2.3.1.3 Application of enzyme kinetics theory and the importance 
of Kcat, Vmax and KM 
Where pH and temperature are strictly maintained, the KM and a Vmax can be derived 
experimentally from measurements of v0 across a range of substrate concentrations, 
where the enzyme is operating under multiple-turnover conditions.  When Michaelis-
Menten kinetics are adhered to, plotting v0 as a function of [S] will yield a rectangular 
hyperbole (Figure 2.4).  Due to the physical limitations of assay construction, Vmax is 
approached asymptotically.  Accordingly, values for KM and Vmax have to be 
estimated from curve fitting.  Whilst a variety on linear transformations of v0 versus 
[S] (e.g. Lineweaver-Burk plot, Eadie-Hofstee plot) have long existed to help derive 
values for KM and Vmax, these methods have largely been superseded with the help of 
computers that allow fitting of the Michaelis–Menten equation directly to data by non-
linear regression. 
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Figure 2.4: Michaelis-Menten equation, v0=Vmax.[S]/[S]+KM, generates a rectangular 
hyperbole.  Profiles of two different hypothetical enzymes (black and red) differing in Vmax 
and KM are displayed. 
 
The KM can therefore be defined as the substrate concentration at which 50% Vmax is 
achieved (i.e. 50% active sites filled) and therefore serves as an indication of how 
much substrate is required to induce significant catalysis by the enzyme.  A low KM is 
indicative of an enzyme that tends to function at maximum activity irrespective of 
substrate concentration, whereas a high KM allows an enzyme to react dynamically 
over a broader range of substrate conditions.   
 
Under the low substrate conditions typical of a physiological environment, Equation 
2.15 shows that kcat/KM is the rate constant for the interaction between substrate and 
enzyme, a measure variously referred to as an enzyme’s ‘catalytic ability’ or ‘catalytic 
efficiency’.  From the derivations of KM (Equation 2.10), it can be seen that kcat/KM is 
limited by k1: 
kcat
Km
=
kcat
(k−1 + k cat )k1
=
kcat
kcat + k−1
k1 < k1  (Equation 2.16) 
 
When kcat>>k-1: 
kcat
KM
= k1  (Equation 2.17) 
v 
[S] 
Vmax 
Vmax 
 
 
Enzyme 1 
Enzyme 
2
KM KM 
½ Vmax 
½ Vmax 
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Association of enzyme-substrate complex, i.e. k1, is itself limited by the diffusion of 
the respective molecules in solution, and thus their encounter, which has the upper 
physical limit of ~109.s-1.M-1 (Alberty and Hammes, 1958). Any enzyme that 
approaches a kcat/KM of 109.s-1.M-1 is said to be a ‘perfect’ enzyme. 
 
kcat represents the maximum number of substrate molecules converted to product 
by each active site can perform in a given time frame.  Under multiple-turnover 
conditions, Vmax is achieved when all enzyme active sites present are saturated 
with substrate, i.e. [ES]= [E]T . Under reaction conditions where [S]>>[E], the kcat 
constant can therefore be derived from the initial slope of product formation over 
time, divided by the known [E]T.  From Equation 2.13: 
kcat =
Vmax
E[ ]T
 (Equation 2.18) 
In reality, the apparent unimolecular rate constant kcat under multiple-turnover 
conditions takes into account any partial rate constants, such as the catalytic step 
and dissociation of the enzyme-product complex, that individually may be rate 
limiting: 
   (Equation 2.19) 
 
Alternatively, incubating enzyme and substrate under ‘single-turnover conditions’, 
where a saturating excess of enzyme over substrate is used, i.e. [E]>>[S], and 
[E]>>KD, all substrate present will be used up in a single round of catalysis within 
the enzyme population.  The single-turnover rate, kstn, that emerges thus 
describes the rate of the catalytic step in isolation and has units of time-1. 
2.3.2 Cas6 Nuclease Assays 
2.3.2.1 Nuclease buffers 
The primary nuclease reaction (NR) buffer composition was adapted from Lintner et 
al. (NR-1, Lintner2011), and incrementally modified (underlined regions) over the 
course of the work presented: 
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NR-1: 20 mM TRIS-HCl pH 7.5, 100 mM Potassium glutamate (K-Glu), 5 mM EDTA, 
0.5 mM DTT (dithiothreitol) 
NR-2: 20 mM Sodium phosphate pH 7.5, 100 mM K-Glu, 5 m M EDTA, 0.5 mM DTT 
NR-3: 20 mM Sodium phosphate pH 7.5, 100 mM NaCl, 5 m M EDTA, 0.5 mM DTT  
2.3.2.2 Cas6 nuclease activity confirmation using fluorescent 
substrates 
Assay protocol was adapted from Lintner et al. (Lintner et al., 2011).  5 µM 
Cas6[1437] WT was incubated with 0.5 µM 5’ [FAM]-labelled repeat RNA (CD, AB, F) 
at 45 ˚C in NR-1 buffer.  At relevant time-points, 10 µl samples were removed from 
the main reaction volume and activity stopped by treatment with 5 µl 0.1 mg 
Proteinase K (PK, 5 µl of 20 mg/ml PK in RNase-free dH2O) for 15 min incubation at 
37˚C.  Finally, samples were mixed 1:1 with formamide and either stored short-term 
on ice/4˚C, or long-term at -20 ˚C.  Products were separated on a denaturing 
polyacrylamide gel as per Section 2.3.2.7 and imaged by laser scanner (Fujifilm FLA-
5000, scanning at 473 nm). 
2.3.2.2.1 Optimisation of assay conditions 
The methodology employed by Lintner et al., whilst sufficient to establish Cas6 
activity (Lintner, Kerou, et al., 2011), proved limited for any subsequent detailed 
characterisation of activity.  Of note: 
 
• Under single-turnover conditions, product and substrate RNA had difficulty 
migrating into the polyacrylamide gels without application of an aggressive 
extraction methodology (e.g. degradation of protein via Proteinase K, data not 
shown).  This is possibly unsurprising given that previously characterised 
Cas6 enzymes bind both the substrate and product sequences with high 
affinity, allowing the product to remain bound to the endonuclease post 
cleavage (Carte et al., 2008; Haurwitz et al., 2010; Sashital et al., 2011; 
Sternberg et al., 2012; Niewoehner et al., 2014).  Such activity presently 
constitutes a defining feature of the Cas6 family activity that will be further 
explored in Chapter 4.  A protocol in which the reaction is stopped via 
combined cooling and degradation by Proteinase K makes it difficult to control 
for accurate and well-defined time-point readings that are necessary for the 
definition of catalytic parameters; therefore, the assay protocol was modified 
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to use phenol-chloroform to stop the reaction and extract products in a single, 
immediate step as was also used successfully in the characterisation of P. 
aeruginosa Cas6f (Csy4) by Haurwitz et al. (Haurwitz et al., 2012). 
• The fluorescently labelled substrate was substituted for a 32P-end-labelled 
oligonucleotide of the CD repeat sequence: 5′-
GAUAAUCUCUUAUAGAAUUGAAAG. This change was made to achieve 
sufficient signal for detection purposes (nM vs µM range for detection of 
fluorescence by laser scanner), which is necessary to establish single-
turnover assay conditions 
• Finally, the NR buffer was modified from TRIS to a Sodium Phosphate due to 
the latter’s minimal temperature induced pKa variation (0.0028 d(pKa)/dT) and 
known suitability in replicating biological systems (AppliChem, 2008). 
 
2.3.2.3 Analysis of Cas6 nuclease activity utilising radio-labelled 
substrate   
Assays were largely performed as per Reeks et al. (Reeks, Sokolowski, et al., 2013) 
with reference to section 2.3.2.1). 
 
Single-turnover conditions:  0.5 – 2 µM purified recombinant ssoCas6[1437] was 
incubated with 1-5 nM 32P-end-labelled repeat RNA (CD, AB or nrNRA) in NR-2 or 
NR-3 buffer.  Multiple-turnover conditions:  4-80 nM ssoCas6[1437] was incubated 
with 0.1-20 µM CD RNA (1-5 nM 32P-end-labelled RNA, remainder unlabelled RNA) 
in NR-3 buffer additionally supplemented with 2 µM BSA. 
 
Protein controls were constructed with the respective substitution volume of GF-
Buffer.  Prior to the assay start, Protein/Buffer pre-mixes and 10x[RNA] volumes were 
incubated separately at assay temperature (60 ˚C) for 5 min, whereupon the reaction 
was initiated by transfer of the required RNA volume. 
 
At relevant time-points, 10 µl samples were removed from the main reaction volume 
and activity stopped by addition to 30 µl pre-aliquoted acid phenol/chloroform 
(Ambion®, AM9720) with vortexing for ~15 sec (as described by Haurwitz et al., 
2012).  5 µl of the aqueous phase resulting from centrifugation at 13.2K rpm was 
extracted and mixed 1:1 with formamide.  Samples were kept on ice/4 ˚C (short-term) 
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or at -20 ˚C (long-term). Products were separated on a denaturing polyacrylamide gel 
as per Section 2.3.2.7. Substrate/product bands were subsequently visualised by 
phosphorimaging; a blanked imagine plate (IP, Fujifilm) plate was placed over 
relevant gel area and apparatus stored O/N at 4 ˚C, whereupon a laser scanner 
(Fujifilm FLA-5000, scanning at 635 nm) was used to image the plate for the latent 
image created by the radiation dose stored in the phosphor layer.  Image analysis 
and band quantification was performed with ImageGuage software (Fujifilm Science 
lab 2003, version 4.21). The Cas6 cleavage rate was derived by plotting the fraction 
product as a function of time and fitting the output to an exponential function (Eq. 3.1, 
single-turnover data) or linear function (multiple-turnover data) using curve-fitting 
software (Kaleidagraph, © Synergy software 2011). 
2.3.2.4 Assaying the effect of pH upon Cas6 nuclease activity 
Assay was conducted as per Section 2.3.2.3, in which the activity of 0.5 µM 
Cas6[1437] WT was assayed against 1 nM 32P-end-labelled CD RNA and the 
products separated on a denaturing PAA gel to be visualised by phosphorimaging 
techniques.  However, nuclease reaction buffer was altered to accommodate a 
specific pH - 50 mM ‘buffer agent’ pH X, 100 mM NaCl, 5 mM EDTA, 0.5 mM DTT, 
where buffer agent (X) was selected for the pH ranges (in parentheses); acetate (pH 
range: 4.0 - 5.5), MES (pH 6.0), sodium phosphate (pH 6.5 - 8.0), CHES (pH 8.5 - 
9.5), CAPS (pH 10.0 - 11.0).  Buffers were constructed and pH calibrated at r/t (24 
˚C) in accordance to calculations made by the online buffer design tool 
http://www.bioinformatics.org/JaMBW/5/4/index.html (© Rob Beynon, 1996) to 
achieve desired final pH at 60˚C (assay temperature). 
2.3.2.5 Assaying S. solfataricus Cas6-3 paralogue [1422] for 
nuclease activity 
2.3.2.5.1 Cloning, expression and purification of Cas6-3 
A Cas6-3[1422] construct with N-terminal MBP (Maltose binding protein) tag (WT and 
K47A variant) was cloned, subjected to SDM, expressed and purified by Dr Shirley 
Graham and is described in Sokolowski et al., 2014.  Briefly: 
 
The gene for Cas6-3 (sso1422) was amplified from S. solfataricus P2 genomic DNA 
by PCR prior to cloning into a derivative of the vector pEHisTEV (Liu2009) using NcoI 
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and EcoRI restriction sites.  The vector permits inducible expression of recombinant 
target protein as an N-terminal polyhistidine-tagged maltose binding protein (MBP) 
fusion.  A similar overexpression and combined nickel-affinity and size-exclusion 
chromatography purification strategy as described in Section 2.1.2.2 was employed.  
However, His-tag removal and second Nickel-column stages were omitted.  The 
recombinant protein was eluted from a Superdex 200 10/300 gel-filtration column 
equilibrated with 20 mM Tris–HCl pH 7.5, 300 mM NaCl, 10% glycerol (Dr Shirley 
Graham, Sokolowski et al., 2014). 
2.3.2.5.2 Probing Cas6-3 cleavage of repeat sequences 
A supermix of 2-10 nM 32P-end-labelled repeat RNA (CD, AB or ncRNA), 1/10th 
volume protein-based RNase inhibitor (SUPERase⋅ In, LifeTechnologies) and pre-
assay buffer [20 mM TRIS-HCL pH 7.5, 5 mM EDTA] was arranged into aliquots.  To 
initiate the reaction, an equal volume of the MBP-Cas6-3[1422] stock (WT/K47A, at 
stock concentration, in [20 mM TRIS-HCL, 250 mM NaCl]) was added to the pre-
incubated (45 ˚C) master-mix aliquot.  Final assay buffer conditions were thus [20 
mM TRIS-HCL pH 7.5, 125 mM NaCl, 5 mM EDTA] with assay conducted at 45 ˚C to 
maintain the thermal stability of the MBP-tag.  At relevant time-points, samples were 
processed with phenol-chloroform as described in Section 2.3.2.3 and reaction 
products separated on a denaturing polyacrylamide gel for phosphorimaging as 
described in Section 2.3.7. 
2.3.2.6 Cas6 processing of multi-repeat transcripts 
Assays to explore crRNA biogenesis from longer CRISPR-like RNA transcripts 
employed the 4-R/S RNA generated in Section 2.2.2.  Assays were largely conducted 
as per the general nuclease reaction scheme using radio-labelled substrates 
described in Section 2.3.2.3.  0.2 nM or 2 µM recombinant Cas6[1437] WT was 
incubated with ~0.5 nM 4-R/S RNA (32P-UTP Internally-labelled) at 60 ˚C in NR-3 
buffer.  At relevant time-points, samples were processed with phenol-chloroform and 
reaction products separated on a denaturing polyacrylamide gel for phosphorimaging 
as described in Section 2.3.7. 
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2.3.2.7 Gel separation of nuclease reaction products and 
visualisation 
To visualise nuclease reaction products, 7 µl samples were separated on a 
denaturing polyacrylamide (PA) gel (20 % Acrylamide, 8 M UREA – 0.2 mm 
thickness) run at 80 W for  ~90 min in 1x TBE running buffer, temperature-regulated 
to 50 ˚C.  All gels were pre-run to temperature (50 ˚C), with wells flushed with running 
buffer prior to sample loading.  A Fujifilm FLA-5000 laser scanner and associated 
software (FlA500 V1.01 Fujifilm ©) was used image the gel directly (fluoroscein-
labelled substrate) or an IP plate dose recording of a gel (Radio-labelled substrate) 
scanning at 473 or 635 nm, respectively.  Gel images were analysed using 
Ima4eGauge software (Fujifilm).  
2.4 Exploring Cas6-RNA Interactions 
2.4.1 Electromobility shift assay (EMSA).  
Assays were conducted in NR-buffer supplemented with 2 µM BSA.  A dilution series 
of ssoCas6[1437] was prepared from 10 µM – 0.5 nM, to which 0.5 nM [γ-32P]ATP-
labelled RNA was introduced to initiate the reaction.  After 15 min incubation at r/t, 
reactions were gently mixed 1:1 with ficoll and 10 µl loaded under reduced voltage 
(30 V) onto a non-denaturing 6 % polyacrylamide gel (0M UREA, 1xTBE – 3 mm 
thickness) in 1x TBE running buffer.  Upon loading of all samples, voltage was raised 
to 120 V for 120 min. Gels were incubated with imaging plate overnight at 4˚C to 
minimise diffusion of bands.  Gels were phosphorimaged and analysed as detailed 
previously (Section 2.3.7).  Binding affinities were determined by plotting fraction of 
RNA bound as a function of Cas6 concentration and fitting the output to Eq. 3.1 using 
curve-fitting software (Kaleidagraph, © Synergy software 2011).  The inverse of the 
association constant (KA) value generated represents the dissociation constant (KD). 
2.4.2 Fluorescence quenching assay 
Fluorescence quenching experiments utilized a Varian Cary Eclipse fluorimeter (λ 
excitation = 480 nm, emission/excitation slits: 10 nm, PMT: 900 V) under temperature 
control at 25 ˚C. All assays were conducted in NR-3 buffer supplemented with 2 µM 
BSA. 
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In a 150 µl starting volume contained within a quartz fluorescence spectroscopy cell 
(PerkinElmer™), changes to fluorescence intensity were recorded on addition of 
aliquots of Cas6 variant to 1 nM CD, AB or CDproduct oligonucleotide with a 5′ 
fluorescein label (Section 2.2.1). The emission data collected in the wavelength 
range 500–560 nm (1 nm data intervals) were summed, adjusted for dilution factor 
and normalized for baseline fluorescence.  To extract a KD estimate, quenching 
profiles were fitted to a modified binding equation with variable hill function (Eq. 4.1) 
using curve-fitting software (Kaleidagraph, © Synergy software 2011). 
2.5 Determination of Protein Stability via Thermal 
Shift Assay 
Protocol was adapted from Niesen et al. 2007 (Niesen et al., 2007).  5 µM protein 
was incubated in nuclease assay buffer (20 mM NaH2PO4/Na2HPO4 pH 7.5, 100 mM 
k-glutamate, 5 m M EDTA, 0.5 mM DTT) supplemented with 2x SyproOrange® 
(5000x concentrate in DMSO, Invitrogen). 100 µl volumes were aliquoted into a 96-
well propylene plate (Agilent technologies) and covered with an optically clear 
adhesive film (Molecular Dimensions Ltd., ClearVue sheets).  Plates were spun 
briefly at 1500xg prior to assay start. The temperature was raised from 25 to 95 ˚C in 
0.5˚C increments, 1 min cycles, and the fluorescence levels motinitored via a QPCR 
System (Stratagene® Mx3005pTM) and related software (Stratagene® MxPro: 
Mx3005p v4.01 build 369, ©2007).  Post-assay manipulation of data was undertaken 
in Excel (Microsoft) using the ‘DFS analysis (Vers.3.0)’ tool developed (and kindly 
provided) by Niesen et al. (Vedadi et al., 2006; Niesen et al., 2007; Niesen, 2010), 
downloadable at ftp://ftp.sgc.ox.ac.uk/pub/biophysics).  Output data was fitted to the 
Boltzmann equation (Equation 3.2) using non-linear regression methods performed 
by curve-fitting software (Kaleidagraph).  The inflection point of the sigmoidal, 
monophasic thermal profile of Cas6[1437] WT/Monomer is taken to be the melting 
temperature (Tm) of the protein (Lo et al., 2004; Vedadi et al., 2006; Niesen et al., 
2007). 
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2.6 Determination of Cas6 Activity in Size-
Fractionated Lysates of S. solfataricus P2 
2.6.1 S. solfataricus culture and lysate preparation 
A S. solfataricus P2 culture was prepared by Dr Shirley Graham using the 
methodologies described in Zhang et al. (Zhang et al., 2012; Sokolowski et al., 2014).  
The sample was subsequently lysed by sonication and the soluble fraction subjected 
to precipitation with 70 % Ammonium Sulphate to enable long-term storage at 4 ˚C 
(Dr Shirley Graham).   
2.6.2 Gel filtration of lysate (size-fractionation of protein 
contents) 
30 ml (~5 g biomass) 70 % ammonium sulphate precipitation of S. solfataricus P2 
lysate was clarified at 14K rpm of 15 min at r/t.  The pellet was resuspended in the 
minimal volume of 20 mM NaH2PO4/Na2HPO4 pH 7.5, 250 mM NaCl, 5 mM EDTA, 
0.5 mM DTT required to achieve a precipitant-free and clear solution (~12 ml).  After 
an additional centrifugation at 4k rpm for 15 min at r/t to remove insoluble debris, the 
entire soluble sample volume was fractionated on a pre-equilibrated Sephadex 26/60 
200 prepgrade (GEhealthcare) size exclusion column at 2 ml.min-1.  The elutated 
volume was collected in 2 ml fractions. 
2.6.3 Screening for RNA-cleavage activity 
Fractions encompassing the entire elution profile were assayed for RNase activity.  A 
supermix of [2-10 nM repeat RNA (CD, AB, ncRNA), 20 mM NaH2PO4/Na2HPO4 pH 
7.5, 5 mM EDTA, 0.5 mM DTT] was arranged into 10 µl aliquots.  To initiate the 
reaction, 10 µl of the relevant lysate fraction was added to the pre-aliquoted supermix 
and incubated at 60 ˚C for 1 h.  Upon completion, each reaction was stopped and the 
RNA contents extracted, products separated on a denaturing 20% polyacrylamide gel 
(8M UREA, 1x TBE) and the cleaved/uncleaved bands visualised by phosphoimaging 
as detailed in Section 2.3.7. 
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2.6.4 Western blotting for Type I and III system 
components  
To detect the presence of Cas6 protein and/or CRISPR/Cas effector complexes 
within the lysate fractions, samples were subjected to an immuno-detection method 
(Western-blot) utilising antibodies raised against a relevant protein component. 
 
Protein/Complex Abs target  
Cas6 Cas6 1437 
Type I-A CASCADE Cas5-Cas7 1441, 1442 
Type III-B CASCADE (CMR) Cmr7 1986 
 
Table 2.3: The CASCADE subunit and Cas6 targets against which the polyclonal antibodies 
(Abs) were raised. 
 
Third bleed sheep antiserum containing the polyclonal primary antibodies, raised 
against the relevant protein targets (Table 2.3), were obtained from the Scottish 
Blood Transfusion Service. 
 
An SDS-PAGE gel was prepared of selected lysate fractions alongside a pre-stained 
protein marker (Fermentas PageRuler™ prestained).  15 µl fraction samples were 
incubated with 5 µl disruption buffer (4:1 NuPage® 4xloading buffer : 1M DTT) at 95 
˚C for 3 min and 12 µl of the resulting sample loaded per well.  Each well thus 
contained 9 µl of original fraction sample.  An additional standard/reference well 
contained either 100 ng purified recombinant or ssoCas6[1437], 
ssoCas5[1441]/Cas7[1442] complex (Purified by Dr Shirley Graham) or Cmr7[1986] 
(Purified by Dr Shirley Graham).  The bands were transferred to nitrocellulose 
membrane as per iBlot kit and protocol (Invitrogen). 
 
Membranes were incubated in blocking buffer (Blocking buffer; Phosphate buffered 
saline (PBS), 0.005 % TWEEN-20, 5 % Powdered Milk (0% Fat)) for a minimum of 1 
h incubation. All wash/incubation steps were conducted at r/t (~22 ˚C) with gentle 
agitation.  Membrane was then transferred to a 1:2500 (Anti-Cas6) or 1:1000 (Anti-
Cmr7, Anti-Cas5/Cas7) dilution of primary antibody in Antibody buffer (Abs buffer; 
PBS, 0.005 % TWEEN-20, 1 % Powdered Milk (0% Fat)) for 1 h incubation.  After 
blots were washed with 3x 10 min cycles using fresh wash buffer (Wash buffer; PBS, 
0.005 % TWEEN-20), membrane was transferred to a 1:20000 dilution of fluorescent-
dye conjugated secondary antibody (IRDye® 800CW, Odyssey) donkey anti-goat) in 
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Abs buffer.  Membrane was incubated for 1 h prior to a further set of 3x 10 min wash 
cycles using wash buffer.  Blots were scanned and analysed using a Li-Cor CLx 
fluorescence scanner and associated software (Odyssey) 
2.7 Bioinformatics 
2.7.1 Structural protein prediction: Phyre 
Protein structure predictions were made by uploading sequences to the online Phyre 
II server (http://www.sbg.bio.ic.ac.uk/~phyre2, (Kelley and M. J. E. Sternberg, 2009)). 
2.7.2 Protein physical and chemical nature prediction: 
ProtParam 
Sequence-based predictions of various physical and chemical parameters were 
made by uploading target sequences to the online ProtParam server 
(http://web.expasy.org/protparam, (Gasteiger, 2003)). 
2.7.3 Sequence alignments: Uniprot 
Sequences were retrieved from and aligned using the online UniProt database 
(http://www.uniprot.org, (The UniProt Consortium, 2013)). 
2.8 General software usage 
Unless specific examples are cited, the majority of work employed the following 
software packages.  Data analysis, graphing and curve-fitting was performed using 
Kaleidagraph (Synergy).  Data processing was managed in Excel (Microsoft).  All 
word processing utilised Word (Microsoft) with figure construction performed in 
PowerPoint (Microsoft).  Image analysis and quantification was performed with 
ImageGauge (Fujifilm).  Construction of RNA secondary structures used the applet: 
VARNA (http://varna.lri.fr, Darty et al., 2009).  3D rendering of protein 
tertiary/quaternary structures used Pymol (Pymol, the PyMOL Molecular Graphics 
System, Version 1.5.0.4 Schrödinger, LLC., http://www.pymol.org).  Sequence 
alignment editing and visualization utilized the Jalview applet (http://www.jalview.org, 
Waterhouse et al., 2009). 
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Chapter 3: Probing the Catalytic 
Mechanism of S. solfataricus Cas6 
3.1 Introduction 
3.1.1 General features of the RAMP superfamily 
The largest class of genes associated with CRISPRs, which includes Cas6, belong to 
the Repeat-Associated Mysterious Protein superfamily (RAMPs, (Makarova et al., 
2002; Haft et al., 2005).   Whilst the diverse members of the RAMP group share very 
little sequence identity (Makarova et al., 2002; Haft et al., 2005; Makarova, Haft, et al., 
2011; Makarova, Aravind, et al., 2011), recent structural and bioinformatics studies 
confirm that members of each subfamily are unified through the employment of 
homologous domains that generate ferredoxin-like folds similar to those elicited by 
RNA-Recognition Motifs (RRMs) employed by RNA-binding proteins (Maris et al., 
2005; Makarova, Aravind, et al., 2011; reviewed in Reeks, Naismith, et al., 2013).  
 
The RRM motif consists of a four-strand, antiparallel β-sheet (β4β1β3β2), within which 
exist two α-helices between β1-β2 and β3-β4 that produce a βαββαβ arrangement of 
helices and sheets (Figure 3.1A and 3.2A).  All RAMPs possess at least one RRM-
like motif (Makarova, Aravind, et al., 2011), where the RAMP specific variations on 
the fold lead it be referred to often as a ‘RAMP domain’.  Additionally, early 
bioinformatics identified five conserved sequence motifs shared by RAMP family 
members; whilst all RAMPS share a C-terminal G-rich loop sequence (Motif V), 
motifs I-IV are not present ubiquitously (Makarova et al., 2002; Makarova, Aravind, et 
al., 2011).  RRMs typically exist in multiple copies in RNA-binding proteins and each 
ferredoxin fold is capable of binding ssRNA through the aromatic, positive residues of 
the beta-sheet (Maris et al., 2005).  RAMPs, on the other hand, utilise cooperating 
RRM-like folds as diverse methods of binding that can coordinate either single-
stranded or structured RNAs (Ebihara et al., 2006; Carte et al., 2008; Haurwitz et al., 
2010; Gesner et al., 2011; Sashital et al., 2011; Wang et al., 2011; 2012; reviewed in 
Wang and H. Li, 2012 and Reeks, Naismith, et al., 2013). 
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The characteristic G-rich motif of Cas6 family members conforms to the consensus 
GrGxxxxxGrG, in which r represents a hydrophobic residue and the series of x 
represents a central variable region composed of any residues but, of which, at least 
one is positive (Makarova et al., 2002).  Cas6 family members generally possess two 
sequential RAMP domains that generate a tandem ferredoxin-like fold connected by 
a hinge (reviewed in Reeks, Naismith, et al., 2013).  The G-rich loop is located 
between α2 and β4 of the second/C-terminal RRM.  Additionally, unique to Cas6 
family members, is a conserved hairpin-loop that links β2-β3 within the C-terminal 
RAMP domain and extends beyond the ferredoxin-like fold (Reeks, Naismith, et al., 
2013).   
 
In contrast, Cas7 family members evolved from a single RRM-containing ancestor 
and possess a single centrally located RRM-fold that is similar to the N-terminal RRM 
within Cas6 but contains four distinctive insertions between each of the β-sheets 
(Figure 3.2) (Lintner, Kerou, et al., 2011; Makarova, Aravind, et al., 2011; Reeks, 
Naismith, et al., 2013). Together, these insertions form two groups located at either 
end of the ferredoxin-like fold and impose a crescent-like conformation on the 
molecule (Lintner, Kerou, et al., 2011; Makarova, Aravind, et al., 2011; Reeks, 
Naismith, et al., 2013).   
 
Figure 3.1: RAMP structures in the Cas5 and Cas6 families. (A) RAMP-domain topology 
illustrating the arrangement of β-strands (dark blue), α-helices in (cyan) and β-strand 
extensions / β2-β3 hairpin seen in some RAMP-family members (green).  The N-terminal (blue 
sphere) and C-terminal (red sphere) are labelled.  The distinctive G-rich loop motif (yellow) of 
the RAMP family is located between α2-β4 of one of the RAMP-domains present.  The colour 
coding is continued in the following crystal structures. (B) Cas6 example: Thermus 
thermophilus Cas6e (PDB:1WJ9).  (C) Cas5 example: Bacillus halodurans Cas5c, unusual for 
the Cas5 family in that it possesses catalytic activity.  The α2-β4 arrangement within the 
RAMP fold is highlighted (box, dashed line).  Adapted from Reeks, Naismith, et al., 2013. 
 
Chapter 3: ssoCas6 Catalytic Mechanism 
 
 100 
Structures of catalytically active homologues of the typically non-catalytic Cas5 family 
have recently been characterised (Figure 3.1C, Cas5c (variably referred to as Cas5d) 
(Nam, Haitjema, et al., 2012; Koo et al., 2013; Garside et al., 2012; Reeks, Naismith, 
et al., 2013).  This example illustrates an intact N-terminal RAMP domain containing 
a G-rich loop motif and β2-β3, which resembles that of the Cas6 C-terminal RAMP 
domain, though the G-rich loop differs from the Cas6 consensus (Reeks, Naismith, et 
al., 2013). The Cas5 family can otherwise be unified largely on the basis of sequence 
similarities where the distinctive C-terminal domain downstream of the G-rich motif 
can in some cases be predicted to form an RRM (Makarova, Aravind, et al., 2011).  
Of the two Cas5 subfamilies thus discernable, one contains a single RRM motif whilst 
the other contains two (Makarova, Aravind, et al., 2011). 
 
Figure 3.2: RAMP structures in the Cas7 family. (A) The typical RAMP domain (blue/cyan) 
contains an αβα motif extension (orange) and two domains (grey) unique to the Cas7 family 
located at terminal end of the molecule. (B) Cas7 example: S. solfataricus Cas7 (PDB:3PSO).   
Adapted from Reeks, Naismith, et al., 2013. 
 
3.1.2 Cas6 structural and functional diversity 
Cas6s process pre-crRNA via repeat sequence cleavage to leave intact spacers with 
5’-tag, 3’-handle (Brouns et al., 2008; Carte et al., 2008; Haurwitz et al., 2010; Lintner, 
Kerou, et al., 2011; Richter et al., 2012).  Although members of the Cas6 family share 
a conserved core fold, there are extensive structural and functional differences 
between the Cas6 enzymes from different species, which, alongside the 
characterisation of a predicted Cas6 from S. solfataricus P2 (gene [sso1437]), will be 
the general focus of this thesis.  The structural differences will be primarily covered in 
this chapter. 
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Whilst extensive divergence is evident, multiple examples for Cas6 structures 
illustrate that members of the group have evolved from a common ancestor that 
possesses two RRM domains (Makarova, Aravind, et al., 2011; Makarova and 
Koonin, 2012).  The twin RAMP-domain architecture is shared, but whilst the N-
terminal more closely resembles the classical RRM fold, the C-terminal RAMP-
domain often contains insertions/deletions that can be specific to a given Cas6.  
Structures for the Cas6 examples from P. furiosus and T. thermophilus, which exhibit 
the predicted tandem ferredoxin-like fold, are typical for the group (Figure 3.3 A/B) 
(Ebihara et al., 2006; Carte et al., 2008).  However, the Cas6 example from P. 
aeruginosa (paCas6f) is significantly diverged and contains only a single intact N-
terminal RRM and a C-terminal RRM motif that appears degraded and generates 
only a partial ferredoxin-like fold (Figure 3.3 C) (Haurwitz et al., 2010).  
 
As discussed in the introduction, CRISPR repeat sequences (i.e. Cas6 substrate) are 
highly variable between species and generally share little similarity, in sequence or 
secondary structure (Mojica et al., 1995; Jansen et al., 2002; Godde and Bickerton, 
2006; Kunin et al., 2007).  However, the clustering of repeats via sequence/structure 
matched closely the pattern of cas gene associations and their subtype delineation 
(Kunin et al., 2007), indicating that the two are paired evolutionarily, which has 
obvious implications for mechanism and function as well as development and 
diversity (Kunin et al., 2007).  Major differences between the cas gene content of 
system types, phylogenies of individual components and the association with varying 
sequences and structures of repeats indicates mechanistic differences that exist as a 
product of co-evolution and divergence (Kunin et al., 2007; Makarova, Aravind, et al., 
2011; Makarova, Haft, et al., 2011). 
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Figure 3.3: Diversity in substrate handling across the Cas6 family. All structures are 
coloured as follows; Repeat RNA (green), active site residues (red sticks), G-rich loop motif 
(yellow).  (A) P. furiosus Cas6 (PDB:3PKM) coordinates an unstructured RNA repeat 
substrate (green) between a recognition domain and active site located on opposite faces of 
the protein. (B) T. thermophilus Cas6e (PDB:2Y8W) and (C) P. aeruginosa Cas6f 
(PDB:2XLK) recognise a stem-loop RNA sequence.  On the same face of the protein, 
interaction with the major groove of the duplexed region is coordinated by C-terminal RAMP-
domain to position the 3’ strand for cleavage mediated by N-terminal domain catalytic 
residues. 
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Such a relationship is evident in the diversity of substrate handling mechanisms 
characterised across the Cas6 family (Figure 3.3A-C).  The T. thermophilus, ttCas6e, 
and P. aeruginosa, paCas6f, target repeats with palindromic sequences that results 
in a stable hairpin structure (Kunin et al., 2007).  Both structural and sequence 
elements of the hairpin are recognised via overlapping recognition and active site 
domains located on the α-helical side of the twin RAMP-domain (Haurwitz et al., 
2010; Gesner et al., 2011; Sashital et al., 2011).  The major groove of the repeat 
RNA stem-loop interacts specifically with features in the C-terminal RAMP domain, 
which orients the RNA cleavage site on the phosphate-backbone of the 3’ strand 
towards the catalytic residues located within the N-terminal RAMP fold (Figure 
3.3B/C) (Haurwitz et al., 2010; 2012; Gesner et al., 2011; Sashital et al., 2011). 
However, the mechanism for recognition of the major groove varies, with each 
recognising a different strand in the duplexed region: Cas6e primarily mediates 3’ 
strand contacts with a positively charged β-hairpin (Figure 3.3B) (Gesner et al., 2011; 
Sashital et al., 2011), Cas6f inserts a unique arginine-rich helix and linker region into 
the major groove forming a complex network of H-bonds mainly with the 5’ strand 
(Figure 3.3C) (Haurwitz et al., 2010).  
 
In contrast, repeats associated with other systems are not palindromic and thus 
unable to form a stable hairpin (Kunin et al., 2007; Lawrence and White, 2011).  The 
structure of archaeal P. furiosus Cas6 (PDB:3I4H) reveals the unstructured substrate 
wraps around the exterior of the protein, connecting the separate active site and 
recognition domains, resembling a string wound around a “yo-yo” (Figure 3.3A) 
(Wang et al., 2011).  S. solfataricus repeats map to cluster 7, constituents of which 
are also unstructured archaeal repeat sequences (Kunin et al., 2007).  At the onset of 
the work conducted in this chapter, it was not know whether the above mechanism 
represented a standard archaeal Cas6 process for coordinating unstructured repeat 
sequences. 
 
Each of the presently characterised (catalytic) Cas6s relies on an essential histidine 
contained within a catalytic dyad/triad of residues that participates in a nucleophilic 
attack upon the scissile phosphate bond, though the precise location of the residues 
differs in each case (Carte et al., 2008; Gesner et al., 2011; Sashital et al., 2011; 
Haurwitz et al., 2012).  The proposed pfCas6 catalytic triad (Y31, K52, H46) residues 
were identified from sequence analysis and comparison to other ribonucleases 
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(Carte et al., 2008) with their mutation severely attenuating activity (Carte et al., 
2010); however, their direct involvement in catalysis has yet to be strictly defined 
(Wang et al., 2011).  Carte et al. suggest that a general acid-base catalytic 
mechanism is employed in which H46 acts as the general acid, Y31 acts as the base 
and, depending on reaction sequence, K52 is variably involved to stabilise the 
developing negative charge of the transition state (Carte et al., 2010).  The authors 
draw a comparison to the mechanism of archaeal tRNA splicing endonuclease 
(Calvin and H. Li, 2008; Carte et al., 2010, Figure 3.4).  A similar mechanism is 
defined for in T. thermophilus Cas6e in which the conserved histidine (H26) and 
tyrosine (Y23) are essential to activity and positively charged side chains (R158, 
K160) contribute to the rate but not directly to the catalytic step (Sashital et al., 2011; 
Gesner et al., 2011).   
 
 
 
Figure 3.4: Proposed catalytic mechanism for phosphodiester bond cleavage by 
archaeal tRNA splicing endonuclease.  Invariant histidine, lysine and tyrosine residues 
form a closely spaced triad in archaeal splicing endonucleases (H257, K287 and Y246, 
respectively, in Archaeglobus fulgidus, Xue et al., 2006) in which they are expected to affect a 
concerted general acid-base catalytic cycle (Calvin and H. Li, 2008).  Although a tyrosine 
would act as a weaker base for deprotonation of the 2’ hydroxyl group than an equivalent 
histidine in this position, as used by RNase A (Raines et al., 1998), such a role is consistent 
with the positioning of the residue relative to the scissile phosphate in co-crystal structures 
(Xue et al., 2006, Calvin and H. Li, 2008).  Figure adapted from Calvin and H. Li, 2008. 
 
A Type I-B associated Cas6 example from M. mariplaudis actually has two histidines 
involved in the catalytic mechanism, where either could act in a similar capacity to 
that of pfCas6 H46, but both are retained as a strategy to flexibly accommodate pre-
crRNA with spacers of different lengths (Richter et al., 2012).  In this instance, 
mutation of a co-located tyrosine (Y41) illustrated an important contribution to the 
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cleavage mechanism, whereas loss of a nearby lysine (K29) side chain had no effect 
(Richter et al., 2012).  However, the conserved histidine may not always function in 
the role of general acid.  It was recently illustrated for the P. aeruginosa Cas6f 
mechanism that the H29 residue is instead employed as a general base with serine 
(S148) in a catalytic dyad that circumvents the need for the contribution of a general 
acid (Haurwitz et al., 2012). 
 
In this chapter, we begin to explore the structures and mechanisms of S. solfataricus 
Cas6 (ssoCas6), which reveal significant departures from the CRISPR 
endonucleases previously characterised. 
3.2 Results 
3.2.1 Purification of ssoCas6[1437] 
The Cas6[sso2004] paralogue had previously been purified by Dr Shirley Graham 
(Lintner, Kerou, et al., 2011), and a similar strategy was adopted for ssoCas6[1437], 
detailed in the ‘Materials and Methods’ and summarised in Figure 3.5.  Briefly, 
samples were processed via two stage nickel-affinity strategy, during which the 
cleavable His-tag was removed to leave the native-length peptide sequence, which 
subsequently underwent a final size-exclusion chromatography step from which it 
eluted in a single peak to generate a homogeneous target protein preparation (Figure 
3.5). 
 
The weight of purified ssoCas6 as estimated from SDS-PAGE analysis (Figure 3.5A) 
matched the sequenced-based predictions for native-length ssoCas6[1437] as 
calculated by the online bioinformatics tool, ProtParam; WT ssoCas6[1437] 32424.8 
Da (http://web.expasy.org/protparam, Gasteiger, 2003). 
 
In conjunction with Dr Shirley Graham and Dr Judith Reeks, optimisations to the 
methodology included raising the NaCl concentration of the purification buffers, from 
0.5 to 1 M, and maintaining samples at r/t or above, as ssoCas6 proved unstable at 
temperatures <10 ˚C.  Consequently, yields were increased from an (initial) ~0.7 to 
~4 mg/l of culture.  Whilst still not dramatically efficient, provision of homogenous 
Chapter 3: ssoCas6 Catalytic Mechanism 
 
 106 
samples at such yields was more than sufficient to provide for the biochemical 
assays performed.  
 
 
Figure 3.5: Purification of recombinant ssoCas6[1437]. Purification of ssoCas6[1437] from 
an E. coli overexpression system via affinity and size-exclusion chromatographic methods.  
(A) Purification monitored by SDS-PAGE.  Gel lanes illustrate the progressive removal of 
contaminants at each stage of the purification strategy.  The post-induction E. coli cell lysate 
(1) was spun down to generate a pellet of insoluble matter (3).  The supernatant (2) 
containing the soluble fraction of protein was passed through a His-trap/nickel-column to 
which the majority of contaminants do not bind and remain in the flow-through (4).   Target 
protein was subsequently eluted under high imidazole concentration (5) and subjected to 
overnight dialysis in the presence of TEV protease to remove the His-tag (6).  The sample 
was concentrated (7) and the flow-through collected when passed again through a His-
trap/Nickel-column (9).  Contaminants including TEV and the His-tags were retained by the 
column (8) and eluted under high imidazole conditions.  The sample was further purified to 
homogeneity by gel filtration prior to storage (10).  The weight of target protein (white arrow) 
corresponds well to the predicted weight of 32.4 kDa.  (B) Summary diagram of the 
purification strategy, numbering as per panel in (A). (C) ssoCas6[1437] WT elutes from gel 
filtration in a single peak at ~210 ml. 
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3.2.2 Behaviour of ssoCas6 paralogues [1437] and [2004] 
3.2.2.1 ssoCas6[1437] is a genuine Cas6 enzyme 
Cas6-like ribonuclease activity was previously confirmed for the S. solfataricus Cas6 
paralogue ssoCas6[2004] (Lintner, Kerou, et al., 2011), with which ssoCas6[1437] 
shares over 90% sequence identity.  However, as P. furiosus Cas6 (pfCas6) catalytic 
activity could not be predicted by sequence analysis (Carte et al., 2008) and non-
catalytically active forms of Cas6 have been noted in certain systems otherwise 
containing active paralogues (Wang et al., 2012), it remains important to confirm the 
activity of Cas6 family members.   
 
Similar assay conditions to those employed by Lintner et al. were used in the initial 
screening of ssoCas6[1437] nuclease activity (Lintner, Kerou, et al., 2011).  The 
radiolabelled RNA substrate used previously resembled the repeat sequence shared 
by both the CRISPR A and B (‘AB’ loci) modified with a 15U 5’ extension (Lintner, 
Kerou, et al., 2011).  This was substituted for a fluorescently-labelled (5’ fluoroscein 
(FAM)) oligonucleotide corresponding to the same repeat sequence (‘AB’ RNA), 
although a single additional 5’ uracil nucleotide was added to prevent quenching by 
the terminal guanidine of the repeat (See below). 
 
5 µM recombinant ssoCas6 (1437 or 2004) was incubated with 0.5 µM AB RNA at 45 
˚C in nuclease reaction (NR) buffer1 (20 mM TRIS-HCl pH 7.5, 100 mM K-Glutamate, 
5 mM EDTA, 0.5 mM DTT).  Cleavage reactions were stopped, by removal to ice and 
introduction of ProteinaseK, and products were separated on a 20% denaturing (8 M 
urea) gel and imaged by laser scanner.  Metal-independent cleavage by 
ssoCas6[1437] unsurprisingly matched that of ssoCas6[2004], and generated a 
single product band (Figure 3.6A). Cleavage was specific for the repeat sequence, 
with no activity against a reverse complement of the AB sequence.  A ladder 
generated from the RNA substrate by alkaline hydrolysis allowed the ssoCas6[1437] 
cleavage site to be mapped 8 nt from the 3’-terminal (* in sequence below): 
 
5′-[FAM]-UGAUUAAUCCCAAAAGGA*AUUGAAAG 
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Such a cleavage pattern is identical to not only pfCas6 (Carte et al., 2008) but all 
other characterised Cas6 examples despite dissimilar repeat substrate sequences 
(Brouns et al., 2008; Haurwitz et al., 2010; Wang et al., 2012).  ssoCas6[1437] is 
thus confirmed as an authentic, catalytically active member of the Cas6 family. 
 
 
Figure 3.6: Confirmation of recombinant ssoCa6[1437] Cas6-like activity. (A) 
Recombinant ssoCas6[1437] and ssoCas6[2004] were incubated with fluorescently-labelled 
AB RNA (AB) for 30 min (time points 15, 30 min) in a buffer free of divalent metal ions, and 
reaction products separated on a denaturing 20% polyacrylamide gel. Image is a composite 
generated from two areas of the same gel.  Substrate RNA is cleaved by both ssoCas6 
enzymes [sso2004, sso1437] 8nt from 3’ end of repeat (white arrows).  Such activity is absent 
in –protein (–P) condition and against control (C) RNA (AB reverse compliment sequence), 
indicating cleavage is sequence specific and the product of Cas6 activity. Intact gel image has 
been truncated to best show selected lanes. (B) Diagrammatic representation of the Cas6 
(scissors) release of crRNA from the CRISPR A locus by AB repeat sequence cleavage.  
Spacer sequences are left flanked at both 5’- and 3’-ends by the remnants of previously 
adjacent repeat sequences. 
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As Lintner et al. observed, the products of such a reaction correlate to the crRNA 
extracted from aCASCADE, which consisted of an intact spacer flanked by a 8 nt 5’-
tag derived from the repeat previously upstream, and a 3’-handle of all remaining 
nucleotides of corresponding activity against the repeat previously downstream (i.e. 
each repeat cut at a single site) (Figure 3.6B (Lintner, Kerou, et al., 2011)).  
Furthermore, the 8 nt 5’-tag is similarly retained in all species of crRNA extracted 
from the Type III-A and III-B complexes of S. solfataricus (Zhang et al., 2012; 
Rouillon et al., 2013).  This indicates that the role of crRNA provision within S. 
solfataricus CRISPR/Cas systems relies on ssoCas6 for primary pre-crRNA 
processing (Lintner, Kerou, et al., 2011; Zhang et al., 2012; Rouillon et al., 2013). 
  
Zhang et al. illustrated that ssoCas6 generated products that could not be extended 
by Poly-A protein (Figure 3.7A), suggesting that the phosphodiester bond is cleaved 
3’ of the scissile phosphate to leave 5’ hydroxyl and 3’ 2’,3’-cyclic phosphate end 
groups (Figure 3.7 B/C) (Zhang et al., 2012).  Such a terminal arrangement has also 
been shown for pfCas6 (Carte et al., 2008), paCas6f (Haurwitz et al., 2010) and 
ttCas6e (Gesner et al., 2011). 
 
 
 
Figure 3.7: ssoCas6 generates products with a 3’ 2’3’-cyclic phosphate. (A) Zhang et al.  
illustrated that PolyA, whose substrate is a 3’ hydroxyl group, could not extend ssoCas6 
cleavage products, thereby indicative of a 3’ cyclic phosphate terminal.  Adapted from (Zhang 
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et al., 2012). (B) Stylised illustration of Cas6 activity (scissors) to induce cleavage 3’ of 
scissile phosphate. Adapted from (Carte et al., 2008). (C) Illustration of 3’ and 5’ termini of 
ssoCas6 repeat RNA cleavage. 
3.2.2.2 ssoCas6 paralogues share similar behaviour against all 
available endogenous S. solfataricus CRISPR repeat sequences 
S. solfataricus possesses six CRISPR loci (A-F) which can be segregated into two 
types based on the repeat sequence present: AB and CD(EF) type loci (see Chapter 
5).  The similar sequences shared by E and F loci are minor divergences from the 
CD type consensus for the group.  To assay for potential differences in cleavage 
pattern/rates between the repeat-type families, the identical protocol applied to AB 
RNA in Section 3.2.2.1 was repeated for CD and F type fluorescently-labelled RNA 
substrates (Figure 3.8). 
 
Again, the expected Cas6 activity pattern emerged (cleavage site denoted with an 
asterisk below) under CD and F RNA conditions, indicating that the sequence 
specificity of ssoCas6 paralogues may not be absolute and open to a certain level of 
flexibility: 
 
CD 5′ -[FAM]- UGAUAAUCUCUUAUAGA*AUUGAAAG 
F 5′ -[FAM]- UGCUAAUCUACUAUAGA*AUUGAAAG 
 
 
 
Figure 3.8: Cleavage pattern of ssoCas6 paralogues against alternative S. solfataricus 
CRISPR repeat sequences. Recombinant ssoCas6[1437] and ssoCas6[2004] were 
incubated with fluorescently-labelled  CD or F RNA (CD, F) for 30 min and reaction products 
separated on a denaturing 20% polyacrylamide gel. Intact gel images have been truncated to 
best show selected lanes.  AB data from Figure 3.6, generated in the same manner, is 
included for comparison.  Each endogenous repeat type is cleaved by both ssoCas6 
paralogues with a similar preference patterns: CD and F RNA are cleaved at a broadly similar 
rate higher than that of AB type RNA.  A ladder (M) was generated from the relevant RNA 
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used in each condition.  A reverse-compliment of CD or F RNA was used in the respective 
conditions as a negative control (C). 
  
Whilst not quantified, the gels indicate that ssoCas6[1437] and ssoCas6[2004] share 
near identical cleavage patterns and cleave CD type RNA preferentially over AB type 
RNA.  That CD type RNA is cleaved at a comparable rate to F type RNA is 
unsurprising given the close sequence similarities.  The nature of these differences 
will be examined and their implications explored in Chapter 5.  However, only CD 
type RNA will be utilised for further characterisation of the ssoCas6[1437] (hereafter 
‘ssoCas6’) catalytic mechanism at present. 
3.2.3 Dissecting ssoCas6[1437] catalytic mechanism 
 
Figure 3.9: Working reaction scheme. kstn is the is the rate of the uni-molecular catalytic 
step (ES!EP) i.e. rate at which substrate (S) is converted to product (P), catalysed by the 
enzyme (E) under a defined set of conditions.  Formation and dissociation of ES complex is 
governed by the rates k1 and k-1, respectively. Current wisdom suggests that Cas6 functions 
strictly as a single-turnover enzyme, therefore release of product crRNA post-cleavage is not 
presently considered. 
3.2.3.1 ssoCas6 cleaves CD RNA at a rate comparable to existing 
Cas6s 
The previous assays (Figures 3.6 and 3.8) (Lintner, Kerou, et al., 2011 and 
unpublished) were sufficient to demonstrate that wild-type ssoCas6[1437] possesses 
the expected cleavage pattern of a Cas6 family member.  However, optimisation of 
the assay conditions and protocol were necessary prior to attempts at accurately 
delineating ssoCas6 catalytic parameters (detailed in Materials and Methods, Section 
2.3.2.2.1, data not shown).  The rate under single-turnover conditions (kstn) was 
subsequently examined. 
 
0.5 µM ssoCas6 was incubated with 1-2.5 nM 32P-end-labelled CD RNA at a range of 
temperatures from 20 to 80˚C in the modified NR buffer; 20 mM Sodium phosphate 
pH 7.5, 100 mM K-Glutamate, 5 mM EDTA, 0.5 mM DTT.  At relevant time-points, 
assays were stopped with phenol-chloroform and the extracted RNA products 
separated on a 20% denaturing PAA gel (8 M urea) for phosphorimaging.  The 
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resolved bands (Figure 3.10A) were quantified and the product fraction data fitted 
(Figure 3.10B) using curve-fitting software to an exponential function of the form: 
 
y = ymax − e −kcatx( )  
Equation 3.1: Exponential function. 
 
An approximate two-fold increase in the rate for every 10˚C increase in assay 
temperature was observed up to 60˚C, with only a modest further increase to the 
maximum rate at 70˚C (0.8 min-1, Figure 3.10).  Such a pattern has previously been 
observed for other thermostable proteins from S. solfataricus (Parker and White, 
2005).  This is largely unsurprising given that S. solfataricus is a hyperthermophilic 
organism that exists comfortably at temperatures 75 – 85˚C (Zillig et al., 1980).  
However, the rate plummets at 80˚C, indicating that under in vitro conditions the 
recombinant protein likely has stability issues and becomes heat-denatured. 
Nevertheless, the data can still be used to tentatively extrapolate for crRNA 
biogenesis activity rates under native temperature conditions (>80˚C).  Thus, in vivo, 
the first order rate constant may feasibly approach 3 - 4 min-1. Nonetheless, the 
obtained rate of ~0.8 at 70 ˚C is considerably slower than that of other characterised 
cas6s.  TtCas6e single-turnover kinetics were at 4.9 min-1 at 65 ˚C (Sashital et al., 
2011), whilst PaCas6f achieved ~4 min-1 at 24 ˚C (Haurwitz et al., 2012). 
 
Figure 3.10: ssoCas6 cleaves a CRISPR repeat sequence with temperature dependent 
activity. Under single-turnover conditions, ssoCas6 was incubated with 32P-radio-labelled CD 
RNA at varying assay temperatures and the products separated on a 20 % PAA gel for 
phosphorimaging (A) Representative gel illustrating a time-course of ssoCas6 activity at 70˚C.  
ssoCas6 processes CD RNA substrate (S) at a single site*, 8 nt from 3’ end, to generate 
product (P).  (B) Example (70 ˚C condition) of primary data processing.  Gel bands were 
quantified and resultant product fractions fitted to an exponential function to derive the rate, 
kstn (min-1). (C) Subsequent single-turnover rates for ssoCas6 activity across the temperature 
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range 20 – 80 ˚C.  Data points are the arithmetic mean of triplicate assays with error bars 
representating the SEM. 
*Note, double bands often resulted from imperfect RNA purification preparations, and are 
reflected in both substrate and product bands 
3.2.3.2 Identification of residues important to the ssoCas6 catalytic 
mechanism in the absence of a crystal structure 
The catalytic triad identified in pfCas6 (Tyrosine, Y31, Histidine, H46, Lysine, L52), 
that cluster within 6 Å of each other and in the vicinity of the G-rich loop (Carte et al., 
2008), is only partially conserved in ssoCas6 sequences (Figure 3.12).  In P. 
furiosus, substitution of either Y31 or H46 to alanine resulted in total loss of pfCas6 
activity (Carte et al., 2010).  The ‘critical’ histidine residue, which has also been 
identified in the highly diverged orthologues Cas6e (Brouns et al., 2008) and Cas6f 
(Haurwitz et al., 2010), is prominently absent within the Cas6 orthologues of 
crenarchaeal species (Figure 3.12).  Of the set, ssoCas6s harbours only the 
conserved lysine, L51.  This likely signifies not only a departure from the expected 
acid/base catalytic mechanism, but a general diversity in mechanisms across the 
archaeal Cas6 family.  
 
Understanding of this has been greatly improved from the efforts to crystallise 
ssoCas6 proteins made alongside the work in this chapter, both by our collaborators, 
the Naismith group (Dr Judith Reeks) and independently by the Li group, which have 
since yielded both the structures of the protein in isolation (Reeks, Sokolowski, et al., 
2013; Shao and Li, 2013) and in complex with crRNA (Shao and Li, 2013).  However, 
the majority of the work presented in this chapter was conducted in the absence of 
crystallographic data.  As such, the chapter will proceed chronologically, with the 
structures independently discussed as they became available to guide the presented 
work.  See Sections 3.2.4 onwards for post-structure influence on experimental 
directions.  
3.2.3.3 ssoCas6 is predicted to share structural features of the 
Cas6-family 
In the absence of crystallographic data, mutants were primarily selected with respect 
to conservation patterns of residues amongst crenarchaeal/euryarchaeal species 
(Figure 3.12).  Aiding such selections were tertiary structure predictions by the 
structured-based threading server PHYRE II, (http://www.sbg.bio.ic.ac.uk/~phyre2, 
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(Kelley and M. J. E. Sternberg, 2009). The server identified homology between 
ssoCas6 and pfCas6 (PDB:3I4H, Carte et al., 2008) (100% confidence)  and even 
between ssoCas6 and the highly divergent orthologue Cas6e from T. thermophilus 
(PDB:1WJ9, Ebihara et al., 2006) (93.5% confidence).  
 
Utilising the previously characterised archaeal Cas6 from P. furiosus (PDB:3I4H, 
Carte et al., 2008) as an input model allowed the server to generate a predicted 
structure for ssoCas6[1437] (Figure 3.11, Kelley and M. J. E. Sternberg, 2009). 
Whilst P. furiosus [1131] and S. solfataricus [1437] gene products both represent 
archaeal Cas6 examples, they belong to different COG families (COG1853 and 
COG5551, respectively) and otherwise share very little sequence similarity (14% 
UNIPROT, 17% PHYREII) outside of the C-terminal glycine-rich loop motif typical to 
the Cas6 family.  Nonetheless, the structural motif of the RRM/ferredoxin-like fold is a 
conserved feature across all Cas6s characterised to date (Figures 3.1, 3.3 and 
3.11A/B, (Ebihara et al., 2006; Carte et al., 2008; Haurwitz et al., 2010; Wang et al., 
2012; Niewoehner et al., 2014), and the standard tandem ferredoxin-fold is similarly 
generated for the ssoCas6[1437] model (Figures 3.11C and 3.12B). 
 
 
Figure 3.11: ssoCas6 is predicted to share structural homology to RAMP family 
members. Structural threading by PHYRE II server predicts structural homology between 
ssoCas6 and Cas6-family members (A) T. thermophilus Cas6e (ttCas6e, PDB: 1WJ9) and 
(B) P. furiosus Cas6 (pfCas6, PDB: 3I4H) with 93.5 and 100 % confidence values, 
respectively.  (C) Using pfCas6 (PBD: 3I4H) as an input structure, a model of ssoCas6 can be 
predicted. Adoption of a tandem-ferredoxin fold is evident between ttCas6 and pfCas6 
structures, typical of the Cas6-family of RAMP proteins, and is additionally predicted for 
ssoCas6. 
 
A number of residues conserved across crenarcheal Cas6 species are found in the 
cleft between the two RRM domains predicted for ssoCas6 (Figure 3.12B).  They are 
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located close to the identified pfCas6 active site (Figure 3.3A, Wang et al., 2011) and 
thus may be important to the catalytic mechanism of ssoCas6.  S. solfataricus 
CRISPR repeats lack predicted structure as is typical of archaeal repeat sequences 
(Kunin et al., 2007).  The CD repeat RNA has been shown in vitro to be unstructured 
at temperatures above 40˚C (Emma Cottel, University of St Andrews, unpublished 
data).  As a result, ssoCas6 substrates are undoubtedly unstructured at both 
physiological/environmental temperatures and at the 60˚C utilised for the majority of 
assays.  Therefore, a wrap-around model of substrate coordination, as observed for 
P. furiosus Cas6 (Figure 3.3A, Wang et al., 2011), was initially envisaged.  
 
3.2.3.4 Generation of sso1437 mutants 
In order to identify residues that may contribute to the catalytic mechanism of 
ssoCas6, a preliminary set of three conserved residues (K28, K51, S268, Figure, 
3.12) was selected from the vicinity of the putative active site (Figure 3.12B) as 
targets for site-directed mutagenesis.  
 
The plasmid vector pET-151-sso1437 was subjected to site-directed mutagenesis to 
yield a range of mutant constructs.   In each case, plasmids from successful 
transformants were sequenced to ensure the constructs present contained the 
intended mutations and were otherwise correct.  Such constructs were transformed 
into the E. coli BL21(DE3) over-expression strain C43 in preparation for expression 
and purification.  ssoCas6[1437] variants were purified as per WT Cas6 (Figure 3.5) 
and adopted similar purification profiles and final homogeneity levels (Figure 3.13). 
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Figure 3.12: Sequence 
alignment of crenarchaeal Cas6 
sequences. (A) Alignment of 
representative Cas6 orthologues 
from crenarchaeal species; 
Sulfolobus solfataricus [1437, 
2004], Sulfolobus islandicus, 
Sulfolobus tokodaii, 
Metallosphaera sedula, Sulfolobus 
acidocaldarius, Ignisphaera 
aggregans, Staphylothermus 
marinus.  Figure adapted from 
Reeks, Sokolowski, et al., 2013.  
ssoCas6[1437] residues targeted 
by site-directed mutagenesis are 
indicated with arrows.  Those 
targeted prior to the acquisition of 
the ssoCas6 crystal structure are 
highlighted with red arrows.  
Residues selected to disrupt the 
ssoCas6 dimer interface (L170, 
V202) are indicated by green 
arrows.  (B) Residues conserved 
across crenarchaeal species (red 
sticks) cluster within the predicted 
RAMP domain interface of 
ssoCas6.  SsoCas6 has a 
glutamine and threonine (blue 
sticks, E32 and T45) in place of 
absent pfCas6 residues Y31 and 
H46, respectively, although a 
lysine is maintained at position 51.  
The G-rich loop motif is 
highlighted in yellow in both 
structure and alignment. 
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Figure 3.13: SDS-PAGE analysis of purification products - E. coli C43 cells containing the 
vector pET-151-Sso1437 (and variants) were induced to overexpress His-tagged recombinant 
sso1437 variants, allowing purification of via a combination of Ni-affinity and size-exclusion 
chromatographic methods. ssoCas6[1437] WT (A), ssoCas6[1437] mutant K28A (B), 
ssoCas6[1437] mutant K51A (C), ssoCas6[1437] mutant S268A (D).  Each protein displays a 
high level of purity. 
 
3.2.3.5 ssoCas6 variants have reduced cleavage activity 
To assess the contribution of the selected residues to the catalytic mechanism, 
triplicate assays were performed in which each variant was incubated under single-
turnover conditions with 32P-end-labelled CD RNA in NR-buffer 2 (20 mM Sodium 
phosphate pH 7.5, 100 mM K-Glutamate, 5 mM EDTA, 0.5 mM DTT).  Assays were 
incubated at 60˚C to ensure a good balance between optimal functionality of the 
enzyme and sufficient resolution of early timepoints for an accurate derivation of the 
initial rate.  Initial rates were determined from by fitting mean product fraction from 
triplicate assays to an exponential function (Equation 3.1).  Under these conditions, 
the recombinant WT ssoCas6 had a kstn of 0.80 min-1 (Figure 3.14B).   
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Figure 3.14: ssoCas6 variants cleave CD RNA at different rates. SsoCas6 variants (WT, 
K28A, K51A, S268A) were incubated under single-turnover conditions with CD RNA at 60 ˚C.  
Products were separated on a 20% denaturing PAA gel for phosphorimaging.  (A) 
Representative time-course gel (reduced number of timepoints) illustrating the relative activity 
of each ssoCas6 variant. (B) Quantified fraction product over full time-course (larger number 
of timepoints) fitted to an exponential function to derive initial rates. Data points are the mean 
(± SEM) from triplicate assays. 
 
Whilst each ssoCas6 variant had reduced activity relative to WT (Figure 3.14A/B), 
they varied considerably in level of reduction.  The largest response was elicited by 
K28 substitution to alanine, which resulted in a ~300 fold reduction in rate to 0.0026 
min-1 indicating that this residue has a critical role in catalysis.  A large impact was 
also seen for the K51A variant, which, similar to the equivalent mutation (K52A) in 
pfCas6 (Carte et al., 2010), resulted in a ~40-fold reduction in cleavage rate.  In 
contrast, the S268A mutation resulted in a relatively modest ~5-fold reduction. 
3.2.4 The structure of ssoCas6 
Successful crystallography work by collaborators in the Naismith structural biology 
group (Dr Judith Reeks, University of St Andrews) resolved the ssoCas6 structure to 
~2.8 Å resolution (Figure 3.15B) (Reeks, Sokolowski, et al., 2013).  The ssoCas6 
monomer possesses the expected twin RAMP-domain topology linked via an α-helix, 
as is typical for the Cas6 family. Upon closer inspection, it can be seen that the N-
terminal domain ssoCas6 example diverges somewhat by an absence of the usual α-
helix bridge between β3-β4 in the N-terminal RAMP domain, a region which instead 
adopts an extended loop conformation.  The end of this loop transitions into a short 
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β-strand that interacts with the central β-sheet domain of the RRM to form an 
additional three-strand extension. The C-terminal domain also contains additional 
elements to the standard RAMP fold, namely the insertion of three additional α-
helices after the first β-strand and a β-hairpin that connects central members of the β-
sheet.  The C-terminally located G-rich loop motif is located in the expected position, 
linking the final β-strand and α-helix of the C-terminal RAMP domain, and adopts the 
same conformation characterised in other examples (Reeks, Sokolowski, et al., 
2013). Overall, ssoCas6 shares the highest structural similarity with the non-catalytic 
(pfCas6nc, PDB:3UFC) and catalytic (PDB:3I4H, Figure 3.14C) Cas6 paralogues 
from P. furiosus (Reeks, Sokolowski, et al., 2013), illustrating the suitability of using 
the latter as an input model for early structural predictions (Figures 3.11). 
 
By far the biggest revelation in obtaining the structure of ssoCas6 was the 
arrangement of endonuclease as dimeric units within the crystal lattice (Figure 3.16A) 
with the presence of large basic surface patches that form a continuous region that 
spans the dimer interface (Figure 3.16B) (Reeks, Sokolowski, et al., 2013).  
 
Figure 3.15: ssoCas6 adopts a twin RAMP-domain architecture with modifications. (A) 
Schematic ferredoxin-fold generated by an RRM. α-helices are represented by green 
cylinders, β-strands by blue arrows. N- and C- terminals are blue and red spheres, 
respectively.  Such colour labels are similarly used in the following crustal structures. (B) 
ssoCas6 (PDB: 3ZFV) with secondary structures labelled, and missing α2-helix labelled. (C) 
The highly similar structure of the pfCas6 (PDB: 34IH) homologue is shown for comparison.  
The G-rich loop motifs are highlighted in yellow.  Adapted from Reeks, Sokolowski, et al., 
2013. 
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Figure 3.16: ssoCas6 adopts a dimeric conformation. (A) Dimeric conformation of 
ssoCas6. (B) Electrostatic surface potential (positive-negative spectrum, blue-red 
respectively) of ssoCas6 dimer.  The active site is indicated by black box (front-facing, solid 
line; rear-facing, dashed line). Adapted from Reeks, Sokolowski, et al., 2013. 
3.2.4.1 Delineation of catalytically important residues post-
structure determination 
The acquisition of the ssoCas6 dimer crystal structure enabled a more refined 
approach to selecting putative catalytic residues.  An additional eight conserved 
residues (Figure 3.12A) were subsequently selected for study via site-directed 
mutagenesis.  Furthermore, the alternative substitution at K28 with a histidine was 
proposed.  These new variants were constructed and purified by Dr Shirley Graham 
and Dr Judith Reeks.  The screening of each of these new variants for cleavage 
activity under single-turnover conditions was carried out directly as a part of this PhD 
experimental work as per Section 3.2.3.5 (Figure 3.17). 
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Figure 3.17: Further definition of ssoCas6 active site. SsoCas6 variants were incubated 
under single-turnover conditions with 32P-end-labelled CD RNA.  Products were separated by 
electrophoresis and phosphorimaged to allow quantification of fraction product. (A) Fraction 
product is displayed as a function of time.  Data points represent the mean (±SEM) of 
triplicate assays to which an exponential function is fitted to derive an initial rate value. (B) 
The initial rate (kstn, min-1) for each ssoCas6 variant is tabulated alongside WT-relative activity 
level.  Data for K28A, K51A and S268A ssoCas6 variants are also included for completeness. 
(C) ssoCas6 crystal structure (PDB:3ZFV) with conserved residues highlighted (magenta, 
side chains shown as magenta sticks) that resulted in at least a 5-fold reduction in activity 
relative to WT levels when substituted to alanine; K25, K28, K51, S268, R231, R269.  
Glycine-rich loop is highlighted in yellow. Adapted from Reeks, Sokolowski, et al., 2013. 
 
Of the conserved basic residues located in/around the putative active site, the 
following variants had a > 10-fold reduction in activity from WT levels and thus likely 
have a role in substrate binding, nucleophile activation and/or stabilisation of the 
transition state: K25A, K28A, K51A, R231A (Figure 3.17).  R269A resulted in a ~8-
fold rate reduction.  However, other variants had little/no impact upon ssoCas6 rate, 
suggesting a lack of importance to the catalytic mechanism: T21A, S46A, K161A, 
Y179F, E192A, S226A.  An attempt to recover activity with substitution at K28 with 
histidine resulted in a rate unchanged from that of alanine substitution, suggesting 
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that histidine, whilst also in possession of a basic side chain, cannot substitute for 
lysine in this context. 
3.2.4.2 ssoCas6 mechanism is not reliant on a single titratable 
residue 
Recently published data by Haurwitz et al. (Haurwitz et al., 2012) reveals that the 
highly diverged Cas6 orthologue from P. aeruginosa (Cas6f), whilst homologous in 
activity and structurally related to Cas6 via a ferrodoxin-like fold (Haurwitz et al., 
2010), is not reliant on histidine-serine acid-base catalysis to cleave repeat RNA as 
previously suggested (Haurwitz et al., 2010).  Instead the endonuclease employs an 
unusual catalytic dyad in which S149 constrains the ribose into the correct geometry 
for deprotonation of the 2’ hydroxyl by H29 acting as a general base (Haurwitz et al., 
2012).  This removes the involvement of a general acid within the cleavage cycle 
and, coupled to a lack of positively charged residues involved in stabilising the 
transition state, makes for a slower reaction (~3 min-1 at pH 7.2).  Additionally, the 
group observed a sigmoidal increase in Csy4 cleavage rates with increasing pH 
above pH 6-7, suggesting that the catalytic mechanism revolves around a 
deprotonated histidine (i.e. pKa ~6.5). The loss of Csy4 activity arising from a H29A 
was partially restored by a further substitution with a lysine (Haurwitz et al., 2012).   
 
To examine the pH profile of ssoCas6 activity, WT ssoCas6 was incubated under 
single-turnover conditions with CD RNA in a range of buffers encompassing the pH 
range 4 to 11 (see Materials & Methods for full list).  Products were analysed by gel 
electophoresis and phosphorimaging, with extracted product fraction fitted to an 
exponential function to derive an initial cleavage rate.  One notable alteration to the 
standard buffer composition was a change in the salt component from K-glutamate 
(itself a buffering agent) to NaCl, so as not to restrict or influence the buffering 
capacity of the buffer systems selected for their optimal performance at certain pH 
levels, which had an unexpected consequence of increasing the ssoCas6 rate at pH 
7.5 using NR-3 buffer (20 mM sodium phosphate pH 7.5, 100 mM NaCl, 5 mM EDTA, 
0.5 mM DTT), which differed only in the salt component from NR-2 buffer (Sections 
3.2.3.1 and 3.2.4.1). 
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Figure 3.18: Impact of pH on ssoCas6 cleavage rate. Recombinant ssoCas6 was 
incubated with 32P-end-labelled CD RNA under single-turnover conditions at 60˚C across a 
range of buffer pH.  Products were separated on a denaturing PAA gel for phosphorimaging.  
Time-course of quantified fraction product was fitted to an exponential function to derive initial 
rate (kstn, min-1) value.  The rate under each condition was subsequently plotted as a function 
of pH.  Rates are labelled where unclear given Y-axis scale.  Whilst a clear time-course of 
Cas6 activity could be resolved in the pH 9 buffer, at buffers of pH 10 and above the RNA was 
non-specifically degraded and any data for Cas6 activity unobtainable. 
 
In contrast to paCas6f activity (Haurwitz et al., 2012), the rate of ssoCas6 does not 
increase monotonically with increasing pH (Figure 3.18).  Instead, ssoCas6 achieves 
a maximal rate between pH 7-8.5 before decreasing again by pH 9, suggesting that 
the ssoCas6 cleavage mechanism does not rely on a single titratable residue. 
3.2.5 Probing the functional contribution of ssoCas6 
dimerisation 
Despite the presence of a large buried surface area of ~1350 Å2, the observed 
dimeric state of ssoCas6 in the crystal lattice could nonetheless represent an artefact 
of crystallisation (Reeks, Sokolowski, et al., 2013).  However, the same subunit 
organisation was also obtained in low-resolution images from alternative crystal 
forms generated under different conditions (Dr Judith Reeks, Figure 3.19).  
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Additionally, hydrophobic residues located at this interface are also conserved 
amongst Cas6 genes of crenarchaeal species, indicating that dimerisation is a 
common attribute of at least this subset of Cas6s and may have functional 
implications (Figure 3.12A). 
 
 
Figure 3.19: ssoCas6 dimer arrangement is conserved in crystal packing within 
multiple crystal forms. (A) ssoCas6. (B) ssoCas6 K28A. (C) Methylated-lysine ssoCas6 
K28A crystals were grown in 20 mM Tris/HCl pH 7.5, 10% glycerol and varying NaCl 
concentrations (1, 0.5, 0.15 M, respectively).  Work conducted by Dr. Judith Reeks, adapted 
from Reeks, Sokolowski, et al., 2013. 
3.2.5.1 ssoCas6 is a native dimer in solution 
Examination of the crystal structure revealed valine (V202) and leucine (L170) 
residues in the centre of the dimer interface (Figure 3.20A).  The two hydrophobic 
residues appear to perform a reciprocating interaction in which their side chains 
interlock at the dimer interface.  It was hypothesised that substitution at these 
positions with a charged residue (aspartate) could be sufficient to disrupt the dimer 
interface, though with no guarantee of subsequent protein stability. 
 
Site-directed mutagenesis and subsequent purification of L170D/V202D ssoCas6 
was performed by Dr Graham.  Unexpectedly, the variant was highly soluble and 
required no modifications to the current purification strategy/protocol (Dr Graham, 
data not shown).  To assay for the native solution conformation, Dr Graham 
subjected purified samples of K28H (same elution profile as the WT) and 
L170D/V202D to size-exclusion chromatography on a HiLoad 26/600 Superdex 200 
gel filtration equilibrated in 20 mM Tris pH 7.5, 1 M NaCl.  The column was calibrated 
with gel filtration standards to enable estimation of molecular masses.  The two 
ssoCas6 variants, K28H and L170D/V202D, ran at 68 and 33 kDa, respectively, 
accurately corresponding to the predicted masses of a dimer (64.8 kDa) and 
monomer (32.4 kDa) (Figure 3.20B).  Therefore, L170D/V202D (hereafter ‘monomer’ 
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or ’monomeric ssoCas6’) is a monomer, and WT ssoCas6 adopts a dimeric 
conformation in solution.  
 
 
Figure 3.20: ssoCas6 adopts a native dimer conformation in solution. (A) At the centre 
of the ssoCas6 dimer interface is a pair of hydrophobic residues, L170 and V202.  (B) 
Calibrated gel filtration of L170D/V202D and K28H. Double mutation of L170 and V202 to 
aspartate disrupted the dimer interface and resulted in a ssoCas6 variant that ran as a 
monomer.  Adapted from Reeks, Sokolowski, et al., 2013. 
3.5.2.2 ssoCas6 dimerisation is important for function 
In order to assess the contribution of dimerisation to ssoCas6 functionality, the 
monomer was assayed for cleavage activity and thermal stability. 
3.5.2.3 Monomer has reduced thermal stability 
The thermal stability of Cas6 was assessed via differential scanning fluorimetry 
(DSF, also known as fluorescence thermal shift assay).  Monomeric and WT 
ssoCas6 variants were incubated with SYPRO-orange in NR-2 buffer (20 mM sodium 
phosphate pH 7.5, 100 mM K-glutamate, 5 mM EDTA, 0.5 mM DTT) as the 
temperature was raised in 0.5 ˚C increments from 24 to 94 ˚C.  SYPRO-orange is a 
dye whose emission properties change upon binding to hydrophobic elements of 
protein structure (i.e. the normally non-solvent-exposed hydrophobic core); therefore, 
changes in sample fluorescence can be used to track protein stability by indicating 
tertiary structure collapse (melting) in response to destabilising conditions (e.g. 
thermal load) (Poklar et al., 1997; Vedadi et al., 2006; Niesen et al., 2007).  The 
sigmoidal change in fluorescence intensity, as a protein population responds to rising 
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temperature by tending towards a melted state, can be fitted to the Boltzmann 
equation (Eq. 3.2), where the inflexion point of the curve is taken to represent the 
melting point (Tm) of the protein (Vedadi et al., 2006; Niesen et al., 2007): 
 
y = ymin +
ymax − ymin( )
1+ ec−x/d( )  
Equation 3.2: Boltzmann Equation. c is the inflexion point and d is the slope. 
 
Under this methodology, the monomer and WT ssoCas6 variants were revealed to 
have Tm values that differed by 6 ˚C: 69 and 75 ˚C, respectively (Figure 3.21).  
Furthermore, the lack of initiation of the melting curves at or below ~60 ˚C indicated 
that both proteins are relatively thermostable at the temperature selected for assay 
60 ˚C.  
3.5.2.4 Monomer has reduced activity levels 
Monomeric ssoCas6 was incubated under single-turnover conditions with 32P-end-
labelled CD RNA at 60 ˚C in NR-2 buffer (20 mM sodium phosphate pH 7.5, 100 mM 
K-glutamate, 5 mM EDTA, 0.5 mM DTT).  Products were analysed by electrophoresis 
on a denaturing PAA gel and phosphorimaged.  Quantified fraction product was fitted 
to an exponential function to derive initial reaction rate (Figure 3.21A).  At 60 ˚C, the 
monomeric ssoCas6 variant cleavage rate (0.034 min-1) is a reduction of 
approximately 24-fold from that of WT levels (0.80 min-1, Figure 3.21A).  Additionally, 
screening for monomer activity across a range of assay temperatures illustrated that 
the reduction of rate is present and proportional to WT even at lower temperatures 
(Figure 3.21B). This suggests that the reduction in monomer activity levels is not 
primarily due to a reduced thermal stability. 
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Figure 3.21: Influence of dimerisation upon stability and single-turnover activity of 
ssoCas6.  (A) Monomeric ssoCas6 variant was incubated under single-turnover conditions at 
60˚C with 32P-end-labelled CD RNA.  Products were separated on a denaturing PAA gel and 
phosphorimaged, from which the product fraction was quantified.  Data points represent the 
mean (±SEM) of triplicate assays, which were fitted to an exponential equation to derive initial 
rate (kstn, .min-1).  WT ssoCas6 data/curve (from Figure 3.14 B) is included for context. (B) 
The temperature of the assay was subsequently varied, and the derived initial rates plotted as 
a function of temperature. From triplicate assays, data points represent the mean (± SEM) 
initial rates as calculated by curve fitting.  Again, the data for the identical assay conducted for 
WT ssoCas6 (from Figure 3.10) is included for context.  Rates are labelled where unclear for 
the given Y-axis scale  (C) Fluorescence level change of ssoCas6 variants (WT, monomer) 
incubated with SyproOrange® fluorescent-dye in response to temperature.  Binding of dye to 
protein hydrophobic core elements induces a positive fluorescence change. The resulting 
sigmoidal plot of fluorescence as a function of temperature is fitted to a Boltzmann equation 
and the inflexion point taken to represent the melting temperature (Tm) of the protein.  Each 
data point represents the mean (± SEM) of triplicate assays.  Adapted from Reeks, 
Sokolowski, et al., 2013. 
 
Re-visiting the WT data temperature-dependent activity data (Figure 3.10C) 
illustrates that the expected correlation between rate and temperature (i.e. approx. 2-
fold per Δ10˚C) holds until the melting temperature (Tm) of the protein is surpassed.  
Despite a melting curve that initiated at ~70 ˚C, WT ssoCas6 achieves highest 
cleavage rate (under these buffer conditions) at 70 ˚C.  Such a relationship is less 
Chapter 3: ssoCas6 Catalytic Mechanism 
 
 128 
well defined for monomeric ssoCas6, where the peak of monomer activity occurs at 
only 40 – 50 ˚C, though the enzyme is thermostable up to 60 ˚C with a Tm of 69 ˚C. 
3.5.3 ssoCas6 binds unstructured RNA in an unexpected 
way 
While this work was being prepared for publication, independent crystallographic and 
biochemical work by Shao and Li, delivered additional crucial insights into the 
interaction between ssoCas6 and its substrate RNA sequences (Shao and Li, 2013).   
 
Figure 3.22: Crystal structure of S. solfataricus Cas6 paralogues, ssoCas6[2004] and 
ssoCas6[1437]. (A) ssoCas6[2004] in complex with a 24 nt repeat RNA sequence (PDB: 4Ill) 
reveals the unstructured RNA substrate is coordinated as a hairpin loop. (B) ssoCas6[2004] 
(PDB: 4ILR). (C) ssoCas6[1437] (PDB: 3ZFV).  Whilst similar in structure to ssoCas6[1437], 
ssoCas6[2004] crystal structure reveals additional alpha-helices (α2, red arrow; α3, black 
arrow, (Shao and Li, 2013)) in sections disordered in the ssoCas6[1437] crystal structure 
(dashed red/black, (Reeks, Sokolowski, et al., 2013)). (D) Illustration of the full dimer from (A) 
in alternative orientations.   
 
The ssoCas6[2004] structure (Figure 3.22B) (Shao and Li, 2013) corroborates much 
of the basic architecture seen in the ssoCas6[1437] structure (Figure 3.15 and 3.22C) 
(Reeks, Sokolowski, et al., 2013), as expected given their high sequence similarity 
(>90%).  Whilst the variation on the canonical C-terminal RAMP domain with an 
additional three α-helical insertion is also present, the missing α-helix of the C-
terminal RAMP in ssoCas6[1437] is observed in select ssoCas6[2004] structures, as 
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well as an additional alpha-helical segment (α-2) that immediately follows α-1 (Figure 
3.22B, Shao and Li, 2013), which was otherwise an unresolved, disordered region in 
our structure (Figure 3.22C, Reeks, Sokolowski, et al., 2013).  
 
 
Figure 3.23: ssoCas6[2004] interactions with repeat RNA. (A) Regions involved in the 
protein:RNA interface highlighted in blue. (B) RNA secondary structure with important 
residues for interaction highlighted.  Select G-rich loop residues mediate base specific 
interactions within the stem loop region whilst other basic residues in the he α2-β2 and G-rich 
loops provide a positively-charged surface for extensive contact along the sugar-phosphate 
backbone of the 3’ side of the stem.  (C) Focus on protein:RNA interaction at the cleavage 
site where the leaving nucleotide (A17) is flipped out of the helical stack, which results in the 
three atoms involved in bond breaking being held in a near in-line conformation (2’ hydroxyl 
group not present in the deoxy-modified A16 nucleotide).  Cleavage point marked with red 
circle.  Adapted from Shao and Li, 2013. 
 
Crucially, the group also obtained the co-crystal structures of ssoCas6[2004] in 
complex with repeat RNA (16 and 24-mers), which were revealed to adopt an 
unexpected 3 base-pair hairpin conformation within the active site pocket (Figure 
3.22A/D, Shao and Li, 2013). This represents a major departure from the previously 
characterised method of coordinating an unstructured repeat adopted by Pyrococcal 
type Cas6s (Wang et al., 2011; 2012).  The three α-helix insertion and α-2 can be 
seen to form a platform for the coordination of repeat RNA (Figures 3.22 and 3.23, 
(Shao and Li, 2013)), with areas on the ssoCas6[2004] structure important to this 
interaction (Figure 3.23A) correlating well to both the patterns of conserved residues 
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identified in Section 3.2.3.2 (Figure 3.12) and spread of activity-related 
ssoCas6[1437] residue locations pieced together in Section 3.2.4.1 (Figure 3.17).  
 
 
 Relative activity (%) 
Variant ssoCas6 [1437] ssoCas6 [2004] 
WT 100 100 
K25A 5.6 20 
K28A 0.32 8.2 
K51A 2.5 0.38 
R231/232 2.8 0.66 
 
Table 3.1: Comparison of equivalent mutations upon ssoCas6 paralogue cleavage rate.  
Rates for each variant displayed with relative activity to respective WT ssoCas6 paralogue.  
Data summarised from Figure 3.17B and Shao et al. 2013. 
 
ssoCas6[2004] forms extensive specific and non-specific contacts with nucleotides in 
the central stem of the hairpin, whilst interacting in a more limited capacity with the 
single-stranded regions (Figures 3.22A/D and 3.23) (Shao and Li, 2013).  The repeat 
sequence used for this work was derived from the CRISPR F and is thus highly 
similar to CD RNA.  The U6-A16 and C7-G15 basepairs were essential for cleavage 
activity, and are recognised via base-specific interactions: U6-A16 by S269 (within G-
rich loop) and Y168 (α6-α7 loop), C7-G16 by R268 (G-rich loop) (Figure 3.23C, Shao 
and Li, 2013).  The region surrounding the scissile phosphate contains K25, K28, 
K51 and R231 to coordinate the RNA molecule (Figure 3.23B/C), putting into context 
their influence upon cleavage rate as seen in Section 3.2.4.1 (Figure 3.17).  As is 
also seen in the structures of Cas6e and Cas6f (Haurwitz et al., 2010; Sashital et al., 
2011), the leaving nucleotide (A17 in ssoCas6[2004] Figure 3.23C) is flipped out of 
the helical stack and into an ‘’ geometry with the other three atoms involved with the 
phosphate bond breakage event (Shao and Li, 2013).  Whilst normally a highly 
unstable conformation (Min et al., 2007; Shao and Li, 2013), the RNA appears 
trapped in this in-line conformation by ssoCas6[2004] (Shao and Li, 2013).  
 
The rate of WT ssoCas6[2004] cleavage of F loci repeat sequence at 45 ˚C, 
calculated at ~0.5 min-1 (Shao and Li, 2013), correlate well with the results obtained 
for ssoCas6[1437] (~0.4 min -1 at 50 ˚C, 0.8 min-1 at 60 ˚C, Figures 3.10 and 3.14, 
respectively).  Any minor differences therein could reflect buffer and assay procedural 
differences between the two labs.  Site-directed mutagenesis in ssoCas6[2004] again 
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confirmed the importance of K25, K28, K51 and R232 to the ssoCas6 cleavage 
mechanism (Shao and Li, 2013), again complementing our studies (Figure 3.14 and 
3.17).  Interestingly, however, this group obtained a different pattern of activity for the 
same alanine substitutions as we did.  Although the group assayed ssoCas6[2004] at 
45 ˚C whereas the majority of our work was conducted at 60 ˚C, the relative activities 
of each mutation are compared in table 3.1. In ssoCas6[2004], K51A and R232A 
substitutions produced the greatest reduction in activities compared to WT (250- and 
150- fold, respectively), whereas K25 and K28A effects were comparatively mild (5- 
and 10- fold, respectively, (Reeks, Sokolowski, et al., 2013; Shao and Li, 2013)).  
Whilst ssoCas6[1437] and ssoCas6[2004] are very closely related, they are 
nonetheless different enzymes and any activity differences may reflect low levels of 
divergence extending to the catalytic mechanism.  However, without a strict side-by-
side comparison any such conclusions are merely speculative. 
3.3 Discussion 
Despite a structural homology, and analogous function, a diverse range of 
recognition and cleavage mechanisms exists across the Cas6 family.  In this chapter, 
we have illustrated that ssoCas6 adopts a native dimeric conformation and is 
catalytically active despite the lack of clearly defined catalytic residues.   
3.3.1 Dimerisation 
The inherent dimerisation property of ssoCas6 is not a trait shared by other 
previously characterised Cas6s, which are all monomeric (Carte et al., 2008; 
Haurwitz et al., 2010; Sashital et al., 2011; Gesner et al., 2011).  However, evidence 
is beginning to emerge that other Cas6s from thermophilic organisms may adopt the 
dimeric state at different phases of their catalytic cycles (Wang et al., 2011; 2012; 
Richter et al., 2013; Niewoehner et al., 2014).  For example, a catalytically active 
Cas6 associated with a Type I-B system from M. mariplaudis was shown to form on 
non-cleavable hairpin substrate as a dimer (Richter et al., 2013).  However, when 
able to function normally, this Cas6 example reverts back to the monomeric state 
upon completion of processing whilst remaining bound to the crRNA product (Richter 
et al., 2013). The crystal structure of the non-catalytic Pyrococcus horikoshii Cas6 
also reveals a dimer, though again only in the presence of repeat RNA (Wang et al., 
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2012). Here, in the 2:2 stoichiometry, each unstructured RNA molecule bridges both 
phCas6 units to allow the dimeric arrangement to be stabilised through ‘cross-
subunit’ interactions (Wang et al., 2012).  A possible dimerisation surface (~500Å2) 
has also been noted in P. furiosus Cas6, which may be sufficient for weak 
dimerisation in solution (Wang et al., 2011).  Maintenance of the dimeric state in the 
absence of RNA (Figure 3.20, Reeks, Sokolowski, et al., 2013; Shao and Li, 2013), 
with a 24 mer (substrate analogue, Shao and Li, 2013) and 16 mer sequences 
(product analogue, Shao and Li, 2013) suggests ssoCas6 retains the dimeric state 
throughout each phase of processing.   
 
Many proteins from thermophilic organisms rely on dimerisation/oligomerisation for 
functionality, which is possibly favoured by evolution as inter-subunit interactions can 
confer enhanced thermostability (Kirino et al., 1994; Byun et al., 2007; Nishitani et al., 
2013).  Monomeric ssoCas6 had highly reduced activity levels (approximately 24-fold 
reduction in cleavage rate); however, collapse in structure cannot entirely account for 
this effect as the monomeric ssoCas6 variant remained soluble with a Tm of 69˚C 
(Figure 3.21C).  Given that a precise manipulation into a stem-loop of an otherwise 
unstructured RNA is required, dimerisation could be a strategy to confer enhanced 
stability to the ssoCas6 active site via an allosteric interaction.  Similarly, any reduced 
activity associated with the monomer could have resulted from disruption to the 
active site geometry without global collapse in structure. 
 
The dimeric arrangement could also (or alternatively) contribute to activity through 
the presentation of additional substrate binding surfaces.  Whilst Shao et al. note that 
the ssoCas6 enzyme only has minimal interactions with the single-stranded regions 
of the substrate (Shao and Li, 2013), the structure does appear to show that the 
second subunit of the dimer contributes to a binding cleft for the crRNA 5’ end (Figure 
3.22D). WT ssoCas6[2004] had reduced activity against a substrate missing the five 
nucleotides upstream of the stem-loop base (Shao and Li, 2013).  Similarly, the 
otherwise stable (Figure 3.21C) monomeric ssoCas6 variant had reduced activity 
against full-length substrate (Figure 3.21A), suggesting that loss of the 5’ crRNA 
interaction could also affect catalysis.  Indeed, a recent publication illustrated that two 
Cas6 paralogues (ttCas6A/B) from T. thermophilus also form dimers in the absence 
of RNA, whereby an additional binding surface, outside of the primary stem-loop 
recognition domain, is formed at the interface and allows the coordination of an 
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otherwise unstructured 5’ region of the repeat RNA (Niewoehner et al., 2014).  This 
represents a significant contributor to the overall Cas6:RNA affinity in this example 
(Niewoehner et al., 2014).  Whilst the hairpin conformation of ssoCas6 substrate only 
leaves a few residues 5’ of the base of the stem-loop to be coordinated, ssoCas6 
otherwise possesses large patches of basic charge that extend across the dimer 
interface (Figure 3.16B, Reeks, Sokolowski, et al., 2013), which may represent a 
novel binding surface for the interaction with much longer RNA species.  In the 
context of a pre-crRNA transcript, in which two cuts are required for the release of 
each spacer, a ssoCas6 dimer may even coordinate sequential repeat sequences 
and is a possibility is explored in Chapter 4. 
 
The existence of some Cas6s strictly as monomers may be an essential requirement 
for their interaction with downstream effector complexes within certain system types.  
The type I-E and I-F Cas6s (Cas6e and Cas6f, respectively), undergo a single 
catalytic cycle and remain tightly bound to the processed crRNA (Sashital et al., 
2011; Sternberg et al., 2012).  This crRNA:Cas6 complex constitutes an essential 
subunit of the associated downstream CASCADE complex (Brouns et al., 2008; Jore 
et al., 2011; Wiedenheft, van Duijn, et al., 2011).  Thus, the ability to function as a 
monomer is a necessity for the correct stoichiometry and/or unhindered formation of 
the downstream CASCADE complex, which only coordinates a single crRNA 
molecule for targeting activities (Jore et al., 2011; Wiedenheft, van Duijn, et al., 
2011).  However, the monomeric P. furiosus Cas6 also remains stably bound to 
cleavage products (Carte et al., 2010), although the endonuclease does not comprise 
a subunit of either the type I-A or III-B complexes present in the organism (Hale et al., 
2009; Lintner, Kerou, et al., 2011; Zhang et al., 2012; Spilman et al., 2013; Rouillon 
et al., 2013). Thus pfCas6 may need to employ other strategies for crRNA delivery.  
The general concept of a Cas6 mechanisms/functionality being modified in 
accordance to the requirements of the system(s) in which it participates is explored 
further in the subsequent chapters. 
3.3.2 Catalytic Triad 
Sequence alignments illustrate that ssoCas6 lacks the hypothesised catalytic triad of 
residues centred on a histidine residue, though many other Cas6 proteins identified in 
bacterial and archaeal genomes similarly lack these residues (Carte et al., 2008).  
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Cas6 paralogues in P. horikoshi are highly similar in structure to that of P. furiosus 
Cas6 and recognise near identical repeat RNA substrate sequences (Wang et al., 
2011; 2012).  Crucially, certain phCas6 paralogues lack the catalytic triad of residues 
identified in pfCas6 (Wang et al., 2011), which in this instance do appear sufficient to 
abolish repeat RNA processing (Wang et al., 2012). However, in our nuclease 
experiments, ssoCas6 remained active despite the missing triad, suggesting that 
there is an alternative mechanism of catalysis employed.   
 
Alanine substitutions at positions K25, K28, K51 and R231 illustrated that these basic 
residues are important for ssoCas6[1437] catalysis.  However, the targeting of other 
conserved residues and logical active site candidates only had modest effects upon 
cleavage rate, e.g. E192, the only acidic residue in the vicinity of the active site, or 
the pfCas6 triad-like T179.  T179 may instead be involved with shape specific 
recognition of RNA sequences as it is located at the tip of the RNA loop and often 
substituted for phenylalanine in ssoCas6 homologues (Shao and Li, 2013) with such 
a substitution having little impact upon cleavage rate in this instance (Figure 3.17).  
Shao et al. observed that the ssoCas6[2004] arginine (R232) is located at the scissile 
phosphate bond where a general base is usually positioned in other metal-
independent endoribonucleases, though, given the high pKa of its guadinium group, 
the authors conclude that R232 is unlikely to perform such a role (Shao and Li, 
2013).  Similarly, a role as general base for K28 is also unlikely given its distance 
from the 2’ hydroxyl group (Shao and Li, 2013) and that ssoCas6 activity could not be 
recovered by a K28H substitution (Figure 3.17).  Alternatively, K28A may function as 
a general acid in a mechanism that does not involve a general base (See below, 
Figure 3.24). 
 
Whilst K28 was the closest to an essential residue, no variant to probe even the most 
highly conserved crenarchaeal residues achieved total inactivation of the cleavage 
mechanism.  This resistance to inactivation is possibly indicative of a relatively 
indirect approach to RNA cleavage.  Basic residues, such as lysine and arginine, are 
well-documented in coordinating nucleic acid substrates and stabilising the growing 
negative charge of the pentavalent phosphate intermediate during RNA cleavage by 
ribonucleases (e.g. RNaseA, Raines, 1998).  It has been suggested that transition 
state stabilisation is a particularly important catalytic mechanism employed by 
ribozymes, which otherwise cannot rely on the variety of functional groups available 
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through amino-acid side chains for general acid-base catalysis (Rupert et al., 2002; 
Lilley, 2003).  In the example of the hairpin ribozyme, crystal structures reveal a rigid 
active site in which more H-bonds are made to the transition state than precursor or 
product (Rupert et al., 2002). 
 
 
 
 
Figure 3.24. Possible ssoCas6 catalytic mechanism.  The ssoCas6 active site pocket 
contains four positively charged residues (K25, K28, K51 and R269) that may orientate the 
scissile phosphate into the unstable in-line conformation of the transition state.  R231 may 
specifically position the 2’ hydroxyl, whislt K28A could function as a general acid available to 
protonate the 5’ leaving group oxygen.  This arrangement could be sufficient to promote an 
attack by the otherwise weakly nucleophilic 2’ hydroxyl group of the adjacent ribose to yield 
the pentavalent phosphate intermediate, the developing negative charge of which is likely 
stabilised by surrounding basic sidechains, eg L25/L51, through hydrogen-bonding events.  
The subsequent transesterification reaction generates products with 3’ 2’3’-cyclic phosphate 
and 5’ hydroxyl termini.  Figure style adapted from Elliott and Lamdomery, 2011. 
 
 
The arrangement of four positively charged sideshains in the ssoCas6 active site 
pocket may function to trap the scissile phosphate in the unstable in-line 
conformation of the transition state (Shao and Li, 2013), promoting a spontaneous 
nucleophilic attack by the 2’ hydroxyl of the adjacent ribose (Figure 3.24).  Whilst 
precise roles for the identified residues are difficult to assign, R231/232 could 
function in a similar manner to the serine (S148) of paCas6f (Haurwitz et al, 2012) 
and correctly orientate the hydroxyl moiety, whislt K28 may act as a general acid and 
stabilise the 5’ leaving group through protonation.  The lack of a basic residue to 
activate the otherwise weakly nucleophilic ribose 2’ hydroxyl may restrict the 
efficiency of such a mechanism and so impose the limited the cleavage rate 
witnessed (~0.8 min-1, Figure 3.14B).  Such a cycle is also probably in effect in other 
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Cas6 mechanisms, though, only as it is a minor contributor to overall rate, it is 
possibly ignored.  Indeed, Sashital et al. comment during their characterisation of 
ttCas6e that even upon mutation of the critical histidine (H26) to alanine, there were 
still low levels of activity, indicative that the extended, in-line conformation of the 
scissile phosphate alone is sufficient for low levels of spontaneous cleavage (Sashital 
et al., 2011).  The same elongated conformation of nucleotides surrounding the 
scissile phosphate was seen in the Shao et al. structure of ssoCas6[2004] in complex 
with RNA, pinned in place by the network of positively charged residues (Figure 
3.23C, Shao and Li, 2013).  
 
In any case, Cas6 cleavage rates of even ~5 min-1 are far lower than other metal-
independent ribonucleases (e.g. certain RNaseA types are capable of single-turnover 
rates reaching 40500 min-1, Katoh et al., 1986) and are instead closer to those of 
ribozymes (Lilley, 2011).  However, it would appear they are nonetheless sufficient to 
satisfy the crRNA provision requirements of the associated systems in vivo.  Indeed, 
this feature probably acts as an important regulatory function.  Indeed, not only does 
a set of base-specific H-bond forming events occur in each case, but the various 
sacrifices in catalytic efficiency shifts in favour of substrate stringency.  This is an 
important consideration as the mis-incorporation of cellular RNA could have 
devastating consequences for the cell.  For example, Cas6f efficiency is limited by a 
lack of basic residues available to stabilise a transition state and a general acid to 
protonate the leaving group (Haurwitz et al., 2012).  ssoCas6 conversely does not 
appear to rely on readily attainable nucleophilic residues that would otherwise boost 
catalytic efficiency (Shao and Li, 2013; Reeks, Sokolowski, et al., 2013).  
 
That an active site/mechanism has been drastically modified, or lost and replaced, is 
not beyond the realms of possibility as the RAMP family exhibits a high degree of 
flexibility and adaptability.  For example, in the Cas6-deficient Type I-C system, 
Cas5d has developed the necessary catalytic abilities to substitute in the essential 
task of crRNA biogenesis (Nam, Haitjema, et al., 2012; Garside et al., 2012; Koo et 
al., 2013).  The Cas5d from B. halodurans targets hair-pin substrates.  Interactions 
are focused at the base of the stem-loop orchestrated through a conserved positive 
patch whilst a nearby putative catalytic triad consisting of Y46, K116 and H117 is 
suggested to mediate an acid-base catalytic cycle (Nam, Haitjema, et al., 2012).     
The triad is likely to have evolved independently to those of Cas6s due to a location 
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on an alternative section of the RAMP domain that consequently delivers cleavage 
products of a different size (11 nt 5’ tag, (Nam, Haitjema, et al., 2012)). 
3.4 Conclusions 
Overall, the structural and functional insights into ssoCas6[1437] emphasise the 
diversity of mechanisms present across the Cas6 family and highlight the diversity 
achieved from co-evolution between RAMP genes and substrate.  The subsequent 
chapters of this thesis will expand upon details of substrate coordination and explore 
what happens after the primary processing event and how a Cas6 endonuclease 
interacts with downstream system components.  
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Chapter 4: Exploring the Interaction 
between ssoCas6 and Substrate 
4.1 Introduction 
In the previous chapter, we showed that whilst ssoCas6[1437, 2004] mechanistically 
and structurally deviates from previously characterised bacterial or archaeal 
Cas6/Cas6-like enzymes, its function to generate crRNA with an 8nt 5’-tag and a 3’-
handle that comprises the remaining nucleotides from the downstream repeat is 
maintained (Lintner, Kerou, et al., 2011; Reeks, Sokolowski, et al., 2013; Shao and Li, 
2013).  Whilst Cas6/Cas6-like activity is essential for crRNA generation (Brouns et al., 
2008), that activity is defined by the larger system it is a part of and is modified 
accordingly depending on the system requirements. 
4.1.1 CRISPR/Cas System Distribution of Cas6 
Whilst functional and structural similarities exist (Ebihara et al., 2006; Brouns et al., 
2008; Carte et al., 2008; Haurwitz et al., 2010; Lintner, Kerou, et al., 2011; Reeks, 
Sokolowski, et al., 2013; Shao and Li, 2013; reviewed in Reeks, Naismith, et al., 
2013), the great mechanistic diversity between Cas6 families must be placed in 
context of their system type distribution and, accordingly, the inevitable co-evolution 
with distinct sets of cas genes and/or substrates (Haft et al., 2005; Kunin et al., 2007; 
Makarova, Haft, et al., 2011).  
 
Cas6e and Cas6f exclusively serve Types I-E and I-F systems, respectively 
(Makarova, Haft, et al., 2011).  Cas6e/Cas6f cleave CRISPR repeats at the base of 
the repeat stem-loop recognition domain and remain tightly bound to the released 
crRNA (Sashital et al., 2011; Sternberg et al., 2012; Niewoehner et al., 2014) to form 
integral components of the downstream e/fCASCADE complexes, influencing both 
their formation and continued stability (Brouns et al., 2008; Jore et al., 2011; 
Wiedenheft, van Duijn, et al., 2011).  The single-turnover kinetics of these Cas6 
orthologues are, therefore, essential to their non-catalytic, structural roles beyond 
crRNA generation (Sashital et al., 2011; Sternberg et al., 2012). 
 
Chapter 4: ssoCas6 Substrate Interaction 
 
 139 
Whilst archaeal Cas6 from P. furiosus also retains an affinity for crRNA (Carte et al., 
2008; 2010), Cas6 is not an integral subunit of the functional archaeal Type I-A 
system CASCADE (aCASCADE) (Lintner, Kerou, et al., 2011; Plagens et al., 2012; 
2014), and otherwise displays only transient interactions with the complex (Lintner, 
Kerou, et al., 2011).  Similarly, Cas6 lacks a physical affiliation with both bacterial or 
archaeal Type III effector complexes, (Hale et al., 2009; Zhang et al., 2012; Rouillon 
et al., 2013; Spilman et al., 2013; Staals et al., 2013) and any interaction via the 
crRNA itself is prevented by loss of the 3’-handle during additional crRNA maturation 
steps required by CMR or CSM (Hale et al., 2008; 2009; Hatoum-Aslan et al., 2011; 
Zhang et al., 2012; Rouillon et al., 2013; Hatoum-Aslan et al., 2013).  In any case, 
the possession of a mature crRNA in Type III and I-A systems indicates that Cas6 is 
capable of a crRNA handover event. 
 
Like other archaea, S. solfataricus possesses more than one CRISPR/Cas system 
(Makarova, Haft, et al., 2011).  ssoCas6-generated crRNA is utilised by the DNA-
targeting aCASCADE (I-A) and Csm (III-A) complexes, in addition to the RNA-
targeting Cmr complex (III-B) (Lintner, Kerou, et al., 2011; Zhang et al., 2012; 
Rouillon et al., 2013).  This increase in complexity requires Cas6 to channel crRNA to 
multiple clients and as such, likely precludes the endonuclease from permanent 
association with any one downstream effector complex and could require that 
ssoCas6 Is not restricted to single-turnover kinetics.  
 
In this chapter the interaction between ssoCas6 and substrate is further defined and 
illustrates that, unlike Cas6e/Cas6f homologues, the S. solfataricus CRISPR 
endonuclease is not restricted to a single-turnover catalytic event.  Furthermore, the 
behaviour of Cas6 when confronted by full-length pre-crRNA is considered, 
expanding from the activity upon isolated repeat sequences to that of a multiple 
repeat-spacer CRISPR transcript.  
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4.2 Results 
4.2.1 Further dissection of ssoCas6 catalytic parameters 
4.2.1.1 Cas6 cleavage rate changes with buffer composition 
As previously shown in Chapter 3, a substitution of NaCl for K-glutamate within the 
buffer medium generates an increase in Cas6 cleavage rate under single-turnover 
conditions (Figure 3.18).  Recombinant ssoCas6[1437] was assayed in this new 
cleavage buffer (NR-3 buffer; 20 mM NaH2PO4/Na2HPO4 pH 7.5, 100 mM NaCl, 5 
mM EDTA, 0.5 mM DTT) under single-turnover conditions (as per Section 3.2.3.5) 
with 5’ 32P radiolabelled CD-type repeat RNA (CD RNA) and the products were 
phosphoimaged after separation on a denaturing polyacrylamide gel.  The analysed 
product fraction data was fitted to an exponential function to derive the catalytic rate 
constant.  The single-turnover rate for CD RNA cleavage was 3.7 min-1 (Figure 4.1), 
over 4.5-fold higher than the rate determined under the alternative NR-2 buffer 
conditions (0.8 min-1, Figure 3.14B).  
 
 
Figure 4.1: Endonuclease activity of ssoCas6. 5’ 32P radiolabelled C/D-type RNA substrate 
was incubated with WT ssoCas6 under single-turnover conditions in the updated NR3-buffer 
at 60 ˚C. Data points are the means of triplicate data (± SEM) fitted to an exponential function.  
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4.2.2 Probing ssoCas6 substrate affinity 
The Cas6 enzymes associated with Type I-E and I-F systems have strict single-
turnover kinetics as a result of tight product binding (Sternberg et al., 2012; 
Niewoehner et al., 2014).  P. furiosus Cas6 also retains an affinity for the cleavage 
products of pre-crRNA processing, by way of the 3’-handle (Carte et al., 2008; 2010).  
Li et al. presented the crystal structure of ssoCas6[2004] bound to the 16mer product 
of a CRISPR F locus repeat sequence, thus illustrating that ssoCas6 too is capable 
of such behaviour (Shao and Li, 2013). However, the substrate/product binding 
affinities for either pfuCas6 or ssoCas6 (archaeal-type and Type I-A/Type-III 
associated Cas6s) have yet to be quantified, and any disparity with the strictly single-
turnover, and exclusively Type I system associated, Cas6e/Cas6f equivalents 
remains unclear.  To gain further insight into how Cas6 interacts with substrate RNA, 
binding affinities were examined.   
 
4.2.2.1 Substrate affinity varied between ssoCas6 variants 
A series of ssoCas6 concentrations of wild-type, K28A and L170D/V202D (monomer) 
variants were incubated with 1nM CD, and the resulting complexes were separated 
on a native polyacrylamide gel to conserve intermolecular interactions. The 
proteins/substrates were incubated together for 15 minutes at room temperature to 
achieve equilibrium prior to gel loading.  
 
Whilst in the presence of high Cas6 concentrations (monomeric or dimeric) 
substrate/protein-bound substrate does not migrate far into the gel (Figure 4.2A-C).  
It was expected from the temperature-dependent activity of Cas6 shown previously 
(Chapter 3, Figure 3.21B) that only minimal cleavage of CD-type substrate would 
occur at the assay temperature (r/t, 22-25˚C).  However, there are nonetheless 
additional well-defined bands bridging the unbound (full-length) substrate and the 
fully bound states.  These are hard to interpret but may represent variable binding 
stoichiometries (Figure 4.2A-C), given the dimeric nature of the endonuclease, and/or 
binding to cleavage products (additional band in WT Cas6 condition, Figure 4.3A).  
An additional band is also present in the monomer condition, below that of the 
unbound substrate (Figure 4.2C).  Whilst some cleavage activity is likely present 
across each of the conditions, binding appears to be weak enough in the monomer 
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condition to result in near-immediate product release.  In contrast, the higher affinities 
of the WT dimer appear sufficient to cause any product generated to remain bound. 
 
 
Figure 4.2: CD-repeat binding affinity of ssoCas6 variant. Titrated (A) WT, (B) K28A or 
(C) monomeric ssoCas6 was incubated with 0.5 nM 32P-labelled CD repeat RNA. Assays 
were conducted at r/t (~22˚C) in NR-3 buffer supplemented with 2 µM BSA.  All Cas6 
concentrations refer to the monomeric unit.  Gel bands were quantified and fitted to a 
standard isotherm (D) from which KD was calculated.  
 
To estimate KD values for repeat RNA binding by ssoCas6 variants, gel bands (Figure 
4.2A-C) were quantified as unbound (bottom band) or gel-shifted/protein-bound 
(remaining bands combined).  Fraction product data did not conform well to a simple 
hyperbolic function, and was thus fitted by non-linear regression as a least-squares fit 
to a four-parameter sigmoidal function: 
y = ymin +
ymin − ymin( )
1+ xKD
"
#
$
%
&
'
a  
Equation 4.1: 4-parameter sigmoidal function. a is the slope of the curve. 
Chapter 4: ssoCas6 Substrate Interaction 
 
 143 
Such a function is purely empirical in its application/formulation and does not 
correspond to an existing molecular model.  The inflexion point of the curve is 
nonetheless taken to represent the apparent KD (ie. 50% [S] bound).  This yields ~11 
and ~19 nM for WT and K28A, respectively (Figure 4.2D).  Such figures are over 
200-fold higher than observed for P. aeruginosa Cas6f and its cognate substrate 
(~50 pM, Sternberg et al., 2012).  The affinity of the Cas6 monomer for substrate 
drops substantially, over 200-fold from WT, to 2162 nM.   
 
The exponent n denotes the slope of the curve (Hill coefficient), which in the case of 
dimeric WT ssoCas6 is n=2.86 (Figure 4.3). The deviance from a simple load dose-
response (Hill slope = 1) and non-integer slope may indicate an element of positive 
cooperativity.  Each ssoCas6 monomer may be capable of simultaneously interacting 
with substrate molecules, which, given the use of isolated repeat sequences, could 
account for the Hill slope of ~2.  However, the biological implications for positive 
cooperativity are unclear. 
4.2.2.2 Fluorescence quenching by ssoCas6 allows KD estimation 
using fluorescein-labelled substrate 
It was observed that dimeric ssoCas6 WT interaction with Fl-labelled substrate 
generated a quenching effect.  The fluorescence curve between wavelengths 500-
560 nm was monitored as WT and K28A were titrated against 1 nM CD-type (CD) 
and CD-type product (CDprod) fluorescein-labelled [5’-FAM] RNA at 25 ˚C in NR-3 
buffer (Figure 4.3).  Data again did not conform well to a simple load dose-response, 
and was fitted to the four-parameter sigmoidal function (Equation 4.1) 
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Figure 4.3: Quenching of fluorescent substrate by ssoCas6[1437]. ssoCas6 WT (A) or 
K28A (B) was titrated against 1 nM 5’-labelled [FAM]-CD or [FAM]-CDprod and the 
fluorescence emissions between 500-560 nm were measured when excited at 480 nm. All 
data points were measured in quadruplicate and the means (± SEM) are plotted. Curves were 
fitted to a four-parameter sigmoidal function and curve fit parameters tabulated (C); KD – 
curve inflexion point, Hill coefficient – curve slope.  Assays conducted at 25˚C in NR-3 buffer 
supplemented with 2 µM BSA.  All Cas6 concentrations refer to the monomeric unit. Data has 
been normalised to account for fluorescence variance between conditions. (D) Overlaid 
structures of ssoCas6[2004]+24mer repeat substrate RNA (PDB: 4ILL, Green), 
ssoCas6[2004]+16mer ‘product’ RNA (PDB: 4ILM, Pink) and ssoCas6[1437] (Yellow).  
Position of K28 (grey sticks) is illustrated. 
 
The profiles for WT Cas6 interaction with CD and CDproduct are identical, which 
could indicate that the mechanism and propensity for CD-type repeat RNA by Cas6 
binding does not change with the loss of 8nt from the 3’-end of the substrate.  In 
contrast, K28A possessed reduced affinity for the substrate, which is unsurprising 
given the alteration to the active site architecture within the mutant such that K28 is 
positioned precisely at the substrate cleavage point (Figure 4.3D, Shao and Li, 2013).  
 
Interestingly, the level of quenching is proportionally less pronounced in the K28A 
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condition, retaining close to 65% initial fluorescence at the plateau.  The impairments 
to Cas6 substrate-affinity due to the K28A mutation appear to result in not only a shift 
in the quenching curve inflexion point (i.e. KD) and slope, but also the absolute level 
of quenching, possibly representing slight modification to how the 5’-end (i.e. –[FAM] 
position) of the bound RNA is held, although no dramatic changes between 
substrate- and product- bound ssoCas6[2004] structures (Figure 4.4D, Shao and Li, 
2013) are evident.  
 
The full quenching levels witnessed in the WT are restored in K28A by the absence 
of the final eight 3’ nucleotides, i.e. the interaction with artificially created CDproduct 
RNA. Such differences suggest two effects in action: 
 
1) The cleavage effects of WT (and subsequent binding to product) may hide a 
K28A-like profile of substrate binding.  Substrate binding is thus weaker than 
product binding. 
2) The residue K28 helps stabilise the full-length substrate in the active site 
pocket, specifically the scissile phosphate and/or nearby downstream 
nucleotides, thus accounting for the weaker binding of K28A to substrate 
without affecting the product binding profile. 
 
Whilst the two options are not necessarily mutually exclusive, K28 maps exactly to 
the repeat cleavage site in the crystal structure of ssoCas6[2004] in complex with 
substrate RNA (Figure 4.3D, Shao and Li, 2013) and is a critical component of the 
organisation of the final base-pair in the short hairpin stem (Shao and Li, 2013, 
discussed in Chapter 3).  A slope closer to 1, as also seen in the gel shift data, for 
the K28A variant could indicate that the possible cooperativity effects of the WT are 
absent or not initiated, possibly due to incomplete binding of substrate that may in 
turn prevent cleavage. 
 
4.2.2.3 Monomeric ssoCas6 interaction with fluoresce-labelled 
substrate produces a dissimilar fluorescence profile to WT/K28A 
The presence of monomeric Cas6 generated minimal quenching effects upon CD-
substrate, falling in a near-linear manner and consistent with those expected from 
dilution, and thus prevented a KD estimate from this methodology (Figure 4.4). The 
Chapter 4: ssoCas6 Substrate Interaction 
 
 146 
highly dissimilar profile to dimeric Cas6 (coupled to the impact of monomerisation on 
activity) strongly suggests a role for the dimer interface in the coordination of the 5’ 
repeat sequence upstream of the hairpin as suggested by the Shao & Li crystal 
structure of ssoCas6[2004] in complex with substrate RNA (discussed in Chapter 3, 
Figure 3.22, Shao and Li, 2013).  Accordingly, no KD estimates are possible from the 
data. 
 
 
Figure 4.4: Quenching of fluorescent substrate by ssoCas6. SsoCas6 Monomer 
(L170D/V202D) was titrated against 10 nM 5’-labelled [FAM]-CD and the fluorescence 
emissions between 500-560 nm were measured when excited at 480 nm.  Quadruplicate data 
(± SEM) is plotted.  Assays conducted at 25˚C in NR-3 buffer supplemented with 2 µM BSA. 
Data has been normalised.  
 
4.2.3 Is ssoCas6 restricted to single-turnover kinetics? 
The behaviour of ssoCas6 under multiple-turnover conditions should provide an 
indication as to how the enzyme interacts with the substrate beyond the primary 
cleavage event.  Current wisdom suggests that Cas6 remains tightly bound to the 
crRNA cleavage product either to co-ordinate assembly of the effector complex or 
simply to ensure correct delivery of the crRNA to the intended recipient (Carte et al., 
2008; 2010; Haurwitz et al., 2010; Sashital et al., 2011; Jore et al., 2011; Wiedenheft, 
van Duijn, et al., 2011).  If so, even under multiple-turnover conditions, product 
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generation is predicted to not exceed a single-turnover as has been well-
demonstrated for bacterial Cas6 examples (Sashital et al., 2011; Sternberg et al., 
2012, Niewoehner et al., 2014).  The equivalent kinetics of the archaeal Cas6 from P. 
furiosus are unclear, as only limited biochemical analyses were performed (Carte et 
al., 2008; 2010; Wang et al., 2011). 
 
With ssoCas6 and product RNA binding with a KD of 12.2 nM, an estimation for a 
maximum k-1 can be made assuming a k1 rate at the diffusion maximum (ie 109.sec-
1.M-1): 
 
 
Consequently, the presence of enzyme-product complex would have a half-life of: 
 
 
In comparison, Cas6f, which displays strict single-turnover kinetics, has a KD for 
product RNA of ~50 pM (Sternberg et al., 2012).  Following the same logic as above, 
Cas6f has a k-1 rate of 0.05 .sec-1 and t1/2 of 18.86.  This is a ~250-fold slower rate of 
enzyme-product complex dissociation than ssoCas6, without even considering the 
effects that the different physiological temperatures experienced by these temperate 
and thermophile representatives would have on such rates.  This represents realistic 
k-1 rates measured in seconds for ssoCas6, whilst those of Cas6f and Cas6e may 
stretch to tens of minutes or even hours.  This opens up the possibility that ssoCas6 
may not be restricted to the single turnover kinetics expected of the Cas6 family.  
Accordingly, the working kinetic scheme (Figure 3.9) could be expanded to: 
 
 
 
Figure 4.5: Reaction scheme for multiple turnover activity. k1 and k2 describe the rate of 
association of enzyme with substrate and product, respectively, whereas k-1 and k-2 describe 
the rate of enzyme-substrate and enzyme-product complex dissociation, respectively.  Whilst 
kstn describes the single turnover rate of the isolated catalytic step, kcat is the pseudo-first 
order rate constant for the overall reaction [ES]![E]+[P] (ie rate during multiple turnover 
activity). 
 
k−1 = k1 ×KD = 109.sec−1.M −1( )× 12.2×10−9M( ) =12.2.sec−1
t1/2 =
ln 2( )
k−1
=
0.693
12.2.sec−1 = 0.0568sec
Chapter 4: ssoCas6 Substrate Interaction 
 
 148 
4.2.3.1 ssoCas6 is capable of multiple-turnover activity 
In order to study the activity of Cas6 under multiple-turnover conditions, ssoCas6 was 
assayed at a range of concentrations in the presence of 4 µM CD RNA (Figure 4.6A). 
The initial rates of product formation were linear (i.e. rate constant with time); thus, 
under these conditions the substrate concentration was saturating and approximate 
steady-state kinetics were in effect (i.e. rates are zero-order with respect to [S] and 
d[ES]/dt=0). In each condition, the amount of product generated increased with time 
beyond that of the starting amount of enzyme, indicative that ssoCas6 is not 
restricted to a single-turnover event and is instead capable of product release and 
renewed substrate acquisition (i.e. multiple-turnover activity).  Indeed, for the 10 nM 
[Cas6] condition it can be seen that over 35 turnovers were achieved per active site 
over the 30 min assay duration (Figure 4.6B). 
 
 
Figure 4.6: Multiple-turnover activity of ssoCas6. A range of WT ssoCas6 concentrations 
(4-80 nM) were incubated with radiolabelled CD-type repeat RNA (4000 nM) in NR-3 buffer 
supplemented with 2 µM BSA at 60 ˚C. (A) Cas6 activity against 4 µM RNA fitted to a linear 
function. Pseudo steady state: Zero order reactions are only applicable over a limited time 
period, thus the time point range to which the primary linear fits are applied (i.e. the initial 
rate) are truncated with rising enzyme concentration, and only the initial linear phase of the 
reaction is shown.  (B) Re-plotting the data from the 10 nM [Cas6] condition as ‘pmoles of 
product per pmoles of Cas6’ against time illustrates the turnover capacity of the enzyme. (C) 
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Rates (pmoles product formed.min-1) derived from linear fits in (A) are displayed as a function 
of Cas6 concentration. Adapted from Sokolowski et al., 2014. 
 
 
As per the law of mass conservation, [E]T remains constant throughout each reaction 
and under the conditions of saturating [S] the reactions display approximate first 
order kinetics, where v0=Vmax=kcat[E]T.  Therefore, plotting the initial rates against the 
known Cas6 concentration, to which a linear function can be fitted, allows the 
derivation of a kcat of ~1.75 min-1 (Figure 4.6C).  As such, 1.75 molecules of substrate 
are processed by each active site per minute.  This is approximately half the catalytic 
rate observed under single-turnover conditions (where [S]<<[E], ~3.69 min-1).  Under 
multiple-turnover conditions, the apparent first order rate constant for [ES]![E]+[P] is 
a summation of partial rate constants (i.e. kstn and enzyme-product complex 
dissociation) that are involved in multiple-turnover activity.  The influence of such 
parameters under single-turnover conditions is effectively absent, allowing the 
observed rate to represent the absolute maximum rate of the catalytic event itself, 
[ES]![EP] (Figure 4.1).  A disparity between these two values (kstn>kcat) would 
indicate that the product release (k-2) contributes as a rate-limiting step, though in this 
case the difference is small enough to consider any such influence by k-1 not to be 
significant . 
4.2.3.2 Probing the dependence of ssoCas6 behaviour upon 
substrate concentration 
To expand on the relationship between ssoCas6 and its substrate, CD-type RNA 
concentration was varied whilst enzyme concentration was held constant, at either 4 
or 40 nM Cas6, to analyse the ssoCas6 rate as a function of [S] (Figure 4.7).  
 
The two ssoCas6[1437] conditions appeared to maintain the linear relationship 
between [Cas6] and rate, where the upper limit for observed velocity in the 40 nM 
condition (~26 nM.min-1) was approximately 10-fold higher than that of the 4 nM 
condition (~3 nM.min-1).  However, the resulting kcat of ~0.6 – 0.75 min-1, obtained by 
dividing the approximate Vmax of product generation (nM.min-1) by the total 
concentration of enzyme in the assay (40 and 4nM conditions, respectively), was 
lower than the 1.75 min-1 expected from Figure 4.6b. 
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Apart from what appears to be velocities approaching Vmax being achieved very 
quickly (lowest [S] condition tested; 100 nM), there is unfortunately no discernable 
information as to the shape of the curve’s dynamic range from either dataset.  
Accordingly, estimates for Km cannot be made from the data set.  ssoCas6 activity 
may not even adhere to Michaelis-Menton kinetics, for example if cooperativity does 
exist within the dimer, leading to a sigmoidal v vs [S] plot.  Whilst ideally substrate 
conditions below 100nM should have been explored, as substrate concentrations 
approach the KD value (10 - 30 nM) it may not be possible to make meaningful 
measurements. 
 
 
 
Figure 4.7: Multiple-turnover activity of ssoCas6. A range of radiolabelled CD-type 
substrate RNA concentrations were assayed against WT ssoCas6 concentrations, 4 or 40 
nM. Reactions were conducted at 60 ˚C in NR-3 buffer supplemented wit 2 µM BSA. At 
selected time-points, reaction samples were stopped with phenol/chloroform and products 
separated on a denaturing polyacrylamide gel. (A) Example of raw assay gel (4 nM Cas6, 0.4 
µM RNA) and (B) its subsequent primary data analysis of triplicate assays by fitting initial 
mean (± SEM) product fractions against time to a linear function.  (C) Secondary processing 
of data, combining velocity (nM.min-1) measurements over a range of RNA concentrations, 
[S].  Lines to indicate the approximate upper threshold for velocity under each [E] condition 
have been included (dashed lines, colours as per condition).  
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4.2.4 In vitro processing of CRISPR transcripts by 
ssoCas6 
For simplicity, previous kinetic analysis of Cas6 has primarily been conducted using 
isolated repeat or reduced pre-crRNA sequences (Carte et al., 2008; 2010; Sashital 
et al., 2011; Sternberg et al., 2012; Haurwitz et al., 2012; Reeks, Sokolowski, et al., 
2013), with the processing of larger pre-crRNA transcripts in vivo being assessed 
indirectly by global RNA analyses (Hale et al., 2008; 2009; Hatoum-Aslan et al., 
2011; Hale et al., 2012; Pougach et al., 2010; Richter et al., 2012; Peng et al., 2013; 
Nickel et al., 2013; Brendel et al., 2014; Deng et al., 2013).   Characterising the 
endonucleolytic processing of full-length transcript sequences, containing multiple 
repeat/spacer units, is thus critical to our understanding of Cas6 within its native 
environment. 
 
Accordingly, an artificial CRISPR array was constructed from which pre-crRNA-like 
transcripts could be generated of consistent length and spacer sequence content 
(detailed in the Materials and Methods, Section 2.2.2); the spacer sequence selected 
was number 63 from the CRISPR D loci (i.e. D63) and the repeat was that of the CD-
type: 
 
Spacer D63:  TTTCGTATAAGGACCAGAACGGCAATACCCAAACTGT 
CD-type repeat: GATAATCTCTTATAGAATTGAAAG 
 
An array containing four repeat-spacer units - (R/S)4 - was selected as the model for 
further investigation (Figure 4.8A), from which a pre-crRNA-like substrate (4-R/S) 
was generated via run-off transcription, internally labelled with α-UTP 32P (Figure 
2.2).  
4.2.4.1 Transcript processing under single-turnover conditions  
2 µM ssoCas6[1437] was incubated with 0.5 nM purified α-UTP(32P)-labelled 4-R/S 
transcript (single-turnover conditions) at 60 ˚C in NR-3 buffer and the products 
separated on a denaturing polyacrylamide gel (Figure 4.9A). The gels were 
subsequently analysed by phosphorimaging and the resolved bands quantified to 
generate the component product fraction profiles in Figure 4.9B.  Bands were 
identified with reference to the cleavage map in Figure 4.8 and the intensity value of 
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each product band adjusted for U nucleotide content, assuming a random but even 
distribution of α-UTP 32P, and so compensates for signal/length ratio (where product 
bands were grouped, the intensity was adjusted for mean UTP content of grouped 
products). 
 
 
Figure 4.8:  Artificial CRISPR transcript generation and Cas6 processing.  (A) An 
artificial CRISPR array containing four repeat-spacer units (repeat - red, spacer - white) is 
illustrated.  Cleavage of the pET28c-(R/S)4 vector with Xho1 permits runoff transcription by T7 
polymerase to generate a substrate of four repeat/spacer units flanked by T7-promoter-
related sequence (Black) and Xbal (cyan) and Xho1 (yellow) restriction site sequences.  (B) 
Cas6 cleavage map for the 4-R/S substrate.  The transcript contains four available cleavage 
sites (dashed lines/scissors icon).  All possible cleavage products and their lengths (nt) are 
indicated, each of which may require either one or two cuts by Cas6 for their complete 
release.  End stage products 49, 51 nt; 2-cut End stage products 61 nt. Intermediate products 
are indicated by black lines, whilst final/end stage products are indicated by orange lines. 
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The gels display the transitory appearance of intermediary products before the 
complete reduction to final lengths comprising a single spacer flanked by partial 
repeat sequences (in addition to any residual sections of parent transcript, i.e. 
restriction sites, transcribed operon sections) (Figure 4.9).  Generally those species 
requiring a single cut are quick to appear, whilst in comparison, the visible 
intermediaries requiring two cuts, 61 and 122 nt, are delayed in their appearance.  
The profile of 61 nt end products begins with a lag phase before increasing to full rate 
as single-cut precursors evidently become available. When the non-lag region of the 
61 nt product curve is fitted to an exponential function, product crRNA is generated 
with a rate of 3.05 min-1, which agrees well with the single-turnover rate (3.69 min-1, 
Figure 4.1) maximum for isolated repeat sequences. 
 
Supposing ssoCas6s cannot bind at consecutive repeat sites, if the 3’ handle of a 
repeat site is occupied then it will require product release to permit binding at the 
adjacent upstream repeat site for any further processing to occur.  For example, 
whilst the generation of single-cut 110/112 nt intermediates reaches its peak early as 
expected, disappearance of these products is much slower than that of single-cut 
intermediates. This is consistent with the influence the koff rate slowing the release of 
Cas6 from the 3’ handle of the 112 nt upstream product, which is needed to allow 
access to the remaining repeat site.  Conversely, the 110 nt downstream product with 
a 5’ 8 nt tag would be released immediately upon cleavage and as such is readily 
available for further processing and disappears quickly.  The appearance of 122 nt 
intermediates, requiring two cuts, would necessitate protection at the central repeat 
site to occur, and again its slow disappearance is explainable by retention of 
substrate by Cas6 via the 3’ handle. 
 
Overall, the pattern appears consistent with intrinsic processing events on a site-by-
site basis that is largely unaffected by the transcript size; however, overall processing 
down to final products by Cas6 is likely restricted by the effects koff due to the 
occlusion of neighbouring repeat sites by the bound enzyme. 
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Figure 4.9: ssoCas6 mediated cleavage of the 4-repeat/spacer RNA transcript (A) An example Cas6 cleavage time-course gel of 4-R/S transcript RNA 
processing (~0.5 nM aUTP-labelled 4-R/S transcript RNA, 2 µM ssoCas6 WT, 60˚C in 20 mM Na2HPO4/NaH2PO4 pH 7.5, 100 mM NaCl, 5 mM EDTA, 0.5 
mM DTT.  Marker generated as per Ambion® Decade™ Marker system kit and protocol and supplemented with full-length 4-R/S transcript). Expected product 
band sizes (nt) were identifiable individually (283 (Full-length, black), 122 (purple), 61 nt (cyan)) or as groups (232/234 (blue), 170/172/183 (green), 110/112 
(magenta), 49/51 nt  (yellow)) dependent on limits of gel resolution.  (B) Product band intensities were quantified, adjusted for UTP content and the resulting 
mean (± SEM) product fractions plotted from triplicate assays. The 61nt profile is fitted to an exponential function. Time range 0 – 120 sec displayed (of 600 
sec total).   
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The absolute population of each intermediate product was limited by gel resolution, 
and not every intermediate band is visible.  As such, the profiles of the grouped 
intermediaries will be a combination of the individual profiles of its members and 
whether they are the upstream or downstream cleavage products.  The generation of 
products 231/234 nt, which simultaneously give rise the 49/50 nt lengths, appears to 
be disproportionately slow compared to fellow single-cut species, though the true 
profile in this case is almost certainly masked by limited time point resolution.  
4.2.4.2 Transcript processing by ssoCas6 under multiple-turnover 
conditions 
To try and slow the transcript processing and improve detection of the rise and fall of 
each intermediate, the concentration of Cas6 used was lowered to 0.2 nM (BSA 
supplementation brought total assay protein concentration to 2 µM) and the assay 
was performed as per Section 4.2.4.1. 
 
The overall pattern of intermediate product profiles and their relative positioning 
appears conserved between the two Cas6 conditions (Figures 4.9B and 4.10).  The 
profiles are simply broader with the lower Cas6 concentration.  The assay comprised 
approximately 0.5 nM of RNA, containing four repeat/spacer units per transcript, 
which brought the available repeat sequence substrate concentration effectively to 2 
nM, i.e. 10-fold excess over ssoCas6 concentration. The activity does not appear to 
vary much from the single-turnover profiles.  However, at 0.2 nM Cas6 and 2 nM 
substrate the rate is far slower than previously observed due to Cas6 functioning well 
below even the lowest estimates for KD/KM.  
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Figure 4.10: ssoCas6 mediated cleavage of the 4-repeat/spacer RNA transcript under 
multiple-turnover conditions. 0.2 nM ssoCas6 WT was incubated with 0.5 nM 4-R/S aUTP-
labelled transcript (Assay conducted at 60˚C in 20 mM Na2HPO4/NaH2PO4 pH 7.5, 100 mM 
NaCl, 5 mM EDTA, 0.5 mM DTT).  At selected time points, reaction samples were stopped 
with phenol/chloroform and products separated on a denaturing polyacrylamide gel. Product 
band intensity was quantified, adjusted for UTP content and the resulting mean (+/-SEM) 
product fractions plotted from triplicate assays.  Expected product band sizes (nt) were 
identifiable individually (283 (Full length), 122, 61 nt) or as groups (232/234, 170/172/183, 
110/112, 49/51 nt) dependent on limits of gel resolution. Time range 0 - 600 sec displayed (of 
2400 sec total). 
 
Subtle variations may exist between the two ssoCas6 concentration conditions, 
however, whether such differences are significant is unclear at present. Curiously, 
the absolute peak population sizes of certain intermediary products appear to be 
different across each of the two conditions.  109/112, 122 and 169/173/183 nt 
products reach ~25% lower peak fractions with the lower ssoCas6 concentration 
(Figure 4.10). 
 
Some differences could simply be a product of the time-points selected and 
increased/decreased resolution of the early portion of each curve, although the early 
portion of the curve appears slightly better represented under the slower reaction 
conditions.  For example, the 232/234 nt profile has now shifted to its expected 
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position as a rapidly appearing single-cut intermediate. The rapid generation of all 
single-cut intermediates would indicate that Cas6 can to bind internal substrate sites 
rather than needing to scan in from strand edges. 
4.3 Discussion 
While exceptions exist (e.g. Type I-C), nearly all Type I and III systems characterised 
to date rely on Cas6 as the essential link between full-length CRISPR transcripts and 
acquisition of crRNA by the downstream effector complexes (Brouns et al., 2008; 
Carte et al., 2008; Haurwitz et al., 2010; Jore et al., 2011; Wiedenheft, van Duijn, et 
al., 2011; Hatoum-Aslan et al., 2011; Lintner, Kerou, et al., 2011; Peng et al., 2013; 
Deng et al., 2013; Brendel et al., 2014).  Any subsequent direct involvement of the 
CRISPR-specific endonuclease with downstream complexes appears variable with 
system type and even subtype (Makarova, Haft, et al., 2011).  This chapter describes 
the first illustration of a CRISPR-associated endonuclease functioning in a multiple-
turnover capacity, which has implications for both effector complex involvement and 
pre-crRNA processing. 
4.3.1 ssoCas6 is capable of multiple-turnover activity 
In accordance with all previously characterised Cas6s, ssoCas6 retains an affinity for 
the upstream products of the repeat cleavage event (Carte et al., 2008; 2010; 
Sashital et al., 2011; Sternberg et al., 2012; Niewoehner et al., 2014).  However, the 
ssoCas6 substrate/product KDs in the >10 nM range are not sufficient to prevent 
product dissociation, thus permitting multiple-turnover activity (Figures 4.6 and 4.7).  
Indeed, product release does not appear to significantly limit the overall reaction rate 
(Figure 4.6C). The 10-30 nM KD binding affinities of ssoCas6 compare well to those 
suggested for Cas6 from P. furiosus, in which substrate and product again share 
similar profiles (~50nM, Carte et al., 2008; 2010), and, despite an alternative binding 
arrangement (Wang et al., 2011), could represent a general feature of Cas6’s that 
cater to multiple system types (Makarova, Haft, et al., 2011). 
 
Conversely, the tight binding to cleavage products by other Cas6 examples restricts 
pre-crRNA processing activities to a single-turnover through strong product inhibition 
(Sashital et al., 2011; Sternberg et al., 2012; Niewoehner et al., 2014).  Cas6f from P. 
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aeruginosa binds both substrate and product RNA with a KD of ~50 pM (Sternberg et 
al., 2012).  Two Cas6 paralogues recently characterised in T. thermophilus have 
similarly low pM KDs (Niewoehner et al., 2014) whilst the ttCas6e orthologue, 
exclusively associated with the Type I-E system present, binds product RNA with a 
KD of ~1 nM (Sashital et al., 2011).  Indeed, within ttCas6e, the U5-A102 interaction 
specifically is critical for Cas6e adherence to strict single-turnover kinetics.  When the 
U5-A102 pairing is disrupted by mutation, the subsequent reduction in product affinity 
allows Cas6e to entertain multiple-turnover activity.  The A102 residue that is 
essential to restricting product dissociation is widely conserved across Cas6e, further 
highlighting the importance of single-turnover kinetics within the Type I-E system 
subtype (Sashital et al., 2011). Similarly, in the Type I-B associated Cas6 of the 
archaean H. volcanii, mutation of two serine residues predicted to coordinate the 
crRNA molecule resulted in increased crRNA levels within the cell, which may reflect 
the induction of multiple-turnover activity (Brendel et al., 2014). 
 
Mutation of residue K28 within ssoCas6 largely abrogates cleavage (Chapter 3, 
Figures 3.14 and 3.17, Reeks, Sokolowski, et al., 2013; Shao and Li, 2013). 
Positioned directly at the cleavage site (Figure 4.3D), K28 provides a significant 
contribution to coordinating the nucleotides at the 3’ base of the transient hairpin (as 
discussed in Chapter 3, Figure 3.22, Shao and Li, 2013).  Disruption of this 
interaction may account for the reduced ability of the K28A ssoCas6 variant to bind 
full-length substrate (Figures 4.2 and 4.3). 
 
The binding assays also show a highly reduced affinity for substrate by the 
monomerised ssoCas6 relative to dimeric WT/K28A (Figure 4.2B).  Dimerisation 
likely stabilises the protein and helps coordinate the 5’ ssRNA region of the repeat 
sequence in a cleft formed at the interface (Figure 3.22D, Shao and Li, 2013).  This 
binding of 5’ substrate nucleotides by this region may have led to the fluorescein tag 
being held against the dimer surface, with subsidiary interactions accounting for the 
quenching effects (Figures 4.3A and B).   Within the monomer, such surfaces are 
absent and could allow the 5’-end of the tethered repeat to protrude into the solution, 
where the fluorescein tag is largely free of quenching effects (Figure 4.4).  This 
disruption to the substrate interaction and associated losses in affinity likely account 
for the majority of the reduction in nuclease activity associated with the monomeric 
ssoCas6 variant (Figure 3.21). 
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Precisely how Cas6s interact with and manage processing of a longer pre-crRNA 
molecule is poorly understood.  Beyond the enhanced 5’ interaction of the isolated 
repeat sequence, the large areas of positive charge that span the dimer interface 
may represent additional RNA binding sites (see Chapter 3 Figure 3.16B, Reeks, 
Sokolowski, et al., 2013).  Under the pfuCas6 wrap-around model, the repeat is 
coordinated across the protein’s circumference between the polar recognition and 
cleavage domains (Wang et al., 2011).  The distances between Cas6 binding sites 
(separated by an unrestricted spacer) on pre-crRNA are sufficient to model 
monomeric P. furiosus Cas6 lining up along the transcript like ‘beads on a string’ to 
occupy consecutive cleavage sites (Wang et al., 2011). However, 
immunoprecipitation of Cas6 from P. furiosus lysate brings through both 2x 
intermediates and 1x mature crRNAs (Carte et al., 2010), suggesting that even this 
35 kDa monomeric Cas6 is incapable of binding at consecutive sites and adopts a 
stepped processing profile (Hale et al., 2008; Carte et al., 2010).  
 
Such a problem is thus doubled for the 65 kDa ssoCas6[1437, 2004] dimer, 
especially given that by constraining repeat sequences into a stem-loop the space 
available space between consecutive binding sites is reduced.  Linter et al. illustrated 
a marked delay in the appearance of mature crRNA from larger intermediates during 
the in vitro processing of a two-spacer transcript by ssoCas6[2004], though this was 
not quantified (Lintner, Kerou, et al., 2011).  Here, whilst the rate of crRNA generation 
from pre-crRNA by ssoCas6 under single-turnover conditions  (3.05 min-1, Figure 
4.9B) was similar to that isolated repeat RNA sequence (3.69 min-1, Figure 4.1), it 
occurred after a distinct lag phase.  In conjunction with the profiles of intermediate 
processing products, this effect suggests ssoCas6 may occlude consecutive repeat 
sites from the simultaneous access by additional dimers, requiring product release 
before the processing at neighbouring sites can occur.  The multiple-turnover 
capacity of ssoCas6 would allow for such pre-crRNA processing in a stepwise 
fashion.  From the presented data it is not possible to determine if a ssoCas6 dimer 
unit is capable of simultaneously binding both of a spacer’s flanking repeats to excise 
a crRNA in one simultaneous cleavage event.  
 
In contrast to pfCas6 and the ssoCas6 dimer, Cas6e (~23 kDa, Brouns et al., 2008) 
and Cas6f (~23kDa, Haurwitz et al., 2010) may be sufficiently small to overcome 
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occlusion issues which would be a logical necessity given the restrictions upon 
product release within their single-turnover mechanisms.   
4.3.2 Serving multiple downstream clients with crRNA 
The functional/mechanistic dichotomy between Cas6e/f and ssoCas6 must be 
examined in context of downstream effector complex involvement and any 
subsequent non-catalytic roles.  Whilst all Types I-E CASCADE subunits are 
essential for antiviral activity (Jore et al., 2011), Cas6e appears to orchestrate 
assembly of eCASCADE subunits (Brouns et al., 2008; Jore et al., 2011) upon 
encountering unprocessed pre-crRNA (Brouns et al., 2008).  The retention of crRNA 
post-processing thus extends this influence upon the overall structural integrity of 
fully assembled complex (Jore2011, Sashital).  The stable assembly of the 350kDa 
P. aeruginosa Type I-F CASCADE complex (Csy11213641-crRNA1) can only occur 
and be maintained upon a crRNA-Csy4 scaffold (Wiedenheft, van Duijn, et al., 2011). 
The retention of the crRNA by Cas6 after pre-crRNA processing is thus a crucial 
element of such systems, and the conserved features required for such an ability 
promote specialised delivery to a particular effector complex and do not allow for a 
multiple-turnover capability (Jore et al., 2011; Sashital et al., 2011; Wiedenheft, van 
Duijn, et al., 2011; Sternberg et al., 2012). 
 
In Type I-C system of Bascillus halodurans, Cas5d has a low affinity for crRNA (Nam, 
Haitjema, et al., 2012).  In vitro, Cas5d only interacts weakly with other CASCADE 
components Cas7 and Cas8c in the absence of crRNA.  However, co-expression of 
CRISPR transcripts alongside these three cas genes leads to the stable formation of 
400 kDa complexes consisting of Cas5d(2):Cas7(6):Cas8c:crRNA capable of mediating 
an interference response.  Thus in the B. halodurans Type I-C system, processing of 
pre-crRNA by the associated CRISPR endonuclease triggers assembly of the 
CASCADE, of which it again remains a subunit.  The presence of two Cas5d subunits 
possibly reflects additional structural roles usually performed by non-catalytic Cas5 
(and/or Cas6) equivalents in other systems (Nam, Haitjema, et al., 2012). 
 
The type I-A aCASCADE complex of S. solfataricus features orthologues of most 
eCASCADE subunits with the exception of Cse1 (as per the Type I-F CASCADE, 
Wiedenheft, van Duijn, et al., 2011) and Cse2 subunit equivalents (Brouns et al., 
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2008; Jore et al., 2011; Lintner, Kerou, et al., 2011).  However, only a weak 
association between Cas6 and aCASCADE has been illustrated in lysate pull-downs 
(Lintner, Kerou, et al., 2011), and the endonuclease is not required for either the 
formation or activity of the DNA-binding core complex of crRNA-Cas7(n)-Cas5a from 
purified recombinant protein (Lintner, Kerou, et al., 2011).  Rather, Cas6 may only 
interact transiently with other aCASCADE components in the presence of pre-crRNA, 
and ultimately dissociates upon the installation of mature crRNA (Lintner, Kerou, et 
al., 2011; Plagens et al., 2012).  Cas7 forms extended helices in the presence of 
crRNA, seemingly unrestricted in growth (Lintner, Kerou, et al., 2011; Plagens et al., 
2014), and may even bind the nascent molecule co-transcriptionally to protect it from 
degradation (Peng et al., 2013).  Thus Cas6 and other transiently interacting proteins 
(Csa5 and Csa4) may supplement Cas5 to act as capping factors and restrain helix 
growth to a given crRNA size until stable assembly is complete (Lintner, Kerou, et al., 
2011).  Plagens et al. showed that the reconstitution of CASCADE where all subunits 
are present showed no extended helices/variable complex sizes (Plagens et al., 
2014).  Some evidence suggests that Cas3” may also enter the Type I-A assembly at 
this point (prior to proto-spacer matching and R-loop formation) and aid any re-
modelling process to achieve a smaller, correctly-sized complex (Peng et al., 2013).  
Maintaining an affinity for product crRNA would aid Cas6 in the initial coordination of 
the RNA and/or guide subunit assembly prior to handover.  However, the full Type I-A 
complex from T. tenax was shown to be capable of stable reconstitution in vitro 
without the presence of crRNA, though readily incorporated the guide RNA when 
available (Plagens et al., 2014).  Thus, a scenario in which Cas6 delivers a crRNA to 
an assembled complex remains feasible, even for type I systems. 
 
In contrast to Type I-A, Cas6 does not co-purify or display even a weak pull-down 
association with Type III components; the CSM or CMR complexes (Hale et al., 2009; 
Zhang et al., 2012; Spilman et al., 2013; Staals et al., 2013; Rouillon et al., 2013).  
Moreover, any Cas6 association via the integrated crRNA of the CSM/CMR complex 
is ultimately prevented by loss of the repeat recognition domain, contained within the 
3’-handle (Hale et al., 2009; Carte et al., 2008; 2010; Shao and Li, 2013; Wang et al., 
2011), resulting from crRNA 3’-handle trimming (Hale et al., 2008; 2009; Hatoum-
Aslan et al., 2011; Zhang et al., 2012; Rouillon et al., 2013).   Primary processing of 
pre-crRNA by Cas6 and later maturation events are distinct steps (Hatoum-Aslan et 
al., 2011), and thus pre-crRNA processing products could be: 
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1. Released to solution and subsequently scavenged by CMR/CSM without the 
need for contact with Cas6.  However, unprotected crRNA has been shown to 
be quickly degraded in the cellular environment, possibly by cellular 
nucleases (Pougach et al., 2010; Peng et al., 2013; Brendel et al., 2014).  
2. Handed over to an intermediate CRISPR nuclease that later hands matured 
crRNA to the CSM/CMR complexes, though none has yet been identified nor 
shown to co-purify (Hale et al., 2009; Hatoum-Aslan et al., 2011; 2013; Zhang 
et al., 2012; Rouillon et al., 2013). 
3. Trimmed in situ by a recruited nuclease once the crRNA uploaded to 
CMR/CSM and the relevant regions protected/unprotected (Hatoum-Aslan et 
al., 2011; 2013).  
 
In S. epidermis, accumulation of crRNA within a cell was reliant on Csm4 and Cas10, 
in addition to Cas6 for its initial generation, most likely by maintaining complex 
assembly which affords protection to the bound crRNA from cellular nucleases 
(Pougach et al., 2010; Hatoum-Aslan et al., 2011). Meanwhile, Csm2, csm3 and/or 
csm5 appear to mediate crRNA 3’-handle maturation in Type III-A systems with a 
ruler mechanism anchored at the 8nt 5’-tag, either by performing the cleavage 
themselves, by recruiting a specific nuclease or by selective protection of the RNA 
from degradation by non-specific nucleases (Hatoum-Aslan et al., 2011).  Recent 
evidence implicates Csm3 specifically as the ruler, whereby each subunit binds a 6nt 
stretch of crRNA and protects it from nuclease attack and thus maintains the 6 nt 
periodicity witnessed in crRNA maturation products (Hatoum-Aslan et al., 2013).  
Within the CMR complex, a similar role for the Cmr6 and Cmr4 (orthologues of Csm3 
and Csm5, respectively) has been proposed (Hatoum-Aslan et al., 2012).  S. 
islandicus KO of CMR abolished the accumulation of the smallest 3’-handle trimmed 
crRNA species present in this system (Deng et al., 2013).  However, beyond simply a 
protective role, synergistic effects between Cas6 and the CMR complex may guide 
3’-handle maturation events, as shown from altered crRNA biogenesis patterns in S. 
islandicus from disruption of either (Deng et al., 2013). 
 
Ultimately Cas6, after release of crRNA or direct handover to client complexes, 
returns to its unbound state allowing it to re-bind pre-crRNA and perform additional 
cleavage cycles (Figure 4.11).  
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Figure 4.11: Multiple-turnover activity enables Cas6 to distribute crRNA to multiple 
downstream clients. Transcription of the CRISPR loci (A) prompts Cas6 to align along the 
pre-crRNA, likely occluded from consecutive sites to release individual crRNAs in a stepped 
fashion (B).  The presence of a Cas6 dimer at a repeat site alone may be sufficient to prompt 
the assembly of aCASCADE components into correct architecture without necessarily 
cleavage occurring (Alternatively, Cas6 could join a preformed Cas7-crRNA filament) (Ci), 
though ultimately Cas6 leaves upon complete processing and/or installation of the crRNA 
within a correctly sized Cas5/7 backbone (Cii). Upon cleavage at flanking repeat sites, the 
excised crRNA in complex with Cas6 (Ciii), which retains a short-lived affinity via the 3’-
handle, may also induce the assembly of a Type-III (Cas10-based) complex or induce full 
assembly upon handover to a preassembled sub-complex (D).  Alternatively, CMR/CSM may 
scavenge previously released crRNA with no direct contact with Cas6 (E).  The successful 
incorporation of crRNA into these type III system clients and/or their full assembly is likely 
directed by the 5’ 8 nt tag, after which a non-specific exonuclease could be recruited to digest 
the crRNA 3’-handle left unprotected by the displaced Cas6. Ultimately, the transiently 
interacting Cas6 is not included as an integral component of any functional effector complex 
and upon crRNA release returns to its base state to perform additional cleavage cycles (Star) 
thus enabling the endonuclease to channel crRNA down multiple channels. 
4.4 Conclusions 
Within single-turnover systems, stoichiometric quantities of the Cas6 would be 
necessary for crRNA biogenesis and incorporation into effector complexes, although 
in systems with a higher number of loci and downstream crRNA recipient types, 
single-turnover mechanisms may become insufficient. A looser affiliation with 
downstream effector complexes (Hale et al., 2009; Lintner, Kerou, et al., 2011; 
Plagens et al., 2012; Zhang et al., 2012; Rouillon et al., 2013) likely allows Cas6 to 
participate in crRNA provision over multiple platforms, a necessity given that recent 
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bioinformatics analysis illustrates that many species encode multiple effector 
complexes but often only a single Cas6 gene copy (Vestergaard et al., 2014). 
However, this complexity is possibly tempered by the co-evolution between distinct 
sets of Cas genes and specific CRISPR loci as discussed next in Chapter 5. 
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Chapter 5: Investigating the role of 
ssoCas6 within the complex S. 
solfataricus CRISPR/Cas system 
5.1 Introduction 
5.1.1 CRISPR/Cas evolution 
Cas genes and the CRISPR clusters they serve display strong co-evolution (see 
Introduction, Grissa et al., 2007), and Cas6 is a good example of this trend. The 
stringent discrimination between substrate and other cellular RNAs suggests a close 
co-evolution between repeat sequences and cas6 genes (Kunin et al., 2007; Brouns 
et al., 2008; Carte et al., 2008; 2010; Haurwitz et al., 2010; Wang et al., 2011; 
Sashital et al., 2011; Gesner et al., 2011; Sternberg et al., 2012; Haurwitz et al., 
2012; Shao and Li, 2013; Reeks, Sokolowski, et al., 2013; Niewoehner et al., 2014).  
Repeat RNA is often diverged between species, both in sequence and the degree of 
secondary structure adopted (Godde and Bickerton, 2006; Kunin et al., 2007).  
Accordingly, pre-crRNA processing by a given Cas6 is generally highly specific to a 
cognate substrate repeat sequence, often combining extensive sequence- and 
shape- specific contacts to identify the correct substrate (Haurwitz et al., 2010; 
Sashital et al., 2011; Gesner et al., 2011; Wang et al., 2011; Haurwitz et al., 2012; 
Shao and Li, 2013; Niewoehner et al., 2014) 
 
For example, P. aeruginosa Cas6f is neither able to cleave the alternative stem-loop 
repeat sequences from S. thermophilus pre-cRNA nor interact with unrelated cellular 
RNA when expressed in E. coli (Haurwitz et al., 2010).  Moreover, Cas6e from E. coli 
K12 cannot cleave the differing repeat sequences from the E. coli strain, UTI89 
(Brouns et al., 2008).  In the archaeon H. volcanii, loss of cognate Type I-B 
associated Cas6 activity cannot be restored by substitution with Cas6 homologues 
from other archaeal Type I-B systems (Brendel et al., 2014).  The rate of evolution of 
RAMP proteins is particularly rapid (Makarova, Aravind, et al., 2011), and the 
subsequent divergence is exemplified by the wide array of mechanisms employed by 
characterised Cas6s (discussed Chapter 3 and 4, Carte et al., 2008; Haurwitz et al., 
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2010; Sashital et al., 2011; Wang et al., 2011; 2012; Sternberg et al., 2012; Haurwitz 
et al., 2012; Reeks, Sokolowski, et al., 2013; Shao and Li, 2013)). 
 
The interactions between Cas proteins that comprise a given system are equally 
susceptible to such forces of co-evolution (Makarova, Aravind, et al., 2011; Makarova, 
Haft, et al., 2011). Whilst the components of cas operons of Type I and III systems 
adopt characteristic arrangements (Figure 1.6), the homologues of Cas5, Cas7 and 
Cas6 that form the basis of each (Makarova, Aravind, et al., 2011; Makarova, Haft, et 
al., 2011) are able to generate effector complexes that are varied in structure, targets 
and mechanisms of activity (discussed in Chapter 1, Wiedenheft, van Duijn, et al., 
2011; Wiedenheft, Lander, et al., 2011; Lintner, Kerou, et al., 2011; Spilman et al., 
2013; Zhang et al., 2012; Rouillon et al., 2013).  Indeed it is this complex and 
dynamic nature of CRISPR/Cas evolution that makes it exceedingly difficult to 
establish a unified classification system (Makarova, Aravind, et al., 2011; Makarova, 
Haft, et al., 2011).  The presence of mature crRNA within Type-I and III effector 
complexes requires an active Cas6 (Brouns et al., 2008; Carte et al., 2008; Haurwitz 
et al., 2010; Jore et al., 2011; Wiedenheft, van Duijn, et al., 2011; Hatoum-Aslan et 
al., 2011; Lintner, Kerou, et al., 2011; Peng et al., 2013; Deng et al., 2013; Brendel et 
al., 2014) or a catalytic Cas5 in some cases, (Nam, Haitjema, et al., 2012).  However, 
outside of the clear downstream roles that Cas6e and Cas6f play within their 
respective CRISPR/Cas systems, the linking steps between crRNA generation and 
its acquisition by Type III and I-A systems remain largely undetermined as Cas6 itself 
is not an integral subunit (as discussed in Chapter 1 and Chapter 4).  Given the 
retention of product post pre-crRNA cleavage by Cas6 (Chapter 4, Carte et al., 2008; 
2010; Haurwitz et al., 2010; Sashital et al., 2011; Sternberg et al., 2012; Shao and Li, 
2013), the endonuclease may still play a regulatory role in the channelling and 
distribution of crRNA within such systems. 
5.1.2 The complex CRISPR/Cas makeup of the S. 
solfataricus P2 genome 
The S. solfataricus P2 genome contains the gene components for five known 
CRISPR effector complexes: three Type I-A (aCASCADE), at least one Type III-B 
(Cmr) and one Type III-A (Csm) systems (Figure 5.1A and 1.26, See Introduction 
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Section 1.13, She et al., 2001; Lintner, Kerou, et al., 2011; Zhang et al., 2012; 
Rouillon et al., 2013).   
 
 
 
Figure 5.1: CRISPR/Cas systems of S. solfataricus P2. (A) The S. solfataricus P2 genome 
contains over 400 spacers distributed amongst six CRISPR loci (A-F, black arrow clusters (1 
arrow = ~15 spacers)) (She et al., 2001; Lillestøl et al., 2009).  The CRISPR loci can be 
further classified based on repeat sequence into two main families: AB (Blue) and CD (Red).  
The repeat sequence for each family is illustrated adopting the stem loop conformation 
expected during Cas6 interaction (Chapter 3, Shao and Li, 2013) with the cleavage site 
indicated. A repeat-like sequence (ncRNA-precursor, yellow arrow) exists in an isolated 
stretch downstream of the CRISPR B locus (Wurtzel et al., 2010).  Over 50 cas genes are 
associated with the clusters, from which at least five effector complex operons spanning three 
system subtypes are identifiable; three type I-A (aCASCADE, cyan), one Type III-B (CMR, 
green) and at least one (Csm, magenta).  There are five Cas6 paralogues (white arrows, 
[gene number]) distributed across the CRISPR/Cas system. (B) A midpoint-rooted neighbour 
joining phylogram illustrates the classification of S. solfataricus Cas6 paralogues into three 
families; Cas6-1[1437, 2004], Cas6-2[1381, 1406] and Cas6-3[1422] (Sokolowski et al., 
2014).  Adapted from Sokolowski et al., 2014. 
 
Serving these systems with crRNA are up to five Cas6 paralogues which can be 
broadly classified into three types that between them share only 20-30% sequence 
identity (Figure 5.1B, Sokolowski et al., 2014): Cas6-1 - ssoCas6[1437, 2004], Cas6-
2 – ssoCas6[1381, 1406] and Cas6-3 – ssoCas6[1422].  Furthermore, there are 400 
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spacer sequences distributed amongst six distinct CRISPR loci, A-F (Figure 5.1A, 
Table 1.4, She et al., 2001; Lillestøl et al., 2009).  The CRISPR loci themselves can 
be categorised into two families based on repeat sequence: CD(EF)-type and AB-
type (Lillestøl et al., 2009; Sokolowski et al., 2014). The differences between repeat 
types are largely contained to the loop-forming region (i.e. recognition domain, Figure 
5.1A) and the 8 nt region that will ultimately comprise the 5’-tag of any excised crRNA 
remains identical in each.  CD-type repeats also include those of the 
‘decommissioned’ E and F loci (Figure 5.1, Lillestøl et al., 2009; Gudbergsdottir et al., 
2010) due to identical stem compositions and have similar cleavage kinetics to those 
of CD-type (Figure 3.8 and Section 3.2.2.2, Shao and Li, 2013).  A complex scenario 
thus presents itself in S. solfataricus, in which multiple effector complexes, Cas6 
paralogues and repeat-types co-exist with the potential for discrete relationships to 
form as a result of co-evolution. 
 
In this chapter Cas6-like activity is confirmed for the ssoCas6 paralogue [1422] and 
illustrate that alternative repeat-type preferences exist between Cas6-1 and Cas6-3 
subtypes.  Furthermore, biases in crRNA uptake by Csm correlating to Cas-3 activity 
may provide evidence that functional-coupling exists between ssoCas6 paralogues 
and effector complexes. 
5.2 Results 
5.2.1 Analysis of S. solfataricus Cas6-1 [1437] kinetics 
with alternative substrate sequences 
5.2.1.1 CD- and AB-type repeat RNAs are processed with different 
rates by ssoCas6 
Recombinant ssoCas6[1437] (hereafter ssoCas6-1) was assayed under single-
turnover conditions with AB-type repeat RNA as per Sections 3.2.3.5 (Chapter 3) and 
4.2.1.1 (Chapter 4).  Assays were performed complementary to Figure 3.14 and 
Figure 4.1 in K-glutamate (NR-2 Buffer) and NaCl (NR-3 Buffer) based buffers, 
respectively.  
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Under both buffer conditions the rate of ssoCas6-1 mediated processing of AB-type 
repeat RNA is substantially slower than that of CD-type repeat and could not be fitted 
to an exponential function (Figure 5.2).  Under the modified buffer conditions (NR-3 
Buffer), ssoCas6 displayed a >50-fold faster cleavage rate for CD-type (3.69 min-1,) 
than for the AB-type RNA substrate (~0.06 min-1, Figure 5.2A, approximate fitting of 
exponential function not shown).  Furthermore, despite an 8-fold change in the rate of 
CD processing generated by the buffer modification, there was little to no 
corresponding change to the rate of AB processing (Figure 5.2 B). 
5.2.1.2 Probing for substrate handling differences by ssoCas6  
Clues to the underlying cause for these activity differences may be gleaned by 
examining the two repeat sequences.  Li et al. 2013 illustrated that the CD-type RNA 
(specifically the F CRISPR loci sequence) is coordinated as a stem-loop structure 
within the binding pocket of ssoCas6-1 (discussed Chapter 3 Section 3.5.3, Figure 
5.3 A, Shao and Li, 2013).  SsoCas6-1 only contacts the penta-nucleotide loop 
through the extruded nucleotides, U11 and U13, in a base-independent manner in 
which L150, L49, Y50 stabilise the sugar-phosphate backbone regions of the 
identified nucleotides (Figure 5.3A, Shao and Li, 2013).  There is no contact with the 
rest of the loop and, as such, increasing the size of the unbound 5’ loop region had 
little effect upon cleavage.  Accordingly, Shao et al. suggested that both the size and 
composition of the loop might be unimportant to substrate recognition.  However, 
changes to 3’ region of the loop were not extensively tested (Shao and Li, 2013).  
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Figure 5.2: Repeat-type cleavage preferences of ssoCas6-1. 5’ 32P radiolabelled AB-type 
RNA was incubated with recombinant WT ssoCas6-1 under single-turnover conditions (500 
nM Cas6, ~1 nM RNA) at 60 ˚C.  Salt component of NR buffer (see Materials and Methods 
Section 2.3.2.1) was either k-glutamine (NR-2) or NaCl (NR-3). Products were separated on a 
denaturing polyacrylamide gel and phosphorimaged to allow quantification of bands.  Data 
points represent the means (± SEM) of triplicate assays.  Equivalent CD-type RNA cleavage 
data from Figures 3.14 and 4.2 is displayed for convenience.  Data is displayed with non-
logarithmic (0-30 min) (A) and logarithmic (0-100 min) (B) x-axes to emphasise the changes 
in both general activity profiles towards each substrate and with respect to buffer condition, 
respectively.  AB data was could not be accurately fitted to an exponential function. All Cas6 
concentrations refer to the monomeric unit. 
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Figure 5.3: Sequence differences between S. solfataricus repeat types may influence 
Cas6-1 interaction. (A) The Shao et al. structure and associated schematic illustrate the 
constrained hairpin adopted by CRISPR F repeat (CD-family) RNA within the active site 
pocket alongside residues K49, Y50 and K150 (pink ovals) which may interact with the sugar-
phosphate backbone of nucleotides U11 and U13 (adapted from (Shao and Li, 2013)).  As 
members of the CD repeat family, C/D and F sequences share a pyrimidine-rich loop domain 
and sequence identity within the 3’ region in contact with the enzyme (B) Equivalent stem-
loop conformation of A/B RNA sequence.  The higher purine content may affect loop structure 
and subsequent electrostatic and H-bonding interactions with the Cas6-1 active site.  The 
precise arrangements of AB RNA loop nucleotides is subsequently difficult to predict.  
Nucleotides A12 and A14 in AB RNA occupy the equivalent positions to U11 and U13 in the 
penta-nucleotide loop of CD RNA.  Cas6 cleavage point indicated (red arrow) and nucleotides 
are coloured by chemical nature (pyrimidine derivatives, white, purine derivatives, yellow). 
 
The loop region of the CD-family RNA is composed mainly of pyrimidine nucleotides 
(Figure 5.3A). As seen in Chapter 3, the ssoCas6-1 paralogues [1437 and 2004] 
appear to process F loci sequence with very similar kinetics to the CD RNA (Figure 
3.8 and discussed Section 3.2.2.2).  Although these sequences differ by two 
nucleotides within the loop region, only one is a pyrimidine-purine conversion and 
crucially the 3’ region remains identical.  In contrast, the same region in AB-type 
repeats primarily contains larger purine nucleotides (Figure 5.3B).  If AB-type RNA 
adopts a similar hairpin structure, the higher purine content would form a 
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comparatively ‘bulkier’ loop region than the pyrimidine-based loop of CD RNA (Figure 
5.3B). Accordingly, disrupted coordination of substrate within the ssoCas6-1 active 
site, due to electrostatic and H-bonding differences between the alternate stem-loop 
sequences, could impact the affinities and processing of these substrate families.  
The influence of shape-dependent recognition within the loop region may be more 
important to overall substrate recognition than previously appreciated. 
5.2.1.3 ssoCas6-1 binds CD and AB-type repeat RNA with 
different affinities 
In order to investigate potential differences in the coordination of alternative 
substrates by ssoCas6-1, the binding affinity to AB- and CD-type RNA were 
examined.  As per section 4.2.2.1 (Chapter 4), gel electrophoretic mobility shift 
assays (EMSAs) of recombinant ssoCas6-1 variants (WT, K28A and Monomeric) 
were incubated at a range of concentrations with 5’-32P radiolabelled AB-type repeat 
RNA at r/t (22-25 ˚C).  Unbound material was separated from protein/RNA complexes 
on a native polyacrylamide gel and resulting bands quantified from a phosphorimage.  
The extracted data was fitted to a standard binding isotherm to generate KD 
estimates.   
 
The binding affinity of WT Cas6-1 to AB-type repeat RNA (KD 236 nM, Figure 5.4) 
was considerably weaker than for CD-type RNA (11-16 nM, Figures 4.2 and 4.3).  No 
intermediate bands were observed in any variant condition (Figure 5.4A), in contrast 
to the CD-type substrate, which likely reflects the highly reduced ssoCas6-1 activity 
with AB-type RNA and possibly altered binding stoichiometries/arrangements.  The 
reduced binding of the K28A variant to AB-type repeat (KD 456 nM, Figure 5.4) 
indicates that the K28 residue maintains its role in the binding event and thus 
suggests that this alternative substrate sequence may still adopt a stem region within 
the active site pocket.  The highly reduced AB binding by the monomeric Cas6-1 is 
as expected and may be attributed to the loss of the additional surfaces at the dimer 
interface. 
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Figure 5.4: AB-type RNA gel shift activity of ssoCas6-1. (A) A range of ssoCas6-1 (WT, 
K28A and Monomeric variants) concentrations was incubated with 1 nM 5’ 32P radiolabelled 
AB-type repeat RNA, and protein/RNA complexes separated on a native polyacrylamide gel 
and phosphoimaged. The gels display no well-defined intermediate bands between the bound 
and unbound states of AB-type repeat RNA by ssoCas6-1. (B) Gel bands were quantified and 
data fitted to a standard binding isotherm (WT – solid red, K28A – yellow, Monomer – blue).  
Data for WT ssoCas6-1 binding to CD-type RNA from Figure 4.2 (Chapter 4) is shown 
alongside for illustrative purposes (red dashed line/hollow circles).  Reduced binding affinity is 
evident for AB-type RNA across ssoCas6-1 variants. All Cas6 concentrations refer to the 
monomeric unit.  
5.2.1.4 ssoCas6-1 induces different fluorescence quenching 
profiles for fluorescein-labelled AB- and CD-type repeats 
SsoCas6-1-induced fluorescence quenching of fluorescently-labelled CD-type repeat 
substrate allowed for an alternative method for KD estimation in the previous chapter 
(Figure 4.3).  The quenching profile of fluorescein-labelled AB-type RNA (5’-[FAM]) 
was thus similarly analysed.  As expected from the gel shift assays, WT ssoCas6-1 
affinity for AB-type substrate appears reduced compared to that of CD-type (Figure 
5.5).  However, the data lacked a clean sigmoidal profile and could not be fitted well 
to the 4-parameter sigmoidal model used previously (Section 4.2.2.1, Chapter 4).   
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Whilst CD-type substrates were quenched to ~30% initial fluorescence over the 
course of a ssoCas6-1 titration, the AB-type substrate retained >70% initial 
fluorescence.  Differing quenching profiles of AB- and CD-type fluorescently labelled 
substrates may reflect changes to the binding/substrate interaction mechanism.  
Alternatively, the simple movement of the fluorescein label one nucleotide further 
away from the base of the hairpin may be sufficient to reduce quenching during the 
binding event.    Unsurprisingly, the monomer maintained its inability to quench the 5’ 
fluorescein tagged substrate (Figure 5.5B) as also witnessed in witnessed for CD 
substrate (Figure 4.4, Chapter 4). 
 
 
 
Figure 5.5: Fluorescence quenching of fluorescein-labelled AB-type repeat RNA by 
ssoCas6-1. Aliquots of recombinant ssoCas6-1 (A) WT and K28A, (B) Monomer) were 
progressively added to 1 nM (A) or 10 nM (B) AB-type RNA (5’-[FAM]) and the fluorescence 
intensity between 500 – 560 nm monitored upon sample excitation at 480 nm.  Mean (+/-
SEM) from quadruplicate data is plotted. (A) The traces for ssoCas6-1 WT (red) and K28A 
(yellow) interaction with AB-type repeat are shown alongside WT interaction with CD-type 
repeat (dashed red/hollow circles, from Figure 4.8, KD = 14.13 nM), highlighting the 
divergence in quenching profiles between the two repeat types. (B) Fluorescence change in 
the monomeric ssoCas6-1 condition is linear.  
 
5.2.2 Assaying alternative S. solfataricus Cas6 paralogues 
The S. solfataricus P2 genome contains five cas6 gene paralogues, divided into three 
families (Cas6-1, Cas6-2 and Cas6-3, Figure 5.1), and two main classes of repeats 
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(CD/(EF)- and AB- type, Figures 5.1A and 5.3A).  The substrate preferences 
displayed by ssoCas6-1 (Figures 5.2, 5.4 and 5.5) suggests a co-evolution with the C 
and D CRISPR loci.  The remaining Cas6 paralogues may present alternative 
specificity profiles as a product of different co-evolutionary branches with other loci. 
 
Ideally, the association between CRISPR loci and the Cas6 paralogues would be 
probed with parallel assays in which each ssoCas6 paralogue is assayed against 
each repeat-type and their relative activities compared.  However, major solubility 
issues were encountered during E. coli overexpression of the majority of S. 
solfataricus Cas6 gene constructs attempted (Dr Shirley Graham, unpublished data). 
The decision to pursue the ssoCas6-1[1437] paralogue for kinetic analysis was 
based upon lack of crystallisation success with Cas6-1[2004], though it could be 
purified efficiently (Lintner, Kerou, et al., 2011).  Shao et al. were alternatively able to 
solve the crystal structure of Cas6-1[2004] (Shao and Li, 2013), which illustrates the 
difference that subtly different methodologies can make when handling these 
proteins.  Indeed, the group was even successful in assaying the Cas6-2 family 
member [1406] for nuclease activity (Shao and Li, 2013) whereas our lab found it to 
be particularly difficult to purify (Dr Shirley Graham, unpublished data). 
 
A Cas6-3[1422] construct with N-terminal MBP (Maltose binding protein) tag, was 
obtained by Dr Shirley Graham after exhaustive optimisation (Sokolowski et al., 
2014).  From E. coli overexpression, the sample was subjected to a single maltose-
affinity purification step prior to gel-filtration and concentration (Figure 5.6).  The MBP 
tag appears to undergo low levels of spontaneous separation from Cas6-3[1422], 
which appears to result in total loss of Cas6-3[1422] solubility (i.e. cleaved MBP 
present without corresponding Cas6-3[1422], Figure 5.6).  The major contaminants in 
all samples were MBP and the E. coli chaperone protein, GroEL indicative of 
problems associated with correct protein-folding (Ellis and van der Vies, 1991) of the 
Cas6-3[1422] component (Figure 5.6, Sokolowski et al., 2014).  The sample 
nonetheless contained sufficient quantities of soluble MBP-ssoCas6-3[1422] for 
simple qualitative assay.  The Cas6-3[1422] variant, K47A, was generated by Dr 
Graham in the same manner (Sokolowski et al., 2014). 
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Figure 5.6: Purification of MBP-tagged Cas6-3[1422]. Recombinant Cas6-3[1422] was 
overexpressed in E. coli as an MBP (Maltose binding protein) fusion construct and purified by 
a single-step maltose-affinity purification strategy. Samples were eluted over a maltose 
gradient and fraction contents (E - early peak, L – late peak) visualised by polyacrylamide gel 
electrophoresis.  Soluble target protein (72 kDa, white arrow) was obtained at sufficient 
quantity and purity levels for assay purposes.  Removal of the MPB tag (43 kDa, green arrow) 
resulted in loss of Cas6-3[1422] solubility (i.e. no reciprocal band (lacking MBP) component at 
29.5 kDa).  Co-purified with the target protein were substantial quantities of the E. coli 
chaperonin, GroEL (60 kDa, pink arrow).  An intact gel image has been truncated to display 
selected lanes.  
5.2.2.1 ssoCas6-3[1422] processes S. solfataricus CRISPR 
repeats with a different specificity profile to ssoCas6-1  
Due to its location adjacent to the B CRISPR cluster, it was predicted that Cas6-
3[1422] (hereafter ssoCas6-3) would have a preference for the AB-type repeat 
sequence (Figure 5.1A).  Accordingly, MBP-1422 was incubated with 32P-end-
labelled CD or AB RNA in 20 mM NaH2PO4/Na2HPO4 pH 7.5, 125 mM NaCl, 5 mM 
EDTA, 0.5 mM DTT, prior to phosphorimaging of products separated on a denaturing 
polyacrylamide gel (Figure 5.7).  To maximise the presence of the unstable protein 
within the assay volume (without excessive concentration steps), the protein 
component at stock concentration comprised 50% assay volume.  Whilst accurate 
concentration estimates for MBP-[1422] cannot be made for the sample (Figure 5.6), 
when utilised in this manner against 1 nM substrate the target protein is assumed to 
be operating at a concentration excess over substrate (i.e. single-turnover 
conditions).  To adjust for potential instability of the MBP tag at elevated 
temperatures, assays were conducted at a sub-optimal 45 ˚C. 
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Figure 5.7: MBP-Cas6-3 displays Cas6-like activity with alternative substrate specificity 
to Cas6-1. (A) MBP-Cas6-3 variants (WT and K47A) were incubated with 1-2.5 nM radio-
labelled CD/AB -type RNA at 45 ˚C, and products separated on a denaturing polyacrylamide 
gel prior to phosphorimaging.  Assays were conducted in 20 mM Na2HPO4/NaH2PO4 pH 7.5, 
125 mM NaCl, 5 mM EDTA, 0.5 mM DTT.   MBP-ssoCas6-3 possesses activity characteristic 
of a Cas6 enzyme, cleaving 8 nt from the 3’-end of substrate RNA.  The K47A mutation 
abolishes such cleavage activity. Marker (m) created by alkaline hydrolysis of respective RNA 
substrate.   
 
MBP-ssoCas6-3 displays activity towards both AB- and CD-type repeat sequences 
expected of a Cas6 enzyme - cleaving 8 nt from the 3’-end (Figure 5.7).  The Cas6-
3[1422] residue K47 represents an absolutely conserved lysine that is equivalent to 
the K51 within ssoCas6-1[1437].  Alanine substitution at the K47 position abolished 
substrate cleavage and confirmed that the activity witnessed was due to Cas6-3 
(Figure 5.7). Without quantification it is difficult to determine a definitive AB/CD-type 
preference for ssoCas6-3 from this assay.  However, the MBP-ssoCas6-3 activity 
towards each repeat appears comparable, in contrast to the clear bias displayed by 
the ssoCas6-1 control (Figure 5.7).  Furthermore, the Cas6-2 family member [1406] 
tested by Shao et al. appeared incapable of cleaving the CD-type (F) RNA, which 
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may represent total specificity for a single repeat type (i.e. AB-type) (Shao and Li, 
2013).  
5.2.3 Exploring the endogenous Cas6 activity within S. 
solfataricus P2 
5.2.3.1 Type III effector complexes display biases in crRNA uptake 
The RNA content of Type III S. solfataricus CRISPR effector complexes has 
previously been examined by next-generation sequencing (Zhang et al., 2012; 
Rouillon et al., 2013).  Each effector complex was purified from S. solfataricus P1 or 
P2 lysate and the RNA component extracted, cloned and deep-sequenced which 
generated 1.88 and 5.45 million reads for the CMR (P2) and CSM (P1) complexes, 
respectively (Zhang et al., 2012; Rouillon et al., 2013).  When indexed against the S. 
solfataricus genome, such data revealed strong biases in the origin of the crRNA 
targeted by each system (Figure 5.8A, Zhang et al., 2012; Rouillon et al., 2013).  
Sequences from the C and D loci constituted 96.6% of the RNA within the Type III-B 
CMR complex (Zhang et al., 2012).  Conversely, 89% of the total sequences 
detected in the Type III-A (CSM) complex were derived from the A and B CRISPR 
loci (Rouillon et al., 2013).  Neither complex possesses much crRNA from E and F 
loci which may be largely attributed to their status as defunct or inactive loci (Lillestøl 
et al., 2009; Gudbergsdottir et al., 2010; Zhang et al., 2012; Rouillon et al., 2013). 
 
A curious sequence of non-CRISPR origin is also present within the crRNA 
populations of CMR and CSM complexes (Zhang et al., 2012; Rouillon et al., 2013).  
This RNA was originally identified in an analysis of the S. solfataricus transcriptome 
and annotated ‘ncRNA-60’ (non-coding RNA) by Wurtzel et al. and is derived from a 
fortuitous repeat-like site that exists in isolation between the CRISPR B locus and 
Sso1421 (Figure 5.1A, She et al., 2001; Wurtzel et al., 2010).  
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Figure 5.8: crRNA uptake biases in the Type III effector complexes of S. solfataricus 
P2. (A) Histogram displaying the percentage of total crRNA corresponding to S. solfataricus 
P2 CRISPR loci A-F within purified CSM (green) and CMR (lilac) complexes as determined by 
next-generation sequencing (Zhang et al., 2012; Rouillon et al., 2013).  The data shows clear 
biases toward crRNA derived from A and B loci within the CSM complex (Rouillon et al., 
2013), and crRNA derived from C and D loci within the CMR complex (Zhang et al., 2012).  
(B) Sequences corresponding to CD- and AB-type repeats and ncRNA-60 precursor are 
displayed adopting the stem-loop structure expected during Cas6-1 interaction (Shao and Li, 
2013).  Whilst the ncRNA has no similar stem-forming sequence to CD- or AB-type repeats, 
the sequence nonetheless shares similarity within loop-region of AB-type repeats and 5’ tag-
forming region associated with all S. solfataricus crRNAs (ncRNA-precursor nucleotides 
shared by AB-type sequence coloured blue, Cas6 cleavage point indicated by black arrow). 
Adapted from (Sokolowski et al., 2014) (C) ncRNA is present at substantial levels within the 
CSM complex (1.5 % total reads, (Rouillon et al., 2013)) and is derived from a precursor 
sequence in an isolated genomic region between the CRISPR B loci and the S. solfataricus 
[1421] gene (She et al., 2001; Wurtzel et al., 2010).  Panel C adapted from unpublished White 
lab image.  
 
The ncRNA-60-precursor shares sequence similarity with the AB-type repeat, with 
strong identity across the loop-forming region (Figure 5.8B). However, ncRNA-
precursor RNA lacks two of the three base-pairs present in CD- or AB-type RNA 
(Figure 5.8B), including the ‘essential’ A-U pair at the base which is necessary to 
form the minimal stem required for Cas6-1 activity, and is thus unlikely to form a 
hairpin (Shao and Li, 2013).  Whilst its function remains unclear, this ncRNA-60-
precursor sequence undergoes processing of the transcribed region by a Cas6 to 
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generate product RNA with the necessary attributes for channelling to Type-III 
systems (Zhang et al., 2012; Rouillon et al., 2013).  The uptake of ncRNA also 
appeared biased, comprising 1.5% of the total RNA population of the CSM complex 
(Rouillon et al., 2013) whereas the figure was 20-fold lower within CMR (0.07%, 
Zhang et al., 2012).  
5.2.3.2 ncRNA60 is cleaved by Cas6-3 
Any uptake bias of crRNA may suggest functional coupling between the effector 
complex and a Cas6 with the corresponding repeat-type specificities.  The ability to 
cleave AB-type RNA efficiently potentially indicates that this crRNA is channelled to 
the CSM complex by Cas6-3, whose gene is co-located with the CSM operon and 
proximal to the CRISPR B locus (Figure 5.1A).  To investigate this possibility further, 
the activity of Cas6-1 and Cas6-3 with ncRNA60-precursor RNA was examined. 
 
Replicating the assay in Section 5.2.2.1, recombinant MBP-Cas6-3 variants (WT and 
K47A) and Cas6-1 were incubated with 1 nM synthetic ncRNA60-precursor 
sequence at 45 ˚C.  Products were separated on a 20% denaturing polyacrylamide 
gel and phosphorimaged.  The ncRNA60-precursor sequence was cleaved by WT 
Cas6-3 to generate the expected product (Figure 5.9A).  In contrast, there was no 
cleavage of the ncRNA sequence by Cas6-1 even after 60 min (Figure 5.9A).   
 
Together with the corresponding crRNA population biases, the ability to cleave 
ncRNA60-precursor, CD- and AB- type sequences efficiently (Figures 5.7 and 5.9A) 
would suggest a functional coupling between the CSM complex and Cas6-3.  The 
presence of ncRNA60 at low levels in the CMR complex may represent product 
release by Cas6-3, prior to association of CSM components, and subsequent 
scavenging from solution by the CMR effector complex. 
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Figure 5.9: Synthetic ncRNA precursor sequence is cleaved by Cas6-3[1422]. (A) 
Recombinant MBP-Cas6-3 variants (WT and K47A) and Cas6-1 were incubated under single-
turnover conditions against 1 nM ncRNA-precursor sequence at 45 ˚C.  Reaction products 
were separated on a denaturing polyacrylamide gel prior to phosphorimaging.  The target 
RNA was cleaved by WT MBP-Cas6-3 with no activity present for the inactived K47A variant.  
No cleavage activity occurred within the Cas6-1 condition.  Gel is a composite image utilising 
the marker lane (m) created by alkaline hydrolysis of AB-type RNA sequence from Figure 5.9.  
(B) 26 nt synthetic ncRNA-precursor sequence used in assay with Cas6-3 cleavage point 
indicated (black arrow).  Sequence displayed in an unstructured state.  
 
5.2.3.3 Multiple S. solfataricus Cas6 paralogues are expressed in 
vivo and are active 
Whilst five Cas6 gene paralogues exist within S. solfataricus P2 genome, it is 
unknown if they are all expressed or functional in vivo. To gain further insight, S. 
solfataricus P2 cell extracts were examined for Cas6 activity.  A volume 
(approximately ~5 g original biomass) was fractionated by size-exclusion 
chromatography.  Fractions encompassing the length of the sample elution profile 
(Figure 5.10A), as detected by UV absorbance, were incubated for 60 min at 60 ˚C 
with ~1 nM ncRNA60-precursor, CD- or AB- type RNA, the products of which were 
separated on a denaturing polyacrylamide gel and phosphorimaged (Figure 5.10B). 
 
Activity corresponding to CD-type crRNA biogenesis was detected as a single peak 
with a retention time centred on 160 ml (Figure 5.10).  Cleavage of AB-type RNA and 
ncRNA60-precursor were also detected in the extract but appeared comparatively 
weaker than for CD-type substrates and adopted a different distribution profile.  
Activity against AB-type and ncRNA60-precursor RNA was present as two peaks 
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spread over a larger elution volume than for equivalent CD-type repeat processing. 
The presence of ncRNA60-precursor processing may thus indicate the presence of 
Cas6-3 within the extract.  Furthermore, the AB and ncRNA60 peaks did not perfectly 
overlap.  A lack of CD-processing within the tail region of the 2nd AB peak (centred on 
~210 ml) may even represent the contribution from a Cas6-2 family member. Whilst 
the ability to generate ncRNA is possibly logical for Cas6-2 given the apparent 
specialisation for AB-type repeats by Cas6-2 [1406] (Shao and Li, 2013), the ncRNA-
precursor processing ability of the Cas6-2 family ([1381, 1406]) has yet to be tested.  
The ncRNA peak within this data does not appear to extend into this region of AB-
only processing and suggests the culprit endonuclease cannot cleave ncRNA-
precursor. However, the resolved bands for ncRNA are very weak and any such 
speculation is far from definitive. 
 
Independent peaks/profiles in CD- and AB- type repeat processing suggest that 
representatives from at least two SsoCas6 families are present within the extract.  To 
explore this possibility, assayed fractions (Figure 5.11B) were processed by SDS-
PAGE and subjected to Western-blotting with antibodies raised against recombinant 
ssoCas6-1 [1437] (Figure 5.11C).  Fluorophore-labelled secondary antibodies 
permitted visualisation of the target protein by fluorescence imaging.  The CD-type 
RNA activity peak coincided exclusively with Cas6-1 ([1437] or [2004]) presence.   
 
The data thus suggests that the predominant Cas6 activity within S. solfataricus P2 
extract belongs to Cas6-1, which possibly indicates higher expression levels of this 
Cas6 family.  However, given the instability of the majority of ssoCas6 paralogues in 
vitro, albeit as a product of overexpression in E. coli and so greater exposure to 
incorrect protein folding and lack of post-translational modifications, the relative 
levels of activity may not be truly representative of the in vivo expression/activity 
levels. Ideally, a wild-type S. solfataricus P2 extract would be prepared fresh for 
direct use in a Cas6 screen.  Prior subjection of the sample to ammonium sulphate 
precipitation and later resuspension may have removed some activity from the 
sample if any of the associated proteins have issues with correct re-folding (See 
Materials and Methods, Section 2.6.1, for details of lysate preparation).  From the 
data, only tentative guesses can be made as to precisely which of the five ssoCas6 
paralogues are present or to what relative degree; however, the fact that multiple 
ssoCas6 families are co-expressed and active within S. solfataricus P2 is clear. 
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Figure 5.10: Endogenous CRISPR-repeat processing activity within S. solfataricus. (A) 
Ammonium sulphate precipitation of S. solfataricus P2 lysate was resuspended and 
fractionated utilising size-exclusion chromatography (black trace).  (B) Identical fractions 
encompassing the lysate elution peak boundaries (white arrows) were assayed for RNA 
nuclease activity for 60 min at 60 ˚C against 1 nM ncRNA60-precursor, CD- or AB- type 
repeat RNA.  Purified recombinant WT ssoCas6-1 [1437] was used as a positive control (c).  
Products were separated on a denaturing polyacrylamide gel and phosphorimaged.   Specific 
cleavage at n-8 is indicative of Cas6-like activity.  Distinct regions of A/B- and C/D-type RNA 
processing activity are evident within the eluted sample, with Cas6-like activity encompassing 
a broad portion of the elution peak.  Whilst much weaker, ncRNA60-precursor processing 
appears to coincide largely with that of the AB-type repeat. 
5.2.3.3 ssoCas6 may associate with downstream effector 
complexes 
Curiously, all previous purifications of wild-type ssoCas6-1 showed the 65 kDa dimer 
to consistently elute a single tight peak centred on ~210 ml as seen in Chapter 3 
(Figure 3.5C).  Indeed, when recombinant Cas6-1 was passed through the same 
column under identical buffer conditions to the lysate sample, the expected single 
peak with ~210 ml retention time was observed (Figure 5.11A).  In contrast, the 
Cas6-like activity within the sample occurs over a broad swath of the early elution 
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profile (Figure 5.11B).  Such a shift in the apparent molecular size may correspond to 
variable Cas6-1 interactions with larger protein complexes.   
 
 
 
Figure 5.11: Cas6-1 is responsible for CD-type repeat processing in S. solfataricus P2 
extracts and co-purifies with aCASCADE components. (A) Fractionation of S. solfataricus 
P2 lysate (from Figure 5.10A, black trace). Purified recombinant ssoCas6-1 [1437] was 
independently subjected to size-exclusion chromatography using the identical gel-filtration 
column and buffer conditions (green trace).  (B) Distribution of Cas6-like product generation 
(n-8) from AB- (AB) and CD- type (CD) RNA within lysate elution profile boundaries (white 
arrows) alongside recombinant Cas6-1 [1437] control (c) (condensed gel images taken from 
Figure 5.10B).  (C) Fractions encompassing the CD-type RNA cleavage peaks (1 ! 2, panel 
B) were separately subjected to western blotting with antibodies raised against ssoCas6-1 
[1437] (Cas6-1), ssoCas5/7 [1441/1442] (aCASCADE) and ssoCMR [1986] (CMR). 
Fluorescently labelled secondary antibodies allowed resolution of targets by fluorescence 
imaging.  100 ng of the respective recombinant protein for the given condition was used as a 
positive control (c). Sizes in kDa are listed for the protein marker (m) used.  Cas6-1 and 
aCASCADE elution peaks coincide with the Cas6 activity against CD-type RNA within the S. 
solfataricus lysate. 
 
 
When fractions were probed for the presence of aCASCADE subunits by western 
blotting with antibodies raised against the Cas5-Cas7 core, the peak converged with 
that of Cas6-1.  This is consistent with transient interactions between Cas6, 
specifically ssoCas6-1 [1437], and aCASCADE previously seen by Lintner et al. (as 
discussed in Chapter 4, Lintner, Kerou, et al., 2011).  This peak position did not 
coincide with similar detection of Cmr7 presence, suggesting Cas6 does not form 
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strong interactions with Type III-B machineries as observed by other authors (Hale et 
al., 2009; Zhang et al., 2012).  Conversely, as the elution of Cmr7 occurs in parallel 
to AB-type repeat and ncRNA-precursor activity (Figures 5.11B and 5.10B) it is 
tempting to speculate that an association between CMR components and an 
alternative Cas6-family enzyme may exist (e.g. Cas6-3).  The extended peak of Cmr7 
elution is nonetheless consistent with an existence of the subunit as both a 
component of the CMR complex (larger than aCASCADE) and as an isolated dimer 
(Zhang et al., 2012).  An alternative explanation of the broad ssoCas6 elution pattern 
is simply the association of the endonuclease with variable lengths of substrate 
molecules (i.e. partially processed pre-crRNA), which may in turn also provide an 
assembly point for CASCADEs.    
5.3 Discussion 
Evidence for co-evolutionary relationships between cas genes and crRNA sequences 
is prevalent (Grissa et al., 2007) and underpins the strict target discrimination by 
Cas6s for their cognate substrate (Brouns et al., 2008; Carte et al., 2010; Haurwitz et 
al., 2010; Wang et al., 2011; Sashital et al., 2011; Gesner et al., 2011; Wang et al., 
2012; Haurwitz et al., 2012; Reeks, Naismith, et al., 2013; Shao and Li, 2013; 
Brendel et al., 2014; Niewoehner et al., 2014).  Where multiple Cas6 paralogues 
and/or CRISPR repeat families co-exist within a system, the rapid rate of RAMP 
evolution (Makarova, Haft, et al., 2011; Makarova, Aravind, et al., 2011) can drive 
diversity in both catalytic mechanisms and substrate specificities internally.  S. 
solfataricus offers a particularly complex melting pot for this to occur with six CRISPR 
loci and up to five effector complexes (I-A, III-A and III-B) that are catered for by five 
Cas6 paralogues (She et al., 2001; Lillestøl et al., 2009; Lintner, Kerou, et al., 2011; 
Zhang et al., 2012; Rouillon et al., 2013).  In this chapter we illustrated that the Cas6 
families of S. solfataricus are not uniform in their substrate preferences possibly as a 
result of mechanistic divergence.  Furthermore, we showed that Cas6s may also 
control how crRNA is channelled to specific systems. This has potential implications 
for the regulation of effector complex activity. 
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5.3.1 S. solfataricus Cas6s display co-evolution with 
substrates 
Cas6-1 displays a clear preference for the CD-type repeat over the AB-type (Figures 
5.2, 5.4 and 5.5).  The recognition/cleavage mechanism of Cas6-1 relies on inducing 
the substrate to adopt a hairpin conformation (as discussed in Chapter 3, (Shao and 
Li, 2013)), and so the coordination of alternate loop sizes/compositions by the active 
site may place restrictions on enzyme performance. 
 
Cas6 proteins can in some cases possess multiple complementary, but separate, 
substrate recognition mechanisms (Niewoehner et al., 2014).  In T. thermophilus 
ttCas6A, an additional recognition domain enables the coordination of the 
unstructured region of an otherwise structured repeat and works in parallel to the 
main active site (Niewoehner et al., 2014). This has also been suggested for 
ssoCas6-1 [1437, 2004] in which the dimer interface presents additional regions of 
positive charge which may have a similar effect (as discussed in Chapters 3 and 4, 
(Shao and Li, 2013)). The behaviour of Cas6-1 in both activity and binding towards 
the AB and CD-type substrates may reflect the mechanistic plasticity enabled by 
such a scenario, in which loop-size restrictions of the active-site could be 
circumvented by taking advantage of the redundancy offered by supplementary 
binding site(s). Conversely, apparent specialisation for AB-type substrates by the 
Cas6-2 family has removed the ability to process CD-type sequences (Shao and Li, 
2013). 
 
Whilst the inability of the ncRNA-60-precursor to form a hairpin may inhibit the 
catalytic mechanism adopted by Cas6-1, this lack of structure does not appear to 
affect Cas6-3 activity (Figure 5.9A).  Indeed, all three substrate types tested were 
processed with comparable efficiencies, which suggests Cas6-3 may adopt an 
entirely different model to substrate coordination and/or cleavage than Cas6-1.  In P. 
furiosus, substrate repeats are also wholly unstructured (and RNA is wrapped across 
the protein surface in a positively charged cleft (Kunin et al., 2007; Wang et al., 2011; 
2012).  Cas6-3 could implement a similar strategy, where specialisations to cater for 
substrate in an unstructured state allows for efficient cleavage irrespective of hairpin 
presence or loop-size/composition differences.  
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Therefore, in S. solfataricus, Cas6-1, Cas6-3 and Cas6-2 potentially employ 
alternative mechanisms resulting in differing levels of crossover activity between 
available repeat types.  A similar scenario exists in T. thermophilus, which contains 
11 loci of three repeat types (R1-3) and three Cas6 genes (ttCas6e, ttCas6A, 
ttCas6b) (Sashital et al., 2011; Gesner et al., 2011; Niewoehner et al., 2014), and 
whilst ttCas6A and ttCas6B both cleave R1 and R3 with comparable efficiencies 
(Niewoehner et al., 2014) neither can cleave the more dissimilar R2 substrate of 
ttCas6e destined for eCASCADE (Jore et al., 2011; Niewoehner et al., 2014).  
Furthermore, despite shared substrate preferences, similar kinetics and structural 
homology, the closely related ttCas6A and ttCas6B paralogues have different 
cleavage and substrate coordination mechanisms (Niewoehner et al., 2014). 
 
Realistically, the extent of Cas6 crossover activity between available substrate 
sequences will be limited by their level of divergence.  In Methanosarcina mazei, 
Cas6b paralogues have a similar activity towards the closely matched repeat 
sequences from either of the two CRISPR loci present (Nickel et al., 2013).  Similarly, 
the archaeon H. volcanii encodes a single Type I-B system with an associated Cas6 
that is able to processes crRNA from all three CRISPR loci that only deviate in repeat 
sequence by a single nucleotide (Fischer et al., 2012; Maier et al., 2012; 2013; 
Brendel et al., 2014).  Any further divergence of the repeats in this case may be 
restricted by the single Cas6 mechanism available to accommodate it.  In contrast, 
the activity of Cas6 paralogues in Synechocystis sp. PCC6803 is strictly partitioned, 
where crRNA generation occurs only from the CRISPR cassette with which their 
gene is associated (Scholz et al., 2013).  Substantial divergence between the repeat 
sequences involved would suggest that specialisation is the result of co-evolution 
between each endonuclease and its respective substrate (Scholz et al., 2013). 
5.3.2 Control of effector complex uptake of crRNA 
In the previous chapter, we discussed a possible disconnect between Cas6 and Type 
III effector complexes (Chapter 4).  However, the strong biases in the crRNA 
populations of both CSM and CMR complexes of S. solfataricus suggest functional 
coupling with Cas6 paralogues may indeed exist (Zhang et al., 2012; Rouillon et al., 
2013).  The crRNA population of Type III complexes tend to be trimmed at the 3’-
handle whereas the 5’ 8nt tag is preserved (Hale et al., 2008; 2009; Hatoum-Aslan et 
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al., 2011; Zhang et al., 2012; Hale et al., 2012; Scholz et al., 2013; Rouillon et al., 
2013; Hatoum-Aslan et al., 2013).  Strict preservation of the 5’-tag region in mature 
crRNA suggests an important downstream role(s) in Type III effector complex uptake 
and indeed its loss has been shown to prevent activity by the CMR complex (Hale et 
al., 2012; Zhang et al., 2012).   
 
In S. solfataricus, upon processing by Cas6, the 5’-tags of both AB and CD-type 
crRNAs are identical and thus lack any intrinsic identifiers to their origin (Figure 5.3).  
Therefore, direct handover by a Cas6 mediated through specific protein-protein 
interactions may allow the varied substrate preferences of a Cas6 family to project as  
biases in crRNA uptake by an associated effector complex.  For example, the CSM 
complex is biased for crRNA derived from AB loci and also contains a high level of 
the ncRNA-60 sequence (Rouillon et al., 2013).  Similarly, the ability of Cas6-3 to 
cleave both CD- and AB-type repeats efficiently (Figure 5.7), in addition to the 
ncRNA-60-precursor (Figure 5.9A), suggests such a functional coupling exists 
between Cas6-3 and the CSM complex. 
 
As discussed in Chapter 4, Cas6 may interact transiently with other Type I-A 
components upon the pre-crRNA transcript and, aided by a short-lived affinity for the 
3’ handle region of crRNA, to help guide the assembly of aCASCADE (Lintner, Kerou, 
et al., 2011).  Evidence is presented in this chapter that implies a similar scenario 
may also exist for Type III-A CASCADE assembly.  Whilst ncRNA-60 possesses a 
near-standard 8nt 5’ region, the RNA lacks a 3’-handle due to processing by Cas6 as 
an ‘isolated’ repeat sequence (i.e. not a product of excision from flanking repeats) 
and would be released to solution unaccompanied by Cas6.  The ncRNA-60 bias 
seen in CSM thus suggests that Cas6 initiates assembly of Type III complexes upon 
the pre-crRNA strand prior to the cleavage step (Figure 5.12).  Post pre-crRNA 
cleavage, Cas6-3 may be released upon product dissociation and/or trimming of the 
3’-handle recognition domain, which subsequently prevents further interactions by 
Cas6 and the installed crRNA (Figure 5.12). 
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Figure 5.12: Model for CSM complex assembly and uptake of AB-family crRNAs to the 
Type III-A system.  Two possibilities exist for interactions between bound Cas6 (dark blue 
spheres) and CSM components (light blue spheres). CSM components may associate with 
Cas6: (A) 3’ of the cleavage site upon pre-crRNA, utilising the soon-to-be 5’ tag sequence, or  
(B) 5’ of the cleavage site, before or after the pre-crRNA cleavage event.  Either scenario is 
valid for the existence of AB loci derived crRNAs in CSM resulting from specific protein-
protein interactions with Cas6-3.  Alternatively, as the 5’ tag sequence is common to all S 
solfataricus repeat-families, any downstream effector complex may incorporate free crRNAs 
without preference if released into solution by Cas6.  The biased uptake of ncRNA-60 by CSM 
is only feasible via interaction (A) (shown on right) as the lack of flanking repeat sequences 
would otherwise result in its immediate release into solution upon Cas6 cleavage. CRISPR 
derived spacer sequences (grey), ncRNA precursor sequence (green), repeat sequences 
(red).  Adapted from Sokolowski et al., 2014. 
 
Whilst the 5’-tag of crRNA may act as a passport for Type III system uptake and/or a 
scaffold for subunit assembly (Hale et al., 2012; Zhang et al., 2012; Staals et al., 
2013; Hale et al., 2009), involvement of a Cas6 may not be absolutely required.  
Indeed, ncRNA-60 is present within CMR at low levels (0.07%, (Zhang et al., 2012)), 
although these are below those expected from complete dissociation between pre-
crRNA processing and effector complex uptake of crRNA at random (~400 spacers in 
S. solfataricus P2 = 0.25 % expected representation of a single spacer based on 
random uptake alone). Thus, whilst the majority of crRNA may be preferentially 
channelled to the coupled effector complex, Type III effector complexes could also be 
able to scavenge any free crRNA released by Cas6 when association with the 
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relevant complex on partially processed pre-crRNA was not successful or fast 
enough.  
 
S. solfataricus also contains three Type I-A systems (She et al., 2001; Lintner, Kerou, 
et al., 2011), and whilst no large-scale, next-generation sequencing has been 
conducted for aCASCADE crRNA, a limited screen of 16 clones was nonetheless 
sufficient to illustrate that crRNAs of each CRISPR loci (CD, AB and EF) were 
represented in the S. solfataricus P2 complex (Lintner, Kerou, et al., 2011). The 
operon for the aCASCADE characterised in this particular study is flanked by the 
CRIPSPR C cassette and ssoCas6-1 [1437] gene.  The weakly associating Cas6 that 
co-purified with this aCASCADE complex was unsurprisingly identified as Cas6-1 
[1437], potentially indicating a further functional coupling given an ability to cleave all 
endogenous repeat types (Figures 5.2 and 3.8). 
 
It is tempting to speculate that genomic location of Cas6s in S. solfataricus may be 
an indicator of both substrate preference and coupling to any co-located system 
types.  Indeed, Cas6-3 [1422] is located adjacent to both Csm and the CRISPR B 
locus, with the AB-repeat specific Cas6-2[1406] gene residing at the opposite flank of 
the B locus.  Conversely, the CMR operon is located amidst CD-type Loci (Figure 
5.1B, She et al., 2001; Lillestøl et al., 2009).  However, the multiple loci in S. 
solfataricus likely represent a complex set of genome duplications, an event common 
in archaea, and which may limit such correlations (Lillestøl et al., 2009).  
 
The co-existence within a system of multiple effector complex types, of differing 
RNA/DNA-targeting abilities, possibly provides a more robust defence network.  
However, it is still largely unclear how the system is controlled to achieve maximum 
effect.  Bioinformatics analysis by Lillestol et al. suggests that different CRISPR 
groups in the sulfolobales target differing arrays of hostile genetic elements (Lillestøl 
et al., 2009).  In the newly acquired spacers within S. solfataricus P2, the D locus 
contains many bicaudaviral matches in contrast to the A and B loci that favour 
rudiviruses (Lillestøl et al., 2009).  More generally across the sulfolobales, the 
CRISPR group that includes the A and B loci of S. solfataricus P2 has a predilection 
for plasmid threats (Lillestøl et al., 2009).  Thus, functional coupling between Cas6 
and effector complexes possibly ensures delivery of tailored sets of crRNA and, 
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accordingly, indicates that each system type may be best utilised against different 
types of targets. 
5.4 Conclusions 
It is clear that RAMP evolution is flexible and diverse in nature and can proceed in a 
myriad of different ways, even alongside shared substrate(s).  In S. solfataricus, 
Cas6 activity in a multi-substrate environment may be tempered somewhat by co-
evolution with select repeat-types.  Coupling between Cas6 types and downstream 
system subtypes may limit the number platforms to which a single paralogue 
channels crRNA, but in turn directs greater focus to the immune response by relaying 
the biased spacer content of select CRISPR loci. 
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Chapter 6: Conclusions and Future 
Directions 
6.1 Introduction 
This thesis has described the characterisation of the CRISPR endonuclease, Cas6, 
from S. solfataricus P2. 
 
Chapter 3 illustrates that ssoCas6-1 [1437] is a bona fide member of the Cas6 family 
and exists in an unusual dimeric conformation.  Additionally ssoCas6 is active 
despite the lack of a conserved catalytic histidine identified in other characterised 
examples.  In Chapter 4, ssoCas6-1 [1437] is revealed as the first Cas6 
characterised with multiple-turnover kinetics.  Chapter 5 showed that multiple 
SsoCas6 paralogues are expressed and active in vivo that have different substrate 
preferences. 
 
Overall, this work showed that despite being structurally homologous and functionally 
analogous, members of the Cas6 family display diverse mechanisms for recognition 
and cleavage.  This is likely a product of rapid coevolution between substrate and 
enzyme, aided by the high degree of plasticity associated with RAMP superfamily 
members. 
6.2 ssoCas6 catalytic mechanism 
ssoCas6[1437] was confirmed as a catalytically active member of the Cas6 family.  
Whilst ssoCas6 retains the expected cleavage profile of this endonuclease family by 
cleaving target sequences in a metal-independent mechanism 8 nt from the 3’ end, it 
lacks the canonical active-site histidine identified in other characterised Cas6s, that 
participates at the heart of the catalytic cycle (Carte et al., 2008; 2010; Brouns et al., 
2008; Haurwitz et al., 2010; 2012; Sashital et al., 2011; Gesner et al., 2011). 
Although no single residue was shown to be absolutely critical to catalysis, four basic 
residues (K25, K28, K51, R231) were identified as contributors to the ssoCas6[1437] 
catalytic mechanism (Chapter 3, Sections 3.2.3.5 and 3.2.4.1).   
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This prediction was validated by the work of Shao et al., which showed Cas6 in 
complex with both substrate and product RNA and the arrangement of the four basic 
residues around the scissile phosphodiester bond (Shao and Li, 2013).  Whilst the 
precise catalytic mechanism has yet to be determined, these four basic residues 
appear to trap the scissile phosphate in the in-line conformation of the transition state 
(Shao and Li, 2013), where it becomes susceptible to spontaneous nucleophilic 
attack by the 2’ hydroxyl of the adjacent ribose (Reeks, Sokolowski, et al., 2013; 
Shao and Li, 2013).  Whilst K28 may function as a general acid to stabilise the 5’ 
leaving group oxygen through proton donation, the system appears to lack a general 
base to activate the otherwise weak 2’ hydroxyl nucleophile, which may limit the 
efficiency of the catalytic mechanism.  Although slow, the observed rate of cleavage 
is assumed to be sufficient to fulfil the crRNA role of ssoCas6 in vivo.  A slow rate of 
cleavage, compared to other metal-independent ribonucleases (Katoh et al., 1986), 
appears to be general feature across other characterised Cas6s and may reflect the 
trade-off of substrate specificity over speed (Carte et al., 2010; Sashital et al., 2011; 
Gesner et al., 2011; Wang et al., 2011; Haurwitz et al., 2012; Sternberg et al., 2012).  
As Cas6 regulates the flow of crRNA to downstream effector complexes that are 
highly efficient, strict substrate discrimination is essential to prevent the uptake of 
unrelated RNA transcripts that could otherwise lead to the targeting of chromosomal 
DNA by Type I and III-A systems. 
6.3 ssoCas6 exists as a dimer  
Unlike previously characterised Cas6s (Carte et al., 2008; Haurwitz et al., 2010; 
Sashital et al., 2011; Gesner et al., 2011), ssoCas6-1 adopts an unexpected dimeric 
conformation (Reeks, Sokolowski, et al., 2013; Shao and Li, 2013) that appears 
important to the activity of this enzyme (Chapter 3, Section 3.2.5).  The monomerised 
ssoCas6 was shown to be far less active than the wild-type dimer, despite being 
highly soluble and stable at assay temperatures.  Such an arrangement may thus 
contribute to localised stability of the active site, via some form of allosteric 
interaction, and/or provide additional surfaces to co-ordinate substrate RNA.  
 
The work in Chapter 4 illustrates that the binding affinity of ssoCas6-1 for isolated 
repeat sequences is severely affected by loss of the dimeric interaction.  This 
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supports what appears to be coordination of the 5’ region of the repeat sequence in a 
cleft formed by the dimer interface as seen in the co-crystal complex (Shao and Li, 
2013).  The large patches of basic charge that extend across the dimer interface may 
also have a role in the coordination of longer pre-crRNA transcript molecules.  
 
Evidence is presented that suggests ssoCas6 processes the long pre-crRNA 
transcript in a step-wise fashion, whereby presence of the endonuclease at a repeat 
site blocks access to any adjacent sites until product release has occurred.  
However, the current assay was limited in the resolution necessary to analyse such 
behaviour in detail.  The intriguing possibility also remains that an ssoCas6 dimer 
could simultaneously coordinate consecutive repeat sites, and excise a crRNA in one 
co-ordinated cleavage event.  Even if such an activity is possible, the biological 
benefit is unclear. 
6.4 ssoCas6 displays multi-turnover activity 
Cas6e and Cas6f are strictly single-turnover enzymes that remain tightly bound to the 
upstream cleavage product with affinities in the sub nanomolar ranges (Sashital et al., 
2011; Sternberg et al., 2012; Niewoehner et al., 2014).  These Cas6-crRNA 
complexes subsequently comprise an essential subunit of the downstream Type I-E 
and I-F Cascade CASCADEs, respectively.  In contrast, Cas6 is not present as a 
permanent subunit of the equivalent Type I-A Cascade complex, displaying only 
transitory associations (Lintner, Kerou, et al., 2011), and does not associate with 
Types III-A or III-B complexes (Hale et al., 2009; Zhang et al., 2012; Rouillon et al., 
2013; Staals et al., 2013).  In Chapter 4, ssoCas6-1 was shown to be capable of 
multiple-turnover kinetics.  Whilst the ssoCas6 also has affinity for cleavage product 
RNA, the higher KDs involved (in the ~10 nM range) permit the enzyme to release 
product RNA and engage in addition catalytic cycles.  Indeed, the overall rate does 
not appear to be significantly limited by product release.  Without a role as a 
structural unit of downstream effector complexes, there is the opportunity for this 
ssoCas6 to serve multiple downstream clients. 
 
However, as was seen in Chapter 5, some element of regulation in crRNA delivery 
nonetheless exists. Type III-A and III-B effector complexes isolated from S. 
solfataricus strains display distinctive biases in the CRISPR loci origin of the spacer 
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populations present (Zhang et al., 2012; Rouillon et al., 2013).  Type III complexes 
rely on the 5’ tag for crRNA uptake, however this 8 nt sequence is identical across all 
repeat families found in S. solfataricus.  Such uptake biases may thus be a product of 
discrete relationships between effector complexes and ssoCas6 paralogue families, 
where control of crRNA uptake operates at the ssoCas6 substrate preference level.   
6.5 Substrate specificity of ssoCas6 
SsoCas6-1 [1437] was shown to preferentially bind and cleave CD family repeat 
sequences over the AB type (Chapter 5).  However, an additional ssoCas6-3 
paralogue, [1422], also shown to be an active Cas6, displayed a different substrate 
specificity profile and showed no clear bias between AB and CD RNA.  Interestingly, 
only ssoCas6-3 also cleaved a non-CRISPR derived RNA (ncRNA-60, (Wurtzel et al., 
2010)), containing a fortuitous repeat-like sequence similar to that of AB, whose 
Cas6-processing products are found at a higher than expected ratio within CSM 
complexes alongside AB-like sequences (Rouillon et al., 2013).  This thus suggests a 
functional coupling between Cas6-3 and the CSM complex.  The lack of a 3’ handle 
element within the processed ncRNA-60 sequence suggests that CSM components 
must associate with Cas6-3, mediated through protein-protein interactions, on the 
unprocessed pre-crRNA transcript (Chapter 5, Figure 5.12). 
 
The basis for discrimination between repeat families by Cas6-1 has not been 
precisely determined though likely relies on shape-dependent recognition of 
sequences focused at the loop-forming region of the adopted hairpin conformation.  
Future studies could probe key residues in contact with these loop regions, identified 
in the Shao et al. structure (Shao and Li, 2013), with SDM and binding studies.  
Additionally, as Cas6-1 was not able to cleave the ncRNA sequence, Cas6-3 may 
use a fundamentally different approach to the cleavage mechanism and/or substrate 
coordination, making Cas6-3 an obvious candidate for further investigation via 
crystallisation and SDM experiments, providing issues concerning protein stability 
during protein purification can be overcome. Finally, little characterisation of 
members of the remaining ssoCas6 family, Cas6-2, has so far been carried out. 
Although Shao et al. show that Cas6-2 does not cleave CD family RNA (Shao and Li, 
2013), our lab had difficulty purifying soluble Cas6-2.  The variations in substrate 
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preference between members of the Cas6 family are likely indicative of mechanistic 
divergence as a result of co-evolution of substrate and enzyme. 
6.6 Future Directions 
Whilst the individual components of the CRISPR/Cas pathway have been extensively 
studied in isolation in vitro, the ultimate goal is to reconstitute the entire CRISPR 
biogenesis pathway to better understand activity of components in context of one 
another.  One application of this would be to study how Type I-A and III complexes 
assemble as a role for Cas6 is hinted at (Lintner, Kerou, et al., 2011; Sokolowski et 
al., 2014), despite its lack of association with and/or presence as an integral subunit 
of the associated complexes (Lintner, Kerou, et al., 2011; Zhang et al., 2012; 
Plagens et al., 2012; Hale et al., 2009; Rouillon et al., 2013; Staals et al., 2013; 
Plagens et al., 2014).  The work in Chapter 5 suggests that at least for the CSM 
complex, the pre-crRNA processing intermediate is used as a scaffold for assembly 
when initialised by the binding of a Cas6 upstream.  The expression of CASCADE 
components affects the crRNA levels within the cell, likely through the protection of 
the Cas6 generated product from degradation, and a synergistic interaction with 
Cas6 may even guide Type III crRNA maturation events (Peng et al., 2013; Deng et 
al., 2013). 
 
It is presently unknown whether loss of the 3’-handle has any intrinsic value to the 
Type III mechanism or if it is simply a by-product of CSM/CMR architecture that 
exposes crRNA lengths to host nuclease degradation (Hatoum-Aslan et al., 2013).  
The nuclease responsible for this step of the crRNA biogenesis pathway is presently 
unknown (Hatoum-Aslan et al., 2011; 2013).  Whilst it was hoped that the activity of 
this protein would be identifiable in the lysate nuclease assays (Section 5.2.3.3), only 
Cas6-like cleavage was observed.  The nature of the lysate preparation may have led 
to some proteins being lost, and future experiments would ideally use fresh 
preparations of the S. solfataricus cell extracts.  
 
Dissecting the pathway in this manner would allow for the determination of the 
minimum components necessary to elicit the RNA-targeting Type III-B response.  
The progression of such understanding could be the development of a plasmid 
containing the relevant components alongside an artificial CRISPR array.  Delivery of 
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such a system could allow RNA knockdown experiments to be conducted in 
prokaryotic organisms for the first time.  The DNA targeting ability of Types I, II and 
III-A also have application for genome editing and/or scientific tools in the form of 
programmable DNases, for which the single-protein package (Cas9) of the Type II 
system is especially attractive. 
 
Understanding the activity of Cas6 and its central role in Type I and III crRNA 
biogenesis is thus critical for any such applications, as well as to our general 
understanding of CRISPR/Cas systems. 
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